Development, characterization and transcriptional profiling of a mouse model of fatal infectious diarrhea and colitis by Borenshtein, Diana
Development, Characterization and Transcriptional Profiling of a 
Mouse Model of Fatal Infectious Diarrhea and Colitis. 
 
 
by 
 
Diana Borenshtein 
 
M.Sc. Nutritional Sciences, 1999 
B.Sc. Nutritional Sciences, 1995 
The Hebrew University of Jerusalem, Israel 
 
SUBMITTED TO THE DEPARTMENT OF BIOLOGICAL ENGINEERING IN PARTIAL 
FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF 
 
DOCTOR OF PHILOSOPHY IN MOLECULAR AND SYSTEMS TOXICOLOGY 
 
at the 
 
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 
February 2007 
 
© 2007 Massachusetts Institute of Technology. All rights reserved 
 
 
 
 
Signature of Author      
 Biological Engineering Division 
December 1, 2006
 
 
 
Certified by  
 David B. Schauer 
Professor of Biological Engineering 
Thesis Supervisor
 
 
Accepted by  
 Ram Sasisekharan 
Professor of Biological Engineering 
Chairman, Committee for Graduate Students
 
 
 
 2
This doctoral thesis has been examined by a committee of the department of Biological 
Engineering as follows: 
 
 
 
 
Certified by  
 Professor James G. Fox, MIT
Chairman
 
 
 
Certified by  
 Professor James L. Sherley, MIT
 
 
 
 
Certified by  
 Professor Eric J. Rubin, Harvard School of Public Health
 
 
 3
 4
Development, Characterization and Transcriptional Profiling of a 
Mouse Model of Fatal Infectious Diarrhea and Colitis 
by 
Diana Borenshtein 
 
Submitted to the Biological Engineering Division on December 1, 2006 
in Partial Fulfillment of the Requirements 
 for the Degree of Doctor of Philosophy in Molecular and Systems Toxicology 
 
Abstract 
 
Citrobacter rodentium is a naturally occurring murine bacterial pathogen which is used to 
model human diarrheagenic E. coli (EPEC and EHEC) infections in mice. C. rodentium causes 
colonic hyperplasia and a variable degree of colitis and mortality in the majority of inbred and 
outbred lines of mice. Differences in C. rodentium-induced disease are determined by the genetic 
background of the host. 
Here, C. rodentium infection in resistant outbred Swiss Webster (SW) mice was 
compared with infection in the cognate inbred FVB strain for the first time. In contrast to 
subclinical infection in SW mice, adult FVB mice developed overt disease with significant 
weight loss, severe colitis, and over 75% mortality. Fluid therapy intervention completely 
prevented mortality in FVB mice, and expression of pro-inflammatory and immunomodulatory 
genes in the colon was similar in both lines of mice, suggesting that mortality in C. rodentium-
infected FVB mice is due to hypovolemia resulting from severe dehydration. 
To identify host factors responsible for the development of mortality, gene expression in 
the distal colon of FVB and SW mice was investigated using a whole mouse genome Affymetrix 
array. Transcripts represented by 1,547 probe sets (3.4%) were differentially expressed between 
FVB and SW mice prior to infection and at 4 and 9 days post-inoculation. Data analysis 
suggested that intestinal ion disturbances rather than immune-related processes are responsible 
for susceptibility in C. rodentium-infected FVB mice. Marked impairment in intestinal ion 
homeostasis predicted by microarray analysis was confirmed by quantitative RT-PCR and serum 
electrolyte measurements that showed hypochloremia and hyponatremia in susceptible FVB 
mice. 
C. rodentium infection was next characterized in additional inbred strains of Swiss origin. 
SWR and SJL mice developed minimal morbidity and no mortality in response to the pathogen, 
demonstrating resistance to disease. Furthermore, C3H mice developed severe diarrhea and gene 
expression changes comparable to those in infected FVB mice, suggesting common pathogenic 
mechanisms in susceptible strains.  
In conclusion, C. rodentium infection in FVB mice is a useful model for fatal infectious 
diarrhea. These studies contribute to our understanding of C. rodentium pathogenesis and 
identify possible candidates for susceptibility to fatal enteric bacterial infection. 
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Chapter 1:  Introduction 
 
  
 
 Citrobacter rodentium (C. rodentium) is a naturally occurring bacterial pathogen of 
laboratory mice. It is a murine homolog of enteropathogenic Escherichia coli (E. coli) and 
enterohemorrhagic E. coli (EPEC and EHEC, respectively), and hence is highly useful in 
modeling these human infections in mice. In addition, this organism elicits signal transduction 
events in host that lead to cell cytoskeletal rearrangements, changes in epithelial proliferative 
capacity and inflammatory responses of the host. Therefore, studies evolving C. rodentium are 
indispensable for elucidating the mechanisms of host-pathogen interactions, inflammation and 
tumor promotion. Below, I discuss recent advances in C. rodentium infection research [reviewed 
in details in Luperchio and Schauer, 2001 and Mundy et al., 2005]. 
 
C. rodentium causes transmissible murine colonic hyperplasia 
 C. rodentium encompasses all of the isolates previously designated as atypical C. 
freundii, C. freundii biotype 4280, and mouse pathogenic E. coli (MPEC) [Luperchio and 
Schauer, 2001]. This organism was originally isolated in the 1960-1970s during outbreaks of 
diarrhea and rectal prolapse in mouse colonies in the United States and Japan [Barthold et al., 
1976; Brennan et al., 1965; Ediger et al., 1974; Itoh et al., 1978; Muto et al., 1969; Nakagawa et 
al., 1969; Silverman et al., 1979]. The disease caused by C. rodentium is primarily characterized 
by epithelial cell hyperproliferation and, hence, named transmissible murine colonic hyperplasia 
(TMCH). The degree of inflammation is variable in mice of different ages, strains, and 
microbiota, and therefore is not considered a main feature of the disease (Luperchio and Schauer, 
2001]. Infection in most adult mice is self-limiting and accompanied by little or no clinical signs 
and minimal mortality. In contrast, suckling mice and substrains of C3H mice are more 
susceptible and develop severe morbidity and high mortality rate [Barthold et al., 1976; Barthold 
et al., 1977; Barthold et al., 1978; Barthold, 1980; Muto et al., 1969; Nakagawa et al., 1969]. 
Clinical signs usually include retarded growth, diarrhea, dehydration, coat ruffling, hunched 
posture, reluctance to move, recumbency, and in some cases rectal prolapse (Figure 1-1). A 
 15
detailed description of the progression of infection is summarized in [Luperchio and Schauer, 
2001]. 
 
C. rodentium infection as a model for proliferative bowel disease 
 The ability of the pathogen to induce hyperplasia in the distal colon can be explained by 
alterations in cell kinetics of colonic epithelium of infected mice. C. rodentium-infected animals 
demonstrate expansion of the proliferative zone and 2- to 4-fold increase in labeling index in 
distal colon, which are similar to alterations observed in idiopathic inflammatory bowel diseases 
(IBD) [Barthold, 1979; Barthold and Beck, 1980; Barthold et al., 1977; Barthold et al., 1978]. 
Moreover, colon tumorigenesis is promoted in DMH-treated animals or ApcMin/+ mice infected 
with C. rodentium [Barthold and Beck, 1980; Barthold and Jonas, 1977; Newman et al., 2001]. 
In addition, alterations in β-catenin pathway [Sellin et al., 2001] and increased mutation rate 
[Sohn, 2005] are observed in infected mice. Therefore, C. rodentium infection can serve as a 
good model for human diseases with predisposition to colorectal cancers, such as IBD [Bernstein 
et al., 2001; Riddel et al., 1983; Rutter et al., 2004]. 
 
C. rodentium as a model for human attaching and effacing pathogenic E. coli 
 The new era in TMCH research started with the discovery of attaching and effacing (A/E) 
lesions in the distal colon of infected mice and responsible virulence factors [Schauer and 
Falkow, 1993a; Schauer and Falkow, 1993b]. A/E lesions are characterized by intimate 
attachment of bacteria to the host epithelium, effacement of microvilli and production of 
pedestal-like structures beneath the adherent bacteria (Figure 1-2, panels A-C) [Frankel et al., 
1998; Nataro and Kaper, 1998; Schauer and Falkow, 1993a; Schauer and Falkow, 1993b]. This 
ascribed C. rodentium to the family of diarrheagenic A/E bacterial pathogens comprised of 
EPEC, an important cause of infant diarrhea in developing countries, EHEC, which causes 
hemorrhagic colitis, hemolytic uremic syndrome and outbreaks of food- and water-borne disease, 
as well as the rabbit enteropathogenic E. coli (REPEC) [Nataro and Kaper, 1998; Vallance and 
Finlay, 2000]. Since EPEC and EHEC do not readily infect laboratory mice [Frankel et al., 1996; 
Klapproth et al., 2005; Mundy et al., 2006], studies with C. rodentium in mice are highly 
valuable for elucidating the mechanisms of human EPEC and EHEC infections. E. coli in 
rabbits, pigs and cattle can produce similar diseases, but the cost of these studies, as well as the 
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limited genetic and immunological reagents available for these animals constrain the use of these 
host species [Vallance and Finlay, 2000]. In this respect, C. rodentium offers an advantage as a 
murine pathogen, providing a relevant and practical animal model with a wide array of available 
reagents, including antibodies, recombinant cytokines, and gene knockout strains. 
 
Virulence factors in A/E pathogenesis 
 Development of A/E lesions depends on a type III secretion system apparatus (TTSS), a 
common virulence mechanism for many human and plant pathogens [reviewed in Frankel et al., 
1998; Garmendia et al., 2005]. TTSS allows translocation of bacterial effector proteins into host 
epithelial cells, altering signaling processes (Figure 1-2D, Table 1-1). The TTSS is encoded by 
the locus of enterocyte effacement (LEE), which is shared by all A/E pathogens and contains all 
of the genes necessary for A/E lesion formation and intimate attachment [Deng et al., 2001; 
Deng et al., 2004; Frankel et al., 1998; Luperchio et al., 2000; Nataro and Kaper, 1998]. This 
includes the main structural components of the bacterial TTSS, such as EspA, EspB, and EspD; 
the outer membrane adhesin intimin and its translocated intimin receptor (Tir), effector proteins, 
including EspB, EspF, Map and others, as well as transcriptional regulators, and other 
polypeptides of currently unknown functions (Figure 1-2E, Table 1-1) [Deng et al., 2001; Deng 
et al., 2003; Deng et al., 2004; Garmendia et al., 2005; Newman et al., 1999; Schauer and 
Falkow, 1993b]. A number of non-LEE-encoded (Nle) proteins were recently identified as 
potential effectors, of which NleA and NleB were defined as important virulence determinants 
[Deng et al., 2004; Gruenheid et al., 2004; Kelly et al., 2006]. In addition, all A/E pathogens 
including C. rodentium have been shown to suppress in vitro host immune responses via a novel 
toxin lymphostatin, alternatively known as EHEC factor for adherence, which is encoded by 
lifA/efa1 gene outside of LEE [Klapproth et al., 2000; Malstrom and James, 1998]. In vivo 
analysis of lifA/efa1 mutants suggests the possible role of lymphostatin in bacterial colonization, 
clinical manifestation of disease, epithelial cell proliferation and colonic inflammation 
[Klapproth et al., 2005]. Signature-tagged transposon mutagenesis and proteomic analysis were 
performed to identify C. rodentium-specific virulence factor(s). Homologs of NleG effector 
protein, previously found in C. rodentium proteome only [Deng et al., 2004], were recently 
discovered in EPEC and EHEC as well [Tobe et al., 2006]. The cfc (colonization factor 
Citrobacter) encodes for the CFC type IV pilus and is the only C. rodentium-specific gene 
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known for today [Mundy et al., 2003]. CFC was suggested to play a role in colonization, 
infection, transmission or host specificity. Although the gene is absent from EHEC, its product 
shares identity to proteins of the type IV COF pilus of enterotoxigenic E. coli (ETEC), the toxin 
co-regulated pilus (TCP) of Vibrio cholerae and the bundle-forming pilus (BFP) of EPEC 
[Mundy et al. 2003], demonstrating again high conservation of virulence determinants among 
diarrheagenic pathogens.  
 
C. rodentium and host defense 
 The advances in genome manipulations allowed production of various knockout/ 
transgenic mouse strains that facilitated research in immune-related aspects of C. rodentium 
infection (summarized in Table 1-2) [reviewed in MacDonald et al., 2003; Mundy et al., 2005]. 
In wild-type animals, the bacteria colonize the colon reaching ~109 CFU/g tissue around 7-14 
days post-infection (DPI). The infection is cleared by about 3-4 weeks thereafter [Luperchio and 
Schauer, 2001; MacDonald et al., 2003]. Mice that recover from infection are generally resistant 
to rechallenge with the pathogen [Ghaem-Maghami et al., 2001; Maaser et al., 2004]. CD4+ T 
cells, B cells, and IgG, but not secretory IgA or IgM, are critical for the protection against this 
infection [Bry et al., 2006; Bry and Brenner, 2004; ; Maaser et al., 2004; MacDonald et al., 2003; 
Simmons et al., 2003; Vallance et al., 2002b]. Innate immunity is also vital, as mast cell-
deficient animals develop septicemia and rapidly succumb in response to C. rodentium [Wei et 
al., 2005]. This effect is not mediated by murine cathelicidin-related antimicrobial peptide 
expressed by mast cells because Cnlp-knockout mice are comparable to their wild-type 
counterparts [Iimura et al., 2005]. In contrast to mast cell-deficient mice, animals lacking TNF-
α, IFN-γ, iNOS and IL-12 signaling usually clear the infection from colon and extra-intestinal 
tissues [Bry et al., 2006; Goncalves et al., 2001; Simmons et al., 2002; Vallance et al., 2002a], 
indicating that these components of the innate immunity are not required for survival, though 
important for development of clinical signs and colonic lesions. The Th1 response elicited by the 
pathogen as well as changes in cell kinetics, which are comparable to those seen in colitis 
patients, make C. rodentium infection an attractive animal model for studying the mechanisms of 
IBD. 
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C. rodentium as a model for diarrhea 
 Acute infectious diarrhea is one of the most common causes of death worldwide, mainly 
affecting children in developing countries [Kosek et al., 2003; Lopez et al., 2006; WHO, 1999]. 
Diarrhea may result in rapid dehydration, decreased circulating plasma volume, increased blood 
viscosity and development of hypovolemic shock [Guyton, 1991; Mello et al., 2004]. Blood 
losses of more than 10% diminish cardiac output and pressure, which stimulates sympathetic 
vasoconstrictor system throughout the body in order to prevent deterioration of the circulation.  
These compensatory mechanisms make tissues more susceptible to local ischemia and may fail 
when volume loss is higher than 25%. Eventually, systemic activation of inflammatory cascade 
when volume losses exceed 40% results in irreversible multiple organ failure and death [Guyton, 
1991; Mello et al., 2004]. With the exception of intestinal pathogens that possess enterotoxins, 
the mechanisms responsible for intestinal dysfunction during infections with many bacteria 
remain largely unestablished. Mice are generally considered inappropriate for studying watery 
diarrhea induced by many human pathogens. Thus, EPEC, EHEC, enterotoxigenic E. coli 
(ETEC), Vibrio cholera, Campylobacter jejuni, Shigella and Salmonella spp., as well as 
rotavirus, either fail to efficiently colonize mice or rarely cause appreciable diarrhea, unless 
young mice (newborn and suckling) or manipulated mice (fasted, germ-free, pretreated with 
antibiotics, iron, and acidity reducing agents) are used [Allen et al., 2006; Baqar et al., 2000; 
Frankel et al., 1996; Klapproth et al., 2005; Kordasti et al., 2006; Mundy et al., 2006; Okuda et 
al., 1997; Santos et al., 2003; Shimamura  et al., 1981; Singer and Sansonetti, 2004; Zhang et al., 
2003]. Therefore, exploring the pathogenesis of acute diarrheal illness is complicated due to lack 
of suitable small animal model. 
 Although initial outbreaks of C. rodentium were associated with diarrhea-like symptoms 
[Barthold et al., 1976; Brennan et al., 1965; Ediger et al., 1974; Itoh et al., 1978; Muto et al., 
1969; Nakagawa et al., 1969; Silverman et al., 1979], studies elucidating the pathogenesis of this 
microorganism for many years have focused on signal transduction and host immune responses. 
Only recently, modeling of diarrhea using C. rodentium-infected mice have received greater 
attention. The mechanisms of diarrhea development in TMCH, as well as in infection with 
pathogenic E. coli, are not clear. The working hypothesis for EPEC and EHEC infections 
[Vallance and Finlay, 2000; Garmendia et al., 2005] consists of loss of absorptive epithelium, 
alterations in tight junction integrity, changes in ion transport, especially of chloride and 
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bicarbonate, and increased permeability and tissue damage as a consequence of the inflammatory 
response (Figure 1-3). Similarly, disruption of tight junctions is found in C. rodentium-infected 
mice. The effect does not depend on the inflammatory status of the host and is mediated by EspF 
and Map effector proteins [Guttman et al., 2006a; Guttman et al., 2006b; Ma et al., 2006]. Recent 
results from the same lab indicate involvement of water channels, aquaporins, in C. rodentium-
induced pathogenesis [Guttman et al., 2007]. In addition, interaction of bacterial effector Map 
with host Na+/H+ exchanger regulatory factor 1 (NHERF1), responsible for regulation of ion 
channels in the intestine [Simpson et al., 2006], further implicates C. rodentium-induced 
transport changes in the development of diarrhea in infected animals. Considering the severe 
consequences of diarrhea, C. rodentium-infected mice may serve as indispensable model for this 
life-threatening condition. 
 
Factors affecting disease outcome 
 C. rodentium infection is influenced by age, diet, genetic background and microbiota 
status, but not by gender. Thus, the disease is more severe in young mice and rapidly fatal in 
suckling animals [Barthold, 1980; Barthold et al., 1976; Barthold et al., 1978; D’Arienzo et al., 
2006; Muto et al., 1969; Nakagawa et al., 1969]. This is particularly significant when infections 
are performed in immune-knockout mice. Weanling mice develop high mortality most likely due 
to overwhelming sepsis [Bry and Brenner, 2004; Vallance et al., 2002b]. Adult animals with 
same immune deficiencies, though fail to clear the infection properly, mainly develop diarrhea 
and little or no mortality [Maaser et al., 2004; Simmons et al., 2003].  
 The role of diet was addressed in only two reports. In the first, infected animals on 
different diets developed significantly different hyperplastic responses. However, the 
composition of the diets was unknown, and factor(s) mediating distinct proliferating responses 
were not discussed [Barthold et al., 1977]. The second more recent study investigated molecular 
consequences of calcium and the soluble fiber pectin administration to C. rodentium-inoculated 
mice [Umar et al., 2003]. Although clinical disease was not affected by dietary intervention, both 
high-calcium and pectin-rich diets inhibited proliferation and crypt length increases in colonic 
epithelium. Moreover, a pectin-rich diet inhibits increases in cellular β-catenin, cyclin D1 and c-
myc levels, further supporting the anti-proliferative effects of pectin in C. rodentium-infected 
mice [Umar et al., 2003].  
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 TMCH is also sensitive to intestinal flora and different disease outcomes were reported in 
germ-free, specific pathogen free (barrier), antibiotics-pretreated and conventionally maintained 
animals [Bathold et al., 1977; Itoh et al., 1978; Itoh et al., 1979; Itoh et al., 1980; Luperchio and 
Schauer, 2001]. More recently, the protective effects of prophylactic administration of probiotics 
on C. rodentium colonization, translocation, colonic hyperplasia and inflammation were shown 
[Chen et al., 2005b; D’Arienzo et al., 2006; Johnson-Henry et al., 2005; Varcoe et al., 2003]. On 
the other hand, concurrent infection with intestinal helminths was reported to augment C. 
rodentium-induced disease [Chen et al., 2005a; Chen et al., 2006]. Therefore, host colonic 
microflora can define the disease outcome and manipulating the mice with probiotics and 
concurrent infection with other organisms may ameliorate or exacerbate the disease progress. 
 Finally, susceptibility to C. rodentium infection is highly dependent on the genetic 
background of the host [Barthold et al., 1977; Itoh et al., 1979; Itoh et al., 1980; Itoh et al., 1988; 
Khan et al., 2006; Vallance et al., 2003]. Among many strains used for modeling TMCH (Figure 
1-4), outbred Swiss Webster (NIH Swiss), and inbred C57BL/6 and C3H mice are the best 
characterized. Outbred Swiss mice show subclinical infection with primarily significant 
hyperplasia and little or no evidence of inflammation. C57BL/6 mice, used as a common control 
strain in transgenic studies, are relatively resistant. Infected C57BL/6 mice do not exhibit 
profound hyperplastic response, but develop clinical signs and have more substantial colitis. 
Substrains of C3H mice, regardless of their TLR4 (LPS responsiveness) status, are highly 
susceptible to C. rodentium, develop necrotic colitis and severe mortality that was proposed to be 
caused by disseminated infection [Barthold et al., 1977; Itoh et al., 1988; Khan et al., 2006; 
Vallance et al., 2003]. Because outbred mice are genetically heterogeneous compared with 
inbred animals, and C57BL/6 and C3H mice belong to different genealogic families, distinct 
disease outcomes between those strains can be explained by genetic polymorphisms. Therefore, 
we sought an appropriate inbred mouse strain derived from Swiss stock that could be used to 
compare disease outcomes with outbred Swiss Webster mice. 
 
Genealogy of Swiss mice 
 In 1926, Clara J. Lynch from the Rockefeller Institute for Medical Research imported 
nine mice from André de Coulon, Switzerland, to the US, establishing the “Swiss” outbred 
colony [Chia et al., 2005] (Figure 1-5). Mice from that colony were sent by Lynch to other 
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researchers, including Leslie Webster in 1932, who passed them to academic and commercial 
breeders which then founded “Swiss Webster” outbred stock. In addition, in 1935, Lynch sent 
her animals to the National Institute of Health who established NIH stock of outbred Swiss mice. 
In 1966, the animals from this colony were selected for sensitivity and resistance to histamine 
challenge following pertussis vaccination resulting in HSFS/N and HSFR/N mice, respectively. 
In the early 1970s, histamine-sensitive mice at the eighth generation of inbreeding were found to 
carry the Fv1b allele which confers sensitivity to the B strain of Friend leukaemia virus. 
Homozygous mice were then inbred as strain FVB/N (referred to hereafter as FVB) (Figure 1-5) 
[Taketo et al., 1991]. Based on the comparison of 44 common biochemical and coat color 
markers located on 15 chromosomes (Table 1-3 and data not shown from [Taketo et al., 1991]), 
strains such as BDP/J, P/J, I/St, and Mus molossinus are most distant from FVB/N (<55% of the 
markers matching), whereas strains such as HSFS/N, NFS/N, and SWR/J are most closely 
related (>75% matching). The main advantages of the FVB strain are large and prominent 
pronuclei beneficial for DNA microinjections, and vigorous reproductive performance with large 
litters [Taketo et al., 1991]. Due to these unique characteristics, FVB mice are widely used for 
production of transgenic animals on a fully inbred genetic background, which avoids using 
hybrid animals for that purpose and simplifies genetic manipulation and analysis [Barthold, 
2002]. SWR and SJL mice also originated from Lynch’s Swiss mice and were inbred at The 
Jackson Laboratory from 1947 and 1955 respectively. SJL/J mice are useful as a control strain 
for studying atherosclerosis and immune defects in a mouse model for type 1 diabetes (IDDM), 
and are susceptible strain to reticulum cell sarcomas. SWR mice are widely used in research as a 
general purpose strain, and also may be used as a control strain in comparison with autoimmune 
diabetic NOD mice [Festing, www.informatics.jax.org].  
  
 
 In this thesis, I investigated the impact of host genetic background on the disease 
associated with C. rodentium infection. In the first aim, I developed and characterized the inbred 
FVB mice infection model for the first time. Compared with closely related resistant outbred 
Swiss Webster mice, FVB mice demonstrated high mortality which most likely was associated 
with severe C. rodentium-induced diarrhea and consequent dehydration. In the next chapter, I 
addressed the phenotypic differences between resistant and susceptible mice with similar genetic 
 22
background at the genomic levels by applying DNA microarray technology. Results from this 
experiment were in agreement with the phenotypic observations observed in the first study. The 
role of genes involved in intestinal ion transport and its regulation in determining the disease 
outcome in inbred FVB and outbred Swiss Webster mice was proposed. In the last chapter, I 
confirmed and extended my observations using additional inbred strains of Swiss origin, SWR 
and SJL mice. These experiments provided the first information on C. rodentium infection in 
SWR and SJL mice, which were resistance to the disease. Furthermore, susceptible C3H mice 
demonstrated severe diarrhea and comparable changes in transcriptional activity of genes 
identified as potential candidates for high susceptibility in infected FVB mice, suggesting 
existence of common mechanisms in development of fatal diarrhea. Although it needs to be 
shown that comparable changes in genes contributing to electrolyte and fluid imbalance occur in 
people infected with EPEC and EHEC, my overall results indicate that C. rodentium-infected 
FVB mice can be used to model human acute diarrheal illness (ADI). These studies are very 
important in elucidating the pathophysiology of infectious diarrhea and identifying host genetic 
factors for susceptibility. 
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1.5 Figures and Tables 
 
 
Figure 1-1. Clinical disease in C. rodentium-infected weanling SW mice. 
Compared with uninoculated control (upper panel), susceptible mice develop signs of retarded growth, 
diarrhea, dehydration, coat ruffling, hunched posture, reluctance to move, recumbency, and high mortality 
in response to C. rodentium (lower panel). Images are courtesy of David B. Schauer.
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Figure 1-2. Microbial pathogenesis of C. rodentium. 
(A) transmission electron micrograph of typical A/E lesions characterized by brush border effacement, 
intimate attachment and pedestal formation in the colon of C. rodentium-induced mice [adapted from 
Luperchio and Schauer, 2001]. 
(B) comparable A/E lesions induced by EPEC on the host epithelial surface (adapted from 
http://www.finlaylab.biotech.ubc.ca/research_projects/E.coli.html).  
(C) molecular structure of the pedestal formation [modified from Vallance and Finlay, 2000]. 
(D) type III secretion system  allowing translocation of bacteria-secreted proteins (Esps)  to a host cell. 
Once translocated outside the bacteria, EspA forms a filamentous translocation tube whereas EspB 
and EspD are inserted into the host cell membrane, putatively forming a pore structure, allowing the 
passage of other effector proteins, such as Tir into the host cell membrane [modified from Vallance 
and Finlay, 2000].  
(E) Genetic organization and assigned functions of C. rodentium LEE [adapted from Deng et al., 2004]. 
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adapted from [Garmendia et al., 2005]. 
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Table 1-2. Host immune response to C. rodentium infection as investigated in 
genetically-manipulated mice (modified from Mundy et al., 2005). 
 
 
Gene deleted mice who 
cannot clear infection 
 
 
Gene deleted mice with 
impaired eradication of 
colonic/systemic infection 
 
 
Gene deleted mice with no 
effect on normal progress of 
infection  
 
 
• RAG-/- (lacking T and B cells) 
• TcRβ-/- (lacking αβ T cells) 
• CD4-/- or depleted mice 
• CD28-/- (T cell signaling) 
• CD40L-/- (T cell signaling)  
• µMT (lacking B cells) 
• Igh-6tm1Cgn (lacking B cells) 
• LTβR-/- (lacking the 
lymphotoxin-β receptor) 
• W/Wv (lacking mast cells) 
 
• J chain-deficient (lacking 
polymeric immunoglobulins) 
• MMP3-/- 
• TcRδ-/- (lacking γδ T cells) 
• TNFα-/- 
• IL-12 p40-/- 
• Interferon-γ -/- 
• Cnlp-/- (lacking antibacterial 
mCRAMP) 
 
• SCID-/- (lacking T and B cells) 
• iNOS-/- 
• IgG3-deficient 
• pIgR-/- (lacking the polymeric 
immunoglobulin receptor on 
epithelial cells) 
• IgA-deficient 
• IgM-deficient 
• CD8-/- 
• β7-/- (largely lacking mucosal 
lymphocytes) 
• αE-/- (largely lacking mucosal 
lymphocytes) 
• PAR2-/- (lacking proteinase 
activated receptor 2) 
• IL4-/- 
 
 
Gene deleted mice who 
show reduced pathology 
 
 
Gene deleted mice who 
show enhanced pathology 
 
Gene deleted mice with no 
effect on pathology 
 
 
• PAR2-/- (lacking proteinase 
activated receptor 2) 
• STAT6-/- 
• young RAG1-/- (lacking T and 
B cells) 
• SCID-/- (lacking T and B cells) 
 
  
• TNFα-/- 
• IL-12 p40-/- 
• Interferon-γ -/- 
• adult RAG1-/- (lacking T and B 
cells) 
• RAG2-/- (lacking T and B cells) 
• LTβR-/- 
• µMT (lacking B cells) 
• Igh-6tm1Cgn (lacking B cells) 
• CD4-/- or depleted mice 
• CD28-/- (T cell signaling) 
• CD40L-/- (T cell signaling) 
• W/Wv (lacking mast cells) 
• TcRβ-/- (lacking αβ T cells) 
 
• iNOS-/- 
• Cnlp-/- (lacking antibacterial 
mCRAMP) 
• IgG3-deficient 
• J chain-deficient (lacking 
polymeric immunoglobulins) 
• pIgR-/- (lacking the polymeric 
immunoglobulin receptor on 
epithelial cells) 
• IgA-deficient 
• IgM-deficient 
• MMP3-/- 
• CD8-/- 
• TcRδ-/- (lacking γδ T cells) 
• β7-/- (largely lacking mucosal 
lymphocytes) 
• αE-/- (largely lacking mucosal 
lymphocytes) 
• IL4-/- 
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Figure 1-3. Hypothetical mechanisms for development of diarrhea in EPEC infection. 
Main contributors include increased epithelial permeability and alterations in Cl  and HCO3  ion 
secretion. Loss of absorptive surfaces, reduced tight junction integrity, and tissue damage may be involved 
as well [adapted from Vallance and Finlay, 2000]. 
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Inbred
 129S1/SvImJ
 129Sv
 A/J
 B10.RIII-H2r
 BALB/c
 BALB/cByJ
 C3H/HeJ
 C3H/HeOuJ
 C3H/HeN
 C57Bl/6
 B6129
 DBA/2J
 DDD
 DDY
 ICR
 NC
 NIH Swiss
 RFVL
Outbred
 CF1
 CD-1
 Swiss Webster
 NIH Swiss (Swiss)
Mouse genealogies:
A) Swiss mice
B) Castle’s mice
C) Strains derived from colonies 
from China and Japan
D) Other inbred/outbred strains
E) C57-related strains
F) Strains derived from wild mice
G) Mice derived from multiple 
inbred strains
 
 
 
Figure 1-4. Strains/stocks of mice studied for C. rodentium infection so far FVB, SWR, and SJL mice 
reported in this thesis are not included). 
Mouse genealogies (color-coded) are adapted from Beck et al., 2000. 
In some reports, NIH Swiss and ICR mice appear as outbred, whereas in other studies, inbred mice of the 
same strain (and name) were used. This factor should be taken in account while comparing literature on C. 
rodentium mouse studies. 
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Figure 1-5. Genealogy of Swiss mice (partial, adapted from Beck et al., 2000). 
Strains and lines of mice used in studies presented in the thesis are highlighted. 
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Table 1-3. Genetic markers of FVB/N mice and common inbred strains
% relatedness*
Inbred strains
76.74%69.77%52.38%59.09%61.36%72.73%63.64%
SWR SJL/J P DBA/2 C57BL/6 C3H 129
*, calculated as percentage of marker alleles similar to FVB/N  in all markers tested from the table above 
(adapted from [Taketo et al., 1991])
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2.1 Introduction 
 Diarrheagenic Citrobacter rodentium causes transmissible murine colonic hyperplasia 
(TMCH), a naturally occurring disease of laboratory mice characterized by epithelial cell 
hyperproliferation in the descending colon [reviewed in Luperchio and Schauer, 2001; Mundy et 
al., 2005]. C. rodentium infection in adult mice of many outbred stocks and inbred strains is self-
limiting, with little morbidity or mortality. In contrast, some animals are more susceptible and 
develop clinical signs of disease, including retarded growth, diarrhea, dehydration, coat ruffling, 
hunched posture, reluctance to move, recumbency, and high mortality. Susceptibility has been 
reported for suckling [Muto et al., 1969; Nakagawa et al., 1969; Barthold et al., 1976; Barthold et 
al., 1978; Barthold, 1980], helminth co-infected [Chen et al., 2005a; Chen et al., 2006], antibiotic 
pretreated [Luperchio et al., 2000], and adult mice of some inbred strains [Barthold et al., 1977; 
Itoh et al., 1979; Silverman et al., 1979; Vallance et al., 2003; Khan et al., 2006], as well as 
genetically engineered mice with varying types of immune defects [Maggio-Price et al., 1998; 
Vallance et al., 2002b; Vallance et al., 2003; Bry and Brenner, 2004; Spahn et al., 2004; Wei et 
al., 2005]. The alterations in cell kinetics in TMCH are similar to those seen in idiopathic 
inflammatory bowel disease (IBD), including a 2- to 4-fold increase in labeling index and 
expansion of the proliferative zone [Barthold, 1979]. Furthermore, colonic mucosal hyperplasia 
associated with C. rodentium infection in mice serves as a promoter for colon tumorigenesis 
[Barthold and Jonas, 1977; Newman et al., 2001], analogous to the increased risk for colorectal 
cancer seen in patients with IBD [Riddell et al., 1983; Bernstein et al., 2001; Rutter et al., 2004]. 
Therefore, C. rodentium was used as an animal model linking bacterial infection, IBD and 
colorectal cancer. 
 The importance of host genetic background in TMCH has been demonstrated, but not 
fully elucidated. First mentioned by Barthold et al., [1977], mouse strain susceptibility to C. 
rodentium infection was further investigated by Itoh et al. [1988], and more recently by Vallance 
et al. [2003]. Distinct lesions with regard to hyperplasia, inflammation, and mortality can be seen 
in different outbred stocks and inbred strains in response to bacterial challenge. Diet and 
indigenous microbiota also play important roles in the outcome of C. rodentium infection. 
Among different stocks and strains of mice, outbred Swiss Webster (SW) mice have been well 
characterized as a model of TMCH [Ediger et al., 1974; Barthold et al., 1976; Barthold et al., 
1977; Barthold et al., 1978; Barthold, 1979; Barthold and Jonas, 1979; Johnson and Barthold, 
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1979; Barthold, 1980; Barthold and Beck, 1980; Umar et al., 2000; Umar et al, 2003]. FVB 
mice, widely used for creating transgenic animals, have been inbred from SW mice for 
homozygosity of the Fv-1b allele that determines susceptibility to the B strain of Friend leukemia 
virus [Taketo et al., 1991]. Although FVB mice have been available since the late 1970s, there 
have been no reports of progression of TMCH in this inbred strain. The aim of this study was to 
characterize C. rodentium infection in adult FVB mice and compare it to disease outcome in 
cognate outbred SW mice. Marked differences in host response to infection were observed in the 
two lines. While outbred SW mice developed subclinical disease with classic features of TMCH, 
FVB mice developed high mortality and severe colitis associated with epithelial atypia. This 
research characterizes C. rodentium infection in FVB mice as a new model for studying fatal 
infectious colitis. 
 
2.2 Results 
FVB mice are highly susceptible to C. rodentium infection 
 As expected, C. rodentium infection in adult outbred SW mice failed to produce clinical 
signs of disease (data not shown). In contrast, 12-week old inbred FVB mice infected with the 
pathogen developed morbidity by 6 days post-inoculation (DPI), and mortality by 9 DPI with a 
median survival of 15 days (Figure 2-1). By 21 DPI, only 23% of inoculated FVB mice survived, 
compared to 100% survival in inoculated SW mice and in uninfected control animals (p < 0.0001 
by log rank test). The cause of death in these mice is not clear. However, clinical signs, 
undetectable serum TNF-alpha levels (below the limit of detection by ELISA of 15.6 pg/ml), rare 
dissemination of bacteria to draining lymph nodes or spleen at 9-12 DPI, and the prevention of 
mortality by fluid therapy (discussed below), are consistent with hypovolemia as the primary 
cause of fatality.  
 Mortality correlated with loss of body weight in infected animals (Figure 2-2A). SW 
mice stopped gaining weight between 9 and 15 DPI (p < 0.05 by paired t test), while FVB mice 
lost weight beginning at 9 DPI (p < 0.0001 by paired t test). There was a recovery of body 
weight loss in FVB mice by 21 DPI, although only 23% of the inoculated animals were still alive 
at that time point, which may have contributed to the apparent increase. Body weight loss was 
significantly greater in FVB than in SW mice throughout the duration of the experiment (p < 
0.0001 by two-way ANOVA compared with SW mice); at 9 DPI (2.8 ± 1.4% vs. 5.3 ± 1.2%), 12 
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DPI (5.2 ± 2.1% vs.17.5 ± 1.4%), 15 DPI (6.4 ± 2.3% vs. 20.2 ± 2.7%), and 21 DPI (6.0 ± 3.1% 
vs. 8.2 ± 1.6%). 
 
Bacterial load of C. rodentium in FVB mice 
 Fecal shedding of C. rodentium was detected beginning at 3 DPI, and the levels of fecal 
shedding were not significantly different between SW and FVB mice through 9 DPI (Figure 2-
2B). By 12 DPI, SW mice had reduced bacterial shedding and by 18 DPI the infection was 
cleared. Although FVB mice cleared the pathogen by 3 weeks post-inoculation (WPI), bacterial 
counts were higher than in SW mice by 12 DPI, indicating delayed clearance. Furthermore, since 
the most severely affected FVB mice often did not have any formed feces, the observed fecal 
counts may have underestimated the actual shedding of C. rodentium between 12 and 21 DPI. 
Fecal shedding correlated with bacterial infection in the cecum and colon of FVB mice (Figure 
2-3A). Substantial attachment of C. rodentium to epithelial cells was observed in the colon at 6 
DPI, with bacterial organisms on the luminal epithelial surface, as well as deeper in crypts 
(Figure 2-3B panel c). The cecum, although comparable to the colon in level of infection at 6 
DPI (Figure 2-3A), did not exhibit C. rodentium attachment to epithelial cells (Figure 2-3B panel 
d). By 12 DPI, C. rodentium organisms in the colon were mainly associated with exfoliated cells 
(Figure 2-3B panel e), while attachment to epithelial cells in the cecum was occasionally 
observed (Figure 2-3B panel f). 
 
Infected FVB mice develop marked colonic hyperplasia 
 SW mice develop profound hyperplasia in the descending colon in response to C. 
rodentium infection [Barthold et al., 1977; Barthold, 1979; Johnson and Barthold, 1979; Umar et 
al., 2000; Umar et al., 2003]. Infected FVB mice were found to have comparable hyperplasia 
characterized by increased colonic crypt height and changes in proliferation by 6 DPI (Figure 2-
4). By 12 DPI, the height of crypts doubled, and the proliferative zone expanded from 29.3 ± 
1.2% to 84.3 ± 2.6% of the crypt column (p < 0.0001 by ANOVA). Mitotic figures and BrdU-
positive cells were found on the surface epithelium (Figure 2-4D), and the labeling index (LI) 
had increased from 8.9 ± 0.6% to 40.1 ± 2.4% (p < 0.0001 by ANOVA). Alterations in the 
cecum were less pronounced with a 1.5-fold increase in crypt length that was significantly 
different from uninfected control FVB mice (p < 0.01 by Student’s t test) and a tendency towards 
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expanded proliferative zone and increased LI by 12 DPI that was not significantly different from 
uninfected control FVB mice (Figure 2-5). 
 Apoptosis was analyzed by immunohistochemistry for activated caspase 3 (Figure 2-6). 
Although occasional apoptotic cells were found in colonic crypts (Figure 2-6B), the majority of 
activated caspase 3 was associated with exfoliated epithelial cells in the lumen (Figure 2-6C and 
D), consistent with rapid removal of apoptotic cells from tissue. 
 
Infected FVB mice develop severe inflammation and associated epithelial atypia 
 In agreement with published reports, SW mice developed limited inflammation in 
response to infection (Barthold et al., 1978; data not shown). In contrast, infected FVB mice 
developed substantial inflammation, erosions and ulcers in the descending colon (Figure 2-7A,   
p < 0.0001 using Kruskal-Wallis test with post hoc Dunn’s multiple comparison test compared 
with uninfected controls). By 6 DPI, minimal to mild mucosal infiltrate of granulocytes and 
mononuclear cells was present. By 12 DPI, infected FVB mice had multifocal coalescing 
moderate to severe mucosal inflammation with mucosal erosions, ulcers and submucosal edema 
(Figure 2-7A, p < 0.001 compared with uninfected and 3 DPI mice, Figure 2-8). Excessive 
mucus accompanied the inflammation in the proximal colon, resembling the catarrhal 
enterocolitis described by Brennan et al. [1965]. Lesions were characteristically most severe in 
the mid- to distal colon, milder at the cecocolic junction, and typically did not involve the 
proximal colon or the body of the cecum. Ileitis was rarely observed.  
 Inflammatory lesions were accompanied by dysplastic changes (Figure 2-7B, p < 0.0001 
using Kruskal-Wallis test with post hoc Dunn’s multiple comparison test compared with 
uninfected controls) that fit the definition of gastrointestinal intraepithelial neoplasia (GIN) from 
a recent consensus report [Boivin et al., 2003]. By 6 DPI, infected FVB mice had mild dysplasia 
in the descending colon, with crypt hyperplasia, minimal alteration of gland shape, and some loss 
of goblet cell differentiation, although moderate dysplasia was observed in a few animals at this 
time point (Figure 2-7B, p < 0.01 and p < 0.05 compared with uninfected and 3 DPI mice 
respectively). By 12 DPI, a greater fraction of mice had moderate dysplasia (Figure 2-7B, p < 
0.001 compared with uninfected and 3 DPI mice). The atypical glands were characterized by 
longer, hypercellular crypts with altered shapes (tortuous, branched), moderate loss of normal 
crypt orientation, and occasional cystic glands (Figure 2-8E-H). Moderate cellular atypia was 
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characterized by loss of goblet cell differentiation, plump and elongate nuclei with 
pseudostratification and nuclear hyperchromatism, loss of cell polarity, dark, elongate to oval, 
hyperchromatic and anisokaryotic nuclei with pseudostratification. Mice with the most advanced 
dysplastic changes had high nuclear-to-cytoplasm ratios, crypt branching with irregular buds, 
and occasional micronests within the abutting lamina propria (Figure 2-8E and F). 
Approximately 65% of infected FVB mice had atypical crypts that had herniated into the GALT 
by 12 DPI (Figure 2-8G and H). Dysplastic lesions were positively correlated with inflammation 
(Spearman r = 0.87, p < 0.0001). Similar changes, although less dramatic, were observed in the 
cecum by 12 DPI, and here too dysplasia was positively correlated with inflammation (Spearman 
r = 0.729, p < 0.0001, Figure 2-9). These results indicate that FVB mice infected with C. 
rodentium may serve as a new model for studying infectious colitis and associated epithelial 
atypia. 
 
Chronic studies show reversibility of most of the lesions in FVB mice 
 Morphologically, the features of regenerative atypia, including prominent crypt 
branching, occasional villous configuration of the surface, persistent mucus depletion and 
nuclear changes in the epithelial cells, can resemble GIN. This makes the histopathologic 
diagnosis more difficult [Riddel et al., 1983].  In order to assess possible progression of the 
lesions in infected FVB mice to neoplasia, the animals were followed for 16 and 30 WPI. In the 
first experiment, without therapeutic intervention, only 25% of infected FVB mice survived. 
These animals were followed to 16 WPI. In a second experiment, fluid therapy was administered 
to infected FVB mice. Daily subcutaneous administration of fluids beginning at 6 DPI prevented 
mortality in FVB mice infected with C. rodentium without affecting bacterial shedding, or the 
severity or extent of colonic lesions. Fluid therapy through 15-21 DPI resulted in 100% survival 
and allowed us to follow the animals through 30 WPI. 
 The lesions fully resolved in the majority of the mice (Figure 2-10A), although the 
colonic disease score at 16 WPI was slightly, but significantly, greater than at 30 WPI or 
uninfected controls (p < 0.0001 by Kruskal-Wallis followed by Dunn’s multiple comparison 
test). This observation provides further evidence that the epithelial dysplasia was associated with 
active inflammation and was reversible. However, one of the mice in each of these two 
experiments (representing 6.7% and 5% for 16 and 30 WPI respectively) developed chronic 
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lesions. A mouse at 16 WPI had moderate to marked inflammation and hyperplasia with adjacent 
areas of normal mucosa that mainly involved the proximal colon and cecum (Figure 2-10B panel 
a). In a mouse at 30 WPI, similar lesions were found diffusely throughout the large intestine and 
consisted of significant inflammation and hyperplasia, multiple lymphoid aggregates throughout 
the mucosa, vascularized lamina propria, and rare crypt abscesses (Figure 2-10 B panels b and c). 
At these time points the animals were no longer infected with C. rodentium, as judged by eae-
specific PCR (data not shown). 
 
Expression of pro-inflammatory and immunomodulatory genes in SW and FVB 
mice 
 Quantitative RT-PCR was performed on RNA isolated from full-thickness descending 
colon tissue to evaluate the expression of some key genes involved in immune regulation in the 
intestine, including the pro-inflammatory cytokines IFN-γ and TNF-α and the 
immunomodulatory cytokine IL-10 (Fig. 2-11). In addition, the expression of inducible nitric 
oxide synthase (iNOS), which contributes to innate antimicrobial host defense by producing 
reactive nitrogen species, was determined. The only difference found was in the expression of 
iNOS prior to infection; uninoculated FVB mice demonstrated 7.5-fold lower expression of 
iNOS message compared with control SW mice (p < 0.01 respectively using one-way ANOVA 
followed by Tukey’s multiple comparison tests). Infection with C. rodentium induced expression 
of INF-γ (12.5-fold, p < 0.05), TNF-α (7-fold, p < 0.001), and iNOS (19-fold, p < 0.001) in SW 
mice compared with uninoculated controls. IL-10 expression (1.6-fold increase) was not 
significantly different than in uninfected SW mice. Similarly, infection in FVB mice stimulated 
expression of proinflammatory genes; INF-γ (4-fold, not significant), TNF-α (7-fold, p < 0.001), 
and iNOS (79-fold, p < 0.001) compared with uninfected FVB mice. On the other hand, the 
expression of IL-10 at 9 DPI had decreased 3-fold in infected FVB mice compared to uninfected 
controls (p < 0.05). By 9 DPI, the transcript levels of all genes were similar in FVB and SW 
mice. 
 
 
 
 40
2.3 Discussion 
 A number of animal models have been developed to investigate different aspects of IBD, 
although none of them reproduce human disease completely. Models of intestinal inflammation 
can be either spontaneous or induced by administration of exogenous agents (chemicals or 
bacteria), gene targeting (knockout or transgenic rodents), and adoptive transfer of cells into 
immunodeficient animals [Blumberg et al., 1999; Hendrickson et al., 2002]. Microbiota have 
profound effects on the host and particularly on the gut, including intestinal epithelium, the 
enteric nervous system, and mucosal immunity [Elson et al., 2005]. Diarrheagenic C. rodentium 
is a unique murine pathogen that has been used to study important disease processes, including 
colitis. Infection is characterized by colonic hyperplasia with varying degrees of inflammation, 
depending on age, diet, microbiologic status and genetic background of the host. Here we report 
a new model of fatal infectious colitis in adult FVB mice infected with C. rodentium. 
 In contrast to subclinical infection in outbred SW mice, adult inbred FVB mice 
demonstrated a high degree of susceptibility. The 77% mortality was accompanied by profound 
inflammatory and erosive changes, including frank lower bowel ulcers, which correlated with 
morbidity. In contrast to susceptibility to infectious colitis, FVB mice are relatively resistant to 
DSS colitis, with milder lesions than ICR, C57BL/6, or BALB/c mice, and only 10% mortality 
12 days after treatment with 5% DSS in the drinking water [Hahm et al., 2001]. Although they 
are immunocompetent, the degree of mortality seen in FVB mice infected with C. rodentium 
exceeds that reported in some immunocompromised mice. For example, little to no mortality 
following C. rodentium infection was reported in adult TNFRp55-/-, iNOS-/- and IFN-γ-/- mice 
[Goncalves et al., 2001, Simmons et al., 2002] or in adult immunodeficient mice lacking 
immunoglobulin or T cells [Simmons et al., 2003; Maaser et al., 2004]. In addition, C. rodentium 
infection only caused mortality rates of 5% in adult Rag1-/-, 10-15% in IL-12p40-/- and 40% in 
mast cells-deficient animals [Simmons et al., 2002; Simmons et al., 2003; Wei et al., 2005]. 
Importantly, adolescent mice between 3 and 5 weeks of age with these same immune defects are 
highly susceptible to C. rodentium infection [Vallance et al., 2002b; Vallance et al., 2003; Bry 
and Brenner, 2004; Wei et al., 2005]. Furthermore, suckling inbred and outbred mice without 
such defects are also susceptible and exhibit a high degree of mortality [Muto et al., 1969, 
Nakagawa et al., 1969; Barthold et al., 1976; Barthold et al., 1978; Barthold 1980]. This suggests 
that susceptibility in young mice may be independent of innate or adaptive immunity, and may in 
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fact be due to a failure to adequately compensate for fluid and/or electrolyte losses in the colon 
during C. rodentium infection. Mice lacking functional T and B cells develop chronic C. 
rodentium infection [Vallance et al., 2002b, Simmons et al., 2003; Maaser et al., 2004], 
demonstrating the importance of adaptive immunity in clearing the infection. Although infected 
FVB mice exhibited a relative delay in C. rodentium clearance compared to SW mice, surviving 
mice and mice receiving fluid therapy invention did successfully eliminate the infection by 3 
WPI. Thus, any intrinsic immune defect that FVB mice have against C. rodentium is partial and 
does not fully explain the susceptibility of this strain to infection. 
 The only immunocompetent inbred strain of mouse with a high degree of susceptibility to 
C. rodentium infection that has been reported previously is the C3H strain. Different C3H 
substrains exhibit 50% to 100% mortality by 3 WPI independent of TLR4 status [Barthold et al., 
1977; Vallance et al., 2003; Khan et al., 2006]. C3H mice develop high levels of C. rodentium in 
the colon as well as bacterial translocation to mesenteric lymph nodes, consistent with a defect in 
the clearance of infection. The mechanism of susceptibility of FVB mice to C. rodentium 
infection appears to be different from that of C3H mice. For example, fecal shedding of C. 
rodentium in FVB mice was similar to that seen in resistant SW mice. Furthermore, serum TNF-
α was not detectable by ELISA, and dissemination of bacteria to extraintestinal tissues was 
minimal and not associated with mortality (data not shown), allowing us to exclude bacteremia 
as the cause of death in infected FVB mice. Sick FVB mice did exhibit signs of severe 
dehydration [Eliason and Lewan, 1998], including sunken eyes, reluctance to move, and 
decreased skin turgor. Based on clinical signs and the success of fluid therapy intervention, we 
suspect hypovolemia was the primary cause of fatality. The relative contribution of 
malabsorption and decreased fluid uptake, increased ion secretion, compromise of barrier 
function and/or exudation to C. rodentium diarrhea, and the role of altered fluid balance in 
morbidity and mortality, remains to be determined. 
 The kinetics of C. rodentium infection in FVB mice was comparable to that in other 
strains of mice. Similar to what has been reported in C57BL/6 mice as measured by 
bioluminescence imaging [Wiles et al., 2004], FVB mice had 2 logs more C. rodentium in the 
cecum than in the colon at 3 DPI. No C. rodentium aggregates were detected in the colon of FVB 
mice at 3 DPI by IHC, also consistent with the lack of microcolonies made up of ≥ 103 bacteria 
in the colon of C57BL/6 mice 3 DPI [Wiles et al., 2004]. By 6 DPI, extensive attachment of 
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bacteria to the epithelial surface of the colon was found in FVB mice. By 12 DPI, the bacteria 
were no longer attached to the colonic epithelial surface, but were attached to exfoliated cells, 
which has been previously reported [Johnson and Barthold, 1979; Umar et al., 2000; Umar et al., 
2003]. C. rodentium were abundant in the cecum of FVB mice by 6 DPI, but attachment to the 
cecal epithelial surface was not observed until 12 DPI. In contrast, Wiles et al. (2004) reported 
attachment to the cecal lymphoid patch by 1 DPI in C57BL/6 mice that persisted focally without 
involving the remainder of the organ. The cecal patch is analogous to the Peyer’s patch in the 
ileum and is present in the apical portion of cecum. Whether these differences are due to 
differing kinetics of infection in FVB versus C57BL/6 mice or to differences in IHC detection 
versus bioluminescence imaging of the cecal surface, following removal of cecal contents, 
remains to be determined. In any case, cecal lesions in FVB mice were associated with C. 
rodentium attachment and not simply the presence of organisms in the lumen of the organ 
(Figure 2-9). 
 The increase in crypt column heights in the colon of FVB mice was comparable to that 
reported for SW mice [Barthold et al., 1977; Barthold, 1979; Johnson and Barthold, 1979; Umar 
et al., 2000; Umar et al., 2003], as well as in other inbred strains [Higgins et al., 1999, Newman 
et al., 2001; Vallance et al., 2002a; Vallance et al., 2002b]. Epithelial hyperplasia reflects an 
imbalance between proliferation and death of cells arising in the crypt. We detected apoptosis by 
staining for activated caspase 3. Few apoptotic cells were identified in colonic crypt columns 
most likely due to their rapid removal from the mucosa. Strong activated caspase 3 signal was 
found primarily in extruded cells in the lumen of the colon. It remains to be determined if C. 
rodentium infection causes apoptosis in epithelial cells which are then shed into the lumen, or if 
infection and subsequent cytoskeletal rearrangements result in exfoliation of cells that then 
undergo anoikis, or perhaps both. In any case, some differences that have been reported with 
regard to the influence of C. rodentium infection on apoptosis may be explained by 
methodology. Evaluation of apoptosis in isolated crypts would exclude exfoliated cells, thus it is 
not surprising that no increase in colon apoptosis in SW mice was detected by TUNEL 12 DPI 
using this method [Umar et al., 2000]. In addition, techniques that rely on DNA fragmentation to 
detect apoptosis, including the TUNEL assay, are not specific but also detect cells with DNA 
damage resulting from cell injury and other forms of cell death [Grasl-Kraupp et al., 1995, 
Stadelmann and Lassmann, 2000]. Thus, increases in TUNEL-positive cells in crypts in tissue 
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sections from C3H mice [Vallance et al., 2003] could correlate with cellular injury and DNA 
damage as well as apoptosis, which would be expected to exceed the number of apoptotic cells 
detected by activated caspase 3 staining. 
 Both FVB and SW mice developed comparable epithelial hyperplasia when infected with 
C. rodentium. FVB mice also developed severe mucosal inflammation associated with epithelial 
atypia (dysplasia). Inflammatory changes in the colon of FVB mice were similar to those in 
mouse models of colitis that have been used to study idiopathic IBD [Sartor, 1997]. These 
lesions included erosions and frank colonic ulcers, infiltration of the lamina propria with 
neutrophils and mononuclear cells, crypt abscesses and gland atrophy, goblet cell depletion, 
epithelial hyperplasia, and epithelial atypia and dysplasia. Dysplasia has been identified as a 
precursor to neoplasia in IBD [Riddell et al., 1983, Ullman et al., 2003], but there can be 
difficulties in distinguishing true dysplasia from regenerative atypia that can accompany severe 
inflammation [Riddell et al., 1983]. Consequently, chronic studies were carried out to determine 
the ultimate fate of these dysplastic changes. The majority of surviving mice in the absence of 
therapy or mice receiving fluid therapy intervention no longer had epithelial inflammation and 
dysplasia in the colon by 16 or 30 WPI, consistent with the complete resolution of lesions 
reported in SW mice [Barthold et al., 1978; Johnson and Barthold, 1979]. However, a small 
fraction of animals (5-7%) developed chronic colitis. Persistent infection or recurrent infection 
could be excluded as a cause of these lesions by eae-specific PCR. There is also evidence for 
long-lasting or perhaps life-long immunity against rechallenge in convalescent animals following 
C. rodentium infection [Barthold 1980; Ghaem-Maghami et al., 2001; Maaser et al., 2004]. 
 To test the hypothesis that cytokines could contribute to the dramatically different 
response of FVB and SW mice to C. rodentium infection, colon message levels of some key 
immunoregulatory cytokines were quantified. Despite initial differences in iNOS expression 
between uninoculated FVB and SW mice, infection as expected  [Higgins et al., 1999; Goncalves 
et al., 2001; Simmons et al,. 2002; Vallance et al., 2002a; Vallance et al., 2002b] induced 
expression of proinflammatory genes to comparable levels in the two lines of mice. This 
suggests that neither IFN-γ nor iNOS or TNF-α play a critical role in determining the differential 
response of FVB and SW mice to C. rodentium infection. As reported in BALB/cByJ mice 
[Chen et al., 2005b], IL-10 expression in SW mice slightly increased by 9 DPI, consistent with 
the induction of a regulatory T cell response [Powrie, 2004] by C. rodentium infection. However, 
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IL-10 expression in FVB mice declined 3-fold by 9 DPI, suggesting a reduced capacity to 
regulate the inflammatory and immune responses directed against the pathogen in these animals. 
The differential IL-10 expression in the colon of FVB and SW mice could contribute to the 
distinct morbidity and mortality observed between these two cognate lines of mice. A protective 
role for IL-10 is in contrast to what has been reported for BALB/cByJ mice co-infected with a 
helminth Heligomosomoides polygyrus and C. rodentium [Chen et al., 2005a; Chen et al., 2006]. 
This may reflect true differences between BALB/cByJ and FVB mice, or it may be that factors 
other than IL-10 contribute to the increased susceptibility to C. rodentium challenge during 
helminth infection. Studies to further define the role of immunoregulatory cytokines in 
susceptibility and resistance to C. rodentium infection are currently underway. 
 In a summary, we have developed and characterized a novel mouse model for studying 
fatal infectious colitis. FVB mice are immunocompetent, yet develop mortality similar to what 
has been reported in immunodeficient lines of mice that fail to control infection. To our 
knowledge, this is the first report demonstrating the protective effect of fluid therapy 
intervention. It remains to be determined if this approach will effectively prevent fatal colitis in 
immunodeficient lines of mice. The availability of susceptible and resistant lines of mice with 
very similar genetic backgrounds should facilitate the identification of host factors that determine 
the outcome of infection with C. rodentium. 
 
2.4 Selected Methods 
 Mouse infections. Specific pathogen free 12-week-old inbred FVB/NTac or outbred 
Tac:SW mice of both sexes (Taconic Laboratories, Germantown, N.Y.) were housed and 
maintained as described in Appendix 1: General methods. The experiments included 16 
uninfected and 20 infected SW mice. The numbers of FVB mice within each experimental group 
(except studies with fluid intervention, see below) are given in Table 2-1, and represent 5 
independent experiments. Mice were inoculated by oral gavage with 100 µl of a bacterial culture 
grown overnight and concentrated 1:10 in LB broth (approximately 3-5 x 109 CFU/mouse as 
determined by plate counts on MacConkey lactose agar) or with 100 µl of sterile LB broth. 
Every three days, fecal shedding of C. rodentium was determined as described in Appendix 1. 
Mice were euthanized and necropsied at 3, 6, 12 DPI and 16 WPI as described in Appendix 1. 
For the second chronic study, groups of 20 control and infected mice were used. Infected mice 
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received wet food from the day of inoculation and daily subcutaneous injections with 1 ml of 
LRS (Lactated Ringer's Injection, USP, Abbott Laboratories, Abbott Park, Illinois) from 6 DPI 
until 15-21 DPI (depending on body weight loss). At 30 WPI, mice were euthanized and 
necropsied as described in Appendix 1. As no gender differences were observed, the results for 
female and male mice were combined. 
 
 Histopathology. The tissues were dissected and processed as described in Appendix 1. 
H&E-stained colonic sections were scored for pathological lesions by a veterinary pathologist 
(PRN) blinded to experimental groups. Inflammation and epithelial atypia within intestinal tissue 
sections were graded on a scale of 0 to 4 as described in Appendix 1. In chronic studies, the 
cumulative disease index was calculated as (inflammation score x distribution score) + 
(hyperplasia score x distribution score) + (dysplasia score x distribution score). The maximum 
possible disease index score was 48. 
 
 Immunohistochemistry. Immunohistochemical analyses of formalin-fixed paraffin-
embedded intestinal sections were performed to assess bacterial attachment to epithelial cells, 
apoptosis and proliferation in situ as previously described [Cahill et al., 1997; Newman et al., 
1999; Erdman et al., 2005]. Polyclonal rabbit anti-C. rodentium [Newman et al., 1999] and anti–
activated caspase 3 (Cell Signaling Technologies, Inc., Beverly, MA) antibodies, and monoclonal 
anti-BrdU antibodies (Dakopatts, Glostrup, Denmark) were used  according to the 
recommendations of the manufacturer. Primary antibodies were detected with either biotinylated 
goat anti-rabbit IgG (Sigma) or using Animal Research Kit (DAKO, Carpinteria, CA). Sections 
were visualized using diaminobenzidine as substrate and counterstained with hematoxylin. 
 
 Quantification of epithelial proliferation. Animals received a single intraperitoneal 
injection of bromodeoxyuridine (BrdU; 50 mg/kg) from a freshly made stock solution of 5 
mg/ml dissolved in PBS. The mice were euthanized 1 h later. The distal 4-5 cm of the colon were 
assessed for crypt length and for BrdU incorporation using quantitative computer-assisted image 
analysis (KS-400 MACROS). Only crypts visible along their entire length were analyzed. The 
number of specimen examined were n = 14 for control, n = 6 for 3 and 6 DPI, and n = 12 for 12 
DPI colons with mean 21.6 crypts/mouse (n = 3-4 mice for cecum with mean 10 crypts/mouse). 
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Crypt length was expressed in either cell number per crypt column or in μm. BrdU incorporation 
was expressed as the labeling index percent (LI%), which was calculated as a percentage ratio of 
labeled cells out of the total number of cells in the crypt. In addition, the proliferative zone was 
calculated as height of the highest positive cell to a total length of the crypt. 
 
 Endpoint PCR for C. rodentium. DNA isolated from frozen tissues using Qiagen 
DNeasy Tissue kit was amplified with primers specific for eae (ECW1, ECW2) as described 
[Wieler et al., 1996].  DNA isolated from DBS120 and eae mutant DBS255 [Schauer and 
Falkow, 1993] were used as positive and negative controls, respectively. 
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2.5 Tables and Figures 
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Figure 2-1. Experimental inoculation of FVB mice with C. rodentium causes significant mortality beginning by 9 
days post-inoculation (DPI).  
By 3 weeks only 23% of infected animals survived. Survival curves were generated from 5 independent experiments 
(n = 41 for control and n = 84 for infected FVB mice). Differences between infected and control animals were 
significant (p < 0.0001 by the Logrank test). There was no mortality in Swiss Webster mice with (n = 20) or without 
infection (n = 16). 
 
 
 
 
  
   
 48
        
80
90
100
110
120
0 3 6 9 12 15 18 21 24
Days Post Inoculation
%
 In
iti
al
 B
od
y 
W
ei
gh
t  
   
   
   
   
 .
control FVB
control SW
infected FVB
infected SW
*
*
*
*
*
*
*
A
 
0
1
2
3
4
5
6
7
8
9
10
0 3 6 9 12 15 18 21 24
Days Post Inoculation
Ba
ct
er
ia
l L
oa
d 
(L
og
 C
FU
/g
 fe
ce
s)
 
.  
  
infected FVB
infected SW
*
*
*
B
 
 
Figure 2-2. C. rodentium infection in FVB mice results in body weight loss and delayed bacterial clearance. 
A. Body weight loss was greater in FVB mice than in SW mice beginning by 9 DPI (p < 0.0001 by two-way 
ANOVA). Shown are mean + SEM of percent body weight change compared with initial body weight for 
surviving mice at each time point, which may overestimate the 21 DPI body weight change for FVB mice 
(see text). *p < 0.05 for SW and p < 0.0001 for FVB mice by the paired t test.  
B. Infection kinetics were similar in both groups through 9 DPI, but bacterial clearance was delayed in FVB 
mice thereafter. Shown are mean + SEM log 10 transformed CFU/g feces for surviving animals with feces 
at each time point, which may underestimate the fecal shedding of C. rodentium in FVB mice (see text). *p 
< 0.05 for 12 DPI and p < 0.0005 for 15 and 18 DPI by Student’s t test. 
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Figure 2-3. Colon and cecum counts of C. rodentium do not correlate with bacterial attachment in FVB mice. 
A. Tissue homogenates were plated at 3, 6, and 12 DPI. Shown are mean + SEM log 10 transformed CFU/g 
tissue.  
B. Although high bacterial burden was found at all time points in both cecum and colon, there was no 
correlation with attachment of bacteria to epithelial cells identified by immunohistochemistry (IHC) for C. 
rodentium (original magnification 200x; panels a, c, and e are colon; b, d, and f are cecum). No C. 
rodentium was present in control colon or cecum of FVB mice (a and b). Bacterial attachment was 
observed in the distal colon beginning by 6 DPI. Bacteria are on the luminal surface, as well as deeper in 
the crypts (c). Although the lumen of the cecum contains bacteria, no attachment to epithelium was 
observed in the cecum at 6 DPI (d). By 12 DPI, most of the positive signal in the colon was associated with 
exfoliated cells (f), though some surface attachment was identified in more proximal regions of the colon 
(not shown). On the other hand, there were occasional areas of focal bacterial attachment to epithelial cells 
in the cecum at 12 DPI (f). 
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Figure 2-4. C. rodentium infection causes epithelial hyperplasia in the colon of FVB mice.  
By 6 DPI, there was an increase in crypt column heights and labeling index (A) and expansion of the proliferative 
zone (B) in the distal colon of infected animals. Shown are mean + SEM values, *p < 0.0001 by ANOVA with post-
hoc Student’s t test comparisons between the groups. BrdU labeling in control (C) and 12-DPI colon (D) reveals 
extensive proliferation of enterocytes throughout the entire crypt including the surface epithelium in infected mice, 
original magnification 100x. 
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Figure 2-5. Epithelial proliferation in the cecum of C. rodentium–infected FVB mice 12 DPI.  
Despite the trend for an increase, no significant differences were found for any of the proliferation parameters, 
except cecum crypt height (p < 0.01 by Student’s t test). The increase in proliferation was less substantial in cecum 
than in the colon of infected FVB mice (Figure 2-4), which correlated with less bacterial attachment in the cecum 
than in the colon. Shown are mean + SEM values.
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Figure 2-6. Apoptosis in infected FVB mice 12 DPI identified by activated caspase 3 staining.  
No apoptosis detected in the colon of uninoculated mice (A). Increased apoptosis was observed in dying atrophic 
crypts (arrow) (B). Apoptosis was mainly associated with exfoliated luminal, but not mucosal cells, indicating that 
apoptotic cells are rapidly removed from the tissues (C). Despite the low number of apoptotic cells seen in the colon, 
substantial staining was observed in the ileum on the same slides (D). Original magnification 200x.  
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Figure 2-7. Colonic histopathology in FVB mice infected with C. rodentium. 
FVB mice infected with C. rodentium developed colonic inflammation (A), by 6 DPI that was more pronounced by 
12 DPI. This was accompanied by an increase in epithelial dysplasia (B) (p < 0.0001 using Kruskal-Wallis non-
parametric test with subsequent Dunn’s multiple comparison test). Each dot represents one animal. Correlation 
analysis of inflammation versus dysplasia revealed a strong association between these two factors (Spearman r = 
0.871, p < 0.0001). 
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Figure 2-8. Microscopic lesions in the colon of FVB mice 12-15 DPI. 
A. Normal colon from an uninoculated FVB mouse. 
B and C. Hyperplastic crypts with increased numbers of mitotic figures and goblet cell depletion. Note significant 
infiltrate of inflammatory cells in the mucosa and submucosa. 
D. Colitis and ulcer (arrow) with marked transmural inflammation and submucosal edema. 
E and F. Epithelial atypia characterized by loss of normal tissue architecture, epithelial cell pleomorphism, gland 
malformation with splitting, branching and infolding. Some mice with more advanced lesions displayed high 
nuclear-to-cytoplasm ratio, crypt branching with irregular buds and occasional micronests within the abutting lamina 
propria. 
G and H. GALT-associated atypia with herniated dysplastic crypts and dilated and attenuated cysts in submucosa. 
H&E stain. Original magnifications are 25x for panel G, 40x for D, 100x for A, B, and H, 200x for C and E, and 
400x for F. 
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Figure 2-9. Cecal histopathology in FVB mice infected with C. rodentium. 
Cecal lesions were identified by 12 DPI in infected FVB mice (p < 0.0001 using Kruskal-Wallis non-parametric test 
with subsequent Dunn’s multiple comparison test). Inflammation and dysplasia were well correlated (Spearman r = 
0.729, p < 0.0001). 
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Figure 2-10. A small percentage of mice develop persistent lesions in the large intestine 16 or 30 WPI with C. 
rodentium. 
A. Lesion scores in the colon and cecum of uninoculated mice and mice at 16 and 30 WPI. Each dot represents one 
animal. The colonic disease score was slightly, but significantly, greater at 16 WPI (p < 0.0001 by Kruskall-Wallis 
followed by Dunn’s multiple comparison test) compared with uninfected controls and 30 WPI. 
B. Photomicrographs of chronic lesions. At 16 WPI, inflamed and hyperplastic tissue, mainly in the proximal colon 
was segmentally distributed (see adjacent normal mucosa). Original magnification 200x (a). At 30 WPI, diffuse 
lesions were observed throughout the colon and cecum. Note the numerous lymphoid aggregates, crypt abscesses 
and dilation. Original magnification 100x (b and c). 
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Figure 2-11. Quantitative RT-PCR for expression of immunomodulatory cytokines. 
Susceptible FVB and resistant SW mice demonstrated comparable expression of proinflammatory and 
immunomodulatory genes in response to C. rodentium infection. Each dot represents one animal. Mean lines are 
presented. 
p<0.01 by one-way ANOVA followed by Tukey's Multiple Comparison Test. 
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Table 2-1. Number of FVB mice used in the study 
 
3 DPIa 6 DPI 12 DPI 16 WPIb Total Inoculum 
M F M F M F M F  
 
Sterile broth 1 2 1 2 7 8 10 10 41 
C. rodentium 3 3 3 4 12 19 24 16 84 
 
adays post-inoculation, bweeks post-inoculation 
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3.1. Introduction 
 Acute diarrhea illness is one the most important health problems in the world today, 
particularly in young children in developing countries. This life-threatening condition occurs in 
about four billion people per year and causes more than 2 million deaths worldwide each year 
[Kosek et al., 2003; Lopez et al., 2006; WHO, 1999]. The most common cause of diarrhea is 
gastrointestinal infection. Infection results in increased intestinal secretion and/or decreased 
intestinal absorption leading to fluid and electrolyte loss and dehydration that can be fatal if not 
treated [Casburn-Jones and Farthing, 2004]. Among the most important bacterial causes of 
diarrhea are enteropathogenic and enterohaemorrhagic Escherichia coli (EPEC and EHEC, 
respectively) [Nataro & Kaper, 1998]. These pathogens produce ultrastructural changes 
characterized by intimate bacterial adhesion to the apical surface of enterocytes, effacement of 
microvilli, and pedestal formation, which are called “attaching and effacing” (A/E) lesions. The 
pathophysiology of diarrhea due to infection with A/E pathogens is not well understood. 
Proposed mechanisms include decreased absorptive surface epithelium, disruption of tight 
junction and intestinal barrier function, impaired ion transport, and induction of inflammation 
[Berkes et al., 2003; Dean et al., 2006; Guttman et al., 2006a; Shifflett et al., 2005; Vallance & 
Finlay, 2000].  
 Citrobacter rodentium, a murine A/E pathogen, possess similar virulence factors as 
EPEC and EHEC, and produces comparable ultrastructural changes in the distal colon of infected 
mice [reviewed in Luperchio and Schauer, 2001; Mundy et al., 2005]. Typically, this organism 
causes severe but temporary epithelial hyperplasia with a variable degree of inflammation in the 
distal colon of most inbred and outbred lines of laboratory mice. Exceptions include suckling 
animals or C3H substrains (independent of TLR4 status), which demonstrate 60% to 100% 
mortality by approximately two weeks after infection with C. rodentium [Barthold et al., 1976; 
Barthold et al., 1978; Barthold, 1979; Khan et al., 2006; Vallance et al., 2003]. We recently 
discovered that adult FVB/N mice (FVB) are also extremely susceptible to C. rodentium 
infection [Borenshtein et al., submitted]. Inbred FVB mice are derived from outbred Swiss 
Webster (SW) mice and, since SW are known to be resistant, comparative studies between those 
cognate lines of mice were performed. Twelve-week old FVB mice infected with C. rodentium 
developed high degree of mortality and severe colitis compared with their outbred SW 
counterparts, which developed more typical subclinical disease in response to infection. 
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Differences in disease outcome were observed despite comparable expression of TNF-α, IFN-γ, 
and iNOS in susceptible and resistant animals. The results of our previous study suggested that 
the cause of death in C. rodentium-infected FVB mice was hypovolemia due to dehydration 
[Borenshtein et al., submitted]. To characterize the mechanistic basis for the striking difference 
in outcome of infection between two closely related lines of mice, we used microarray 
technology to determine global patterns of gene expression in susceptible FVB and resistant SW 
mice infected with C. rodentium. Gene Chips from Affymetrix were employed to identify and 
quantify both strain-dependent and infection-dependent alterations in host gene expression, and 
results were confirmed by quantitative real-time PCR and serology. We discuss predominant 
functional categories of differentially regulated genes, potential candidates for susceptibility and 
implications for future studies of C. rodentium pathogenesis. We suggest novel testable 
hypotheses about newly implicated host genes and their potential role in the development of 
infectious colitis and diarrhea.  
 
3.2 Results 
Infection of FVB and SW mice with C. rodentium 
 To characterize how differentially expressed genes determine susceptibility to C. 
rodentium infection, FVB and SW mice were analyzed before and at two different time points 
post-inoculation. Time points were selected to reveal differentially expressed genes prior to 
infection, following establishment of infection but before development of disease (4 dpi), and 
after the development of colitis but before the development of appreciable mortality (9 dpi). As 
expected, sham-dosed 12-week old mice were found to be indistinguishable 4 and 9 dpi, 
therefore, samples from these uninoculated control animals were combined and treated as a 
single group for each line of mouse (experimental design is presented in Table 3-1).  
 Details of FVB susceptibility to C. rodentium infection were previously reported 
[Borenshtein et al., submitted]. Here, FVB and SW mice infected with C. rodentium developed 
comparable alterations in body weight, fecal bacterial shedding, and no appreciable colonic 
lesions at 3-4 dpi (Figure 3-1). By 8 dpi, body weight gain in infected and uninoculated control 
SW mice was not significantly different (107.5 ± 2.0 % and 106.3 ± 1.8 % of initial body weight 
respectively, Figure 3-1A), whereas infected FVB mice developed significant weight loss (103.4 
± 1.8 % and 97.6 ± 2.2 % for control and infected mice respectively, p<0.05). Likewise, fecal 
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bacterial shedding was higher in FVB mice than in SW mice at 8 dpi (8.1 ± 0.2 vs. 7.5 ±  0.2 
log10 CFU/g feces, respectively, p<0.05, Figure 3-1B), although the significance of this 
difference is not completely clear. At 9 dpi, FVB mice infected with C. rodentium developed 
significant pathological lesions, including colonic inflammation, hyperplasia, and mild dysplasia 
(Figure 3-1C). Infected SW mice developed comparable hyperplasia, but less inflammation and 
no dysplasia at 9 dpi (p<0.0001). The median lesion scores for infected versus control FVB mice 
were 2.5 vs. 0 for inflammation, 2 vs. 0 for hyperplasia, and 0.5 vs. 0 for dysplasia. The median 
lesion scores for infected versus control SW mice were 2 vs. 0 for inflammation, 2 vs. 0 for 
hyperplasia, and 0 vs. 0 for dysplasia. Samples for microarray analysis were selected based on 
the clinical signs, infection status, and severity of lesions, and are shown in Figure 3-1. 
 
Gene expression analysis of FVB and SW mice during C. rodentium infection  
 Differential expression analysis of pairwise comparisons (Material and Methods) 
identified 462 probe sets (1% of the total number of probe sets) significantly different between 
SW and FVB mice prior to infection (Figure 3-2A). In response to C. rodentium inoculation, 
5,123 probe sets (11.4%) were either induced or repressed by more than two-fold in one or both 
of the lines of mice. The number of significantly modulated genes in response to infection was 
greater in susceptible FVB mice than in resistant SW mice, particularly as disease progressed. 
Specifically, infected FVB mice had 2,195 and 3,297 differentially expressed probe sets at 4 and 
9 dpi, respectively, compared with uninoculated controls, whereas infected SW mice had 1,798 
and 1,945 differentially expressed probe sets at 4 and 9 dpi, respectively, compared to 
uninoculated controls (Figure 3-2A). Overall, alterations in 5,585 (12.4%) probe sets 
corresponding to 4,257 genes were detected during the course of the experiment. Most of the 
differences were within +/- 7-fold range (Table 3-S1, available at 
http://web.mit.edu/diana_b/www/TableS1.xls) 
 
Validation of microarray results by quantitative RT-PCR  
 To confirm the results obtained with Gene Chips, quantitative real-time fluorigenic RT-
PCR (TaqMan) was performed for 35 selected genes. Correlation analysis was performed by 
comparing expression ratios from microarray results versus ratios determined by TaqMan 
analysis (Figure 3-2B). Significant correlation was observed between the two assays (Pearson 
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correlation coefficient r = 0.87, R2 = 0.75, p<0.0001). Individual Pearson correlation coefficients 
ranged from 0.67 to 1 in all but two out of 35 genes (Crry and Slc10a2) (Table 3-2). The overall 
predictability rate of the microarray results by quantitative real time PCR was 94%, which 
compares favorable or even exceeds that reported for data processing by dChip [Rosati et al., 
2004]. Side-by-side comparisons of microarray and qRT-PCR results are presented in Figure 3-3. 
 
Analysis of genes exhibiting a host effect  
 To identify genes that were differentially expressed between susceptible FVB mice and 
resistant SW mice, referred to here as a host effect, comparative analysis of common and unique 
genes modulated at individual time points was performed (Spvs.Fp or Si4vs.Fi4 or Si9vs.Fi9). 
Transcripts (1,303) represented by 1,547 probe sets (3.4%), were more than two-fold 
differentially expressed between the two lines of mice (a complete list of genes with host effects 
is presented in Table 3-S2, available at http://web.mit.edu/diana_b/www/TableS2.xls).  
 Principal Component Analysis (PCA) was applied to the resulting data (Figure 3-4A, 
Table 3-3), yielding distinct groups correlating to the line of mouse and infection status. 
Consistent with their inbred strain background, there was tighter clustering of uninoculated 
control FVB mice than uninoculated control outbred SW mice. Discrimination of FVB mice as a 
function of time during infection was quite good, whereas classification of SW mice as a 
function of time during infection was less robust, reflecting greater variation between individuals 
and milder disease overall. Similar results were obtained by hierarchical clustering (Figure 3-5). 
Distinct branches for uninoculated, 4 dpi, and 9 dpi FVB mice, along with good separation 
between uninoculated and infected SW mice was in good agreement with the results of PCA.  
 Differentially expressed genes between SW to FVB mice as a function of time during 
infection were divided into 7 sub-groups (Figure 3-4B). Group A represents genes that were 
differentially expressed between the lines of mice at all times. Groups B, C, and D represent 
genes that were differentially expressed at two time points. Groups E, F, and G represent genes 
uniquely differentially expressed between uninfected mice, or infected mice at 4 or 9 dpi, 
respectively. Enrichment analysis was performed to identify, group, and permit further 
characterization of genes that contribute to specific biological functions. Many transcripts 
identified by enrichment analysis were uncharacterized genes or expressed sequence tags, but 
1,015 (77.9%) transcripts were assigned to a Gene Ontology (GO) node, 347 (26.6%) to a 
 66
Protein Domain node, 164 (12.6%) to a Pathway node, and 1,136 (87.2%) to a Chromosome 
node. The complete list of enriched GO categories, as well as in each sub-groups, is shown in 
Table 3-S3 (available at http://web.mit.edu/diana_b/www/TableS3.xls).  
 To analyze GO terms enriched between the two lines of mice for biological function, fast 
assignment and transference of information GO (FatiGO) was used. After excluding genes with 
unknown function and redundant probe sets, 902 genes out of 1,547 were used for analysis. 
Approximately 25% of these genes were assigned to GO “transport” at the fifth level of 
hierarchical clustering, making it one of the most prevalent categories. On the other hand, only 
11% of genes were assigned to “immune response” category (Figure 3-4C). 
 The most significantly differentially expressed genes are presented in Table 3-4 
(hierarchical clustering of those genes is shown in Figure 3-6). A number of these genes were 
consistently overexpressed in one line of mouse compared to the other line before and at all time 
points after infection (Group A).  These genes included arginase type II (Arg2), hypoxia 
inducible factor alpha (Hif1a), interferon activated genes 202b and 203 (Ifi202b and Ifi203), 
membrane-spanning 4-domains (Ms4a4b, aka Chandra), proton-dependent high affinity 
oligopeptide transporter Pept2 (Slc15a2), sorting nexin 6 (Snx6), sialyltransferases St3gal4 (aka 
Siat4c) and St6galNac1 (aka Siat7a), and ubiquitin carboxyl-terminal esterase L5 (Uchl5 aka 
Uch37). Other genes, such as angiogenin (Ang4), immunoglobulin chains (IgK, Igh-VJ558), and 
intelectin (Intl) were overexpressed in one line of mouse prior to infection, but became 
overexpressed in the other line at some point during infection. Some genes were profoundly 
modulated in one line of mice at a particular time point. Among those transcripts were 
apolipoprotein C-II (Apoc2), aquaporin 8 (Aqp8), carbonic anhydrases 1 and 4 (CA I and CA IV), 
chloride channel calcium activated 3 (Clca3), cytochrome P450 (Cyp2d9), meprins 1 alpha and 
beta (Mep1a and Mep1b), resistin-like beta (Retnlb, aka Fizz2 or Relmb), oligopeptide 
transporter Pept1 (Slc15a1), and down-regulated in adenoma Dra (Slc26a3). A few genes, 
namely Krt6a, Stfa3, Rptn, and Krtdap, showed variable expression within the group of 
uninoculated animals in both FVB and SW strains, and hence were excluded from further 
analysis.  
 Enrichment analysis of the top genes using the hypergeometric test for establishing a 
cutoff threshold revealed 9 genes in “transporter activity”, 6 genes in “oxidoreductase activity”, 
5 genes in “carrier activity”, and 4 genes in “immune response” categories (p<0.05) (Table 3-5). 
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Most of those genes, including ATP-binding cassette Abcg5, Apoc2, Aqp8, Clca3, Slc15a1, and 
Slc26a3 were substantially down-regulated in FVB mice at 9 dpi. Radial spokehead-like 2 
(Rshl2) was expressed at higher level in SW mice, especially at 4 dpi. Two other genes, Slc15a2 
and Snx6, were expressed at a significantly lower level in FVB mice at all time points (Table 3-4 
and Figure 3-6).  
 To address temporal changes in response to infection, delta eta analysis was performed 
(see methods). Out of 1,385 probe sets detected by delta eta analysis, 468 were differentially 
expressed between the lines of mice at 4 dpi, 1,173 transcripts at 9 dpi, and 256 at both time 
points. The top candidates differentially expressed by more than 8-fold included 36 genes, most 
of which were also identified by pairwise comparisons described above. Interestingly, delta eta 
analysis also discovered novel candidates that were not identified by pairwise comparisons 
(Figure 3-7, Table 3-S4 http://web.mit.edu/diana_b/www/TableS4.xls), including aquaporin 4 
(Aqp4) which was upregulated in SW mice but not in FVB mice. Enrichment analysis of these 
transcripts revealed 8 genes in “organismal physiological process”, 7 genes in “transporter 
activity”, 6 genes in "immune response", 6 genes in “antigen binding”, 4 genes in “channel or 
pore class transporter activity”, and 4 genes in “carbohydrate binding” categories (p<0.05, Table 
3-6)  
 
Comparative analytical approach 
 To independently confirm the results obtained by dChip analysis, Robust Multichip 
Analysis (RMA) using Bioconductor was also applied to the data. Comparison of uninoculated 
mice by Limma resulted in 232 host-related genes (Table 3-S5, available at available at 
http://web.mit.edu/diana_b/www/TableS5.xls).). Temporal changes in infected mice were 
determined by contrasting linear models for expression with different slopes for the two lines of 
mice and resulted in 167 host x infection time-related genes (Table 3-S6, available at available at 
http://web.mit.edu/diana_b/www/TableS6.xls). Only 12 genes were shared between the two sets 
of genes. GO category “transporter activity” was the most highly enriched functional cluster 
within genes altered by infection in a host-dependent manner (p<0.0005, Table 3-7). Categories 
with transport functions were markedly overrepresented compared with immune-related clusters 
as detected by FatiGO analysis (Figure 3-8). When random forest evaluation of gene importance 
in predicting four classes (host x infection status) was applied, 19 genes appeared to have high 
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predictive capacity (p<0.05) (Figure 3-9). Among them were the transcripts for Slc26a3 and 
Aqp8, which were as well detected by dChip analysis as most differentially expressed between 
infected SW and FVB mice. 
 
Differential expression of genes involved in intestinal ion transport and its 
regulation 
 The prevalence of transport genes within the set of differentially expressed transcripts 
detected by different analytical methods supports the hypothesis that high mortality in C. 
rodentium-infected FVB mice results from severe diarrhea and dehydration as a consequence of 
electrolyte imbalance [Borenshtein et al., submitted]. We next concentrated on genes implicated 
in intestinal ion transport as well as genes with regulatory and/or signaling functions. GO 
annotations are not complete for all transcripts. Moreover, some genes involved in intestinal 
transport, though included in other annotational categories, do not comprise a single distinct 
“intestinal transport” group in pathway analysis. Therefore, differentially expressed genes to be 
validated by quantitative RT-PCR (Figure 3-10) and further characterized (Figure 3-11) were 
selected based on current understanding of colonic ion transport [reviewed in Field, 2003; 
Kunzelmann and Mall, 2002].  
 Differential expression of a number of transcripts was observed between the two lines of 
mice at all time points (Group A). For example, FVB mice had consistently higher expression of 
the adenosine A2B receptor (Adora2b). Other genes were consistently overexpressed in FVB 
mice compared to SW mice, but also exhibited different expression as a function of time during 
infection. Sorting nexin Snx6 (overexpressed in FVB mice by 16 to 31-fold compared with SW 
mice) had increased expression at 4 dpi by approximately 2-fold in both lines of mice. However, 
at 9 dpi, expression of Snx6 remained elevated in FVB mice but returned to normal in SW mice. 
Slc15a2 (overexpressed in FVB mice by 50-, 15-, and 2-fold before infection and at 4 and 9 dpi, 
respectively) had increased expression in infected SW mice by 2-fold, but was downregulated in 
infected FVB mice by 1.5- and 11-fold at 4 and 9 dpi, respectively.  
 Some genes were differentially modulated in infected mice as early as 4 dpi, indicating a 
rapid response and/or involvement in regulation. For example, expression of the Na+/K+-ATPase 
beta 2 subunit (Atp1b2) was increased in SW mice by only 2.5- and 6-fold at 4 and 9 dpi, 
whereas in infected FVB mice it was induced by 10- and 55-fold respectively. Similar changes 
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were observed in transcription factor FBJ osteosarcoma oncogene B (Fosb), with 3-fold 
increased expression in infected SW mice at both time points, and 12- and 16-fold changes in 
FVB mice at 4 and 9 dpi, respectively. The calcium/calmodulin-dependent protein kinase 
Camk2b had 4-fold decreased expression in SW mice at 4 dpi, but 2.5-fold increase in expression 
in FVB mice at 9 dpi. Expression of the basolateral water channel Aqp4 was induced in both 
lines of mice at 4 dpi, but more significantly in SW mice (6- to 7-fold increase compared with 2-
to 3-fold increase in FVB mice). At 9 dpi, expression of Aqp4 remained elevated in SW mice, 
but returned to baseline in FVB mice, resulting in 6- to 8-fold difference between the lines. 
 The number of differentially regulated genes between infected FVB and SW mice 
increased over time. Many of these genes had profound decreases in expression, including 
Slc26a3 (1,100- vs. 3-fold change in FVB vs. SW mice at 9 dpi), Aqp8 (268- vs. 2-fold change), 
the sodium/hydrogen exchanger Slc9a2 (NHE2) (22.5- vs. 6-fold change), the apical iodide 
transporter (Slc5a8) (13- vs. 2-fold-change), and carbonic anhydrases CA I and CA IV (87- vs. 
0.8-, and 586- vs. 2.5-fold change, respectively). Less dramatic changes included more than 2-
fold upregulation of the potassium channel Kcnn4 (SK4) and the cGMP-dependent protein kinase 
Prkg2 in FVB mice without notable change in the expression of these genes in SW mice. 
Likewise, downregulation of the sodium/hydrogen exchanger Slc9a3 (NHE3) (8- vs. 3-fold 
decrease in FVB vs. SW mice), alpha and beta subunits of the epithelial Na+ channel (ENaC) 
encoded by Scnn1a and Scnn1b (2.7-fold decrease in FVB mice vs. 1.8-fold decrease or no 
change in SW mice, respectively), the sodium-hydrogen exchanger regulatory factor Slc9a3r1 
(NHERF1 aka EBP-50) (2-fold vs. no change) and 2010110P09Rik encoding the calcineurin B 
homologous protein Chp2 (8- vs. 2-fold change) was observed. Expression of the ouabain-
sensitive H+, K+-ATPase Atp12a (cHKA) had decreased in FVB mice by 2.5-fold, but increased 
in SW mice by 1.5-fold at 9 dpi (Figure 3-11, Table 3-S1). 
 In addition to genes identified by array, we verified the expression of cystic fibrosis 
transmembrane conductance regulator homolog (Cftr), which serves as the main chloride 
transporter in intestine and other tissues. Two transcripts corresponding to this gene showed 
opposite results by array (Figure 3-11, Table 3-S1), bringing into question the importance of 
changes in expression of the gene in our model. Nevertheless, to create a clearer picture of 
intestinal ion transport in C. rodentium-infected mice, we analyzed that gene by qRT-PCR and 
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found no difference in Cftr expression between SW and FVB mice, though subtle decrease in 
mRNA levels was observed at 9 dpi (2- and 4-fold respectively; Figure 3-10).  
 
Alterations in serum electrolytes  
 Gene expression profiling identified significant differences in expression of ion 
transporters which could contribute to diarrhea and fluid and electrolyte loss in FVB mice. 
Because severe alterations in electrolyte homeostasis could be reflected in changes in serum 
chemistry, we measured serum electrolytes in SW and FVB mice (Figure 3-12). While no 
changes in electrolytes levels were detected in SW mice during infection, infected FVB mice 
developed significant hypochloremia and hyponatremia (p<0.001). The mean concentrations of 
serum chloride was 102.4 ± 1.8, 105.5 ± 2.3, and 104.8 ± 2.3 mEq/L in SW mice before infection 
and at 4 and 9 dpi, respectively; and 102.9 ± 1.8, 99.6 ± 2.1, and 91.5 ± 2.3 mEq/L in FVB mice 
before infection and at 4 and 9 dpi. Sodium concentration in serum was 146.4 ± 1.5, 144.7 ± 1.9, 
and 147.2 ± 1.9 mEq/L in SW mice before infection and at 4 and 9 dpi; and 144.2 ± 1.5, 139.6 ± 
1.7, and 138.5 ± 1.9 mEq/L in FVB mice before infection and at 4 and 9 dpi. Anion gap, total 
CO2 and potassium levels were comparable in all groups at all time points (data not shown), 
whereas Na+/K+ ratios was lower in infected FVB mice at 9 dpi (16.0 ± 0.9 compared with 20.5 
± 0.9 in SW at 9 dpi, p<0.005). 
 
3.3 Discussion 
 Global expression profiling is emerging as a powerful method to characterize host-
pathogen interactions [Coombes et al., 2004], although many of the studies to date have been 
performed on cultured cells rather than in vivo. Here we present global expression analysis of 
host response to infection with an A/E pathogen for the first time. The goal of this study was to 
characterize the pathophysiologic basis of susceptibility to C. rodentium infection in FVB mice. 
In order to accomplish this, we performed quantitative analysis of the transcriptome of distal 
colon tissues from FVB and SW mice before and during C. rodentium infection. These studies 
revealed profound differences in response to infection between susceptible FVB mice and 
resistant SW mice. 
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 Many studies of C. rodentium interactions with host cells have focused on immune 
responses and the actin cytoskeleton [Luperchio and Schauer, 2001; Mundy et al., 2005]. Indeed, 
a substantial fraction of functional categories of differentially expressed genes that we identified 
are involved in immune responses and cellular adhesion (Table 3-S3). However, studies from our 
group as well as others suggest that innate and adaptive immunity, though important in 
determining the development of morbidity, is not the most important factor in determining 
mortality. Susceptible FVB mice were able to clear C. rodentium infection, were fully protected 
against mortality by fluid therapy (without affecting the severity or extent of colonic lesions), 
and demonstrated similar expression of pro-inflammatory and immunomodulatory genes in the 
colon compared to resistant SW mice [Borenshtein et al., submitted]. Likewise, the status of LPS 
responsiveness (TLR4 sufficiency) in different substrains of C3H mice infected with high load of 
C. rodentium did not affect the incidence of mortality [Khan et al., 2006; Vallance et al., 2003]. 
These observations suggest that immune status of the mice does not contribute to ability to 
survive through the infection, but most likely affects the clearance of the pathogen.  
 Genes differentially expressed between FVB and SW mice, including the most significant 
candidate susceptibility genes, were remarkably enriched for transport activity (Figure 3-4C and 
Table 3-5). These results were confirmed using multiple algorithms and demonstrated a larger 
fraction of transport genes than immune-related genes in determining susceptibility to C. 
rodentium infection. In addition, serum chemistry analysis showed significant hypochloremia 
and hyponatremia in infected FVB mice (Figure 3-15), consistent with marked electrolyte losses 
in animals suffering from severe diarrhea [Al-Majali et al., 2000; George and Lerche, 1990; 
Schweinfest et al., 2006]. We previously suggested that high mortality in FVB mice infected 
with C. rodentium could be attributed to hypovolemia induced by severe diarrhea [Borenshtein et 
al., submitted]. Results from this study suggest that intestinal ion disturbances rather than 
immune-related processes are responsible for dramatic phenotype in C. rodentium-infected FVB 
mice. Here, we discuss potential candidate genes for susceptibility identified in microarray 
analysis and how they could contribute to mortality in FVB mice infected with C. rodentium. 
Our working hypothesis for the overall mechanism of susceptibility is presented in Figure 3-13.  
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Candidates for susceptibility – genes involved in ion transport and its regulation.  
 The main function of the adult colon is to absorb Na+, Cl-, short-chain fatty acids 
(SCFAs) and fluid and to secrete K+, Cl-, HCO3-, and mucus [reviewed in Field, 2003; 
Kunzelmann and Mall, 2002] (Figure 3-13A). Osmotic gradient created by active salt transport is 
the driving force for passive water movement in/out of the lumen. Water transport can also occur 
actively through specific water channels, aquaporins [Barrett and Keely, 2000]. The absorptive 
functions of the colon are usually dominant, whereas transport is changed toward more 
electrolyte secretion and less absorption resulting in loss of fluid into intestinal lumen during 
diarrhea [Field, 2003; Kunzelmann and Mall, 2002]. Secretion of fluid and mucus into the lumen 
is an important mucosal defense mechanism that serves to dilute and wash away deleterious 
substances from the epithelial surface [Hecht, 1999]. However these mechanisms also can lead to 
hypovolemia, circulatory collapse and multiple organ failure when profound fluid losses result in 
marked decrease in plasma volume [Mello et al., 2004].  
 In FVB mice, transcriptional changes in transporters and signaling or regulatory genes 
were more dramatic than in SW mice during C. rodentium infection (Figure 13-3B and C). 
 Chloride absoprtion. The most striking difference between infected FVB mice and SW 
mice was in Slc26a3 which encodes the down-regulated in adenoma (Dra) protein. Dra mediates 
apical sodium-independent reabsorption of chloride into epithelial cells and excretion of 
bicarbonate into the lumen [Ko et al., 2002; Makela et al., 2002]. Mutation in Dra is associated 
with congenital chloride diarrhea (CLD), a recessive inherited intestinal disorder characterized 
by watery diarrhea and severe dehydration, high levels of fecal chloride, electrolyte disturbances, 
including hypochloremia and hyponatremia, leading to metabolic alkalosis, hypokalemia, and 
death if untreated [Hoglund et al., 1996, Holmberg et al., 1975]. Dra-/- mice are the only mouse 
model for intestinal transporter deficiency that develop substantial diarrhea and serum electrolyte 
imbalances [Schweinfest et al., 2006], whereas NHE2-/-, NHE3-/-, cHKA-/-, Aqp4-/- and Aqp8-/- 
mice have subtle if any changes in stool water content and normal serum levels of chloride and 
sodium  [Bachmann et al., 2004; Meneton et al., 1998; Schultheis et al., 1998a; Schultheis et al., 
1998b; Wang et al., 2000; Yang et al., 2005]. Remarkable downregulation in Dra expression in 
infected FVB mice (by 1,100-fold at 9 dpi) suggests Slc26a3 as one of the most plausible 
candidate genes for susceptibility to mortality.  
 73
 Chloride secretion. There are conflicting data regarding regulation of Slc26a3 by CFTR, 
the major chloride channel [Chernova et al., 2003; Greeley et al., 2001; Simpson et al., 2005; 
Wheat et al., 2000]. In this study, expression of Cftr was only slightly decreased in FVB mice at 
9 dpi and was not associated with changes in Slc26a3 message. Similar observations were made 
by Umar et al. [2000] who reported subtle changes in Cftr expression in whole distal colon from 
SW mice infected with C. rodentium. Although isolated crypts exhibited a greater increase in the 
levels of Cftr mRNA and protein, this did not correlate with large increases in transmucosal 
cAMP-dependent Cl  current, suggesting that other factors play an important role in regulating 
chloride transport during C. rodentium infection [Umar et al., 2000]. For example, chloride 
secretion via CFTR and other chloride channels can be activated by cAMP, cGMP, and calcium 
[Barrett and Keely, 2000; Berkes et al., 2003]. Camk2b and Prkg2, which would be expected to 
be downstream of these signals, were increased in infected FVB but not SW mice. This is 
consistent with a post-transcriptional mechanism of CFTR involvement in C. rodentium-induced 
diarrhea. Notably, the same signaling pathways are also implicated in inhibition of 
sodium/proton exchange and electrogenic Na+ absorption in colon [Kunzelmann and Mall, 2002; 
Lamprecht et al., 2002; McSwine et al., 1998; Zachos et al., 2005].  
 Sodium absorption. Expression of ENaC, NHE2 and NHE3, which are the main sodium 
channels involved in apical electrogenic and electroneutral sodium absorption, pH maintenance 
and fluid balance in intestine [Kunzelmann and Mall, 2002; Zachos et al., 2005], was decreased 
by infection in FVB mice, and to a lesser extent in SW mice. Downregulation of the calcineurin 
B homologous protein (CHP), which is required for Na+/H+ antiport activity [Pang et al., 2001] 
further indicates that intestinal transport is affected at transcriptional and post-transcriptional 
levels in infected FVB mice. Coupling of DRA, CFTR, and NHE3 activity is mediated by PDZ-
binding scaffold proteins [reviewed in Lamprecht and Seidler, 2006]. One such protein, EBP50 
encoded by Slc9a3r1 (NHERF1), is required for cAMP-mediated inhibition of NHE3 activity 
and stimulation of CFTR activity. The interaction of NHERF1 with the type III secretion system 
effector Map was recently implicated in the pathogenesis of EPEC and C. rodentium [Simpson et 
al., 2006]. The decrease in expression of EBP50 in infected FVB mice may represent an 
unsuccessful attempt to control diarrhea. It is notable that decreased expression of individual 
sodium transport genes was mild (2- to 3-fold), but collectively of the failure to reabsorb sodium 
contributes mortality.  
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 Potassium transport. The driving force for apical Cl- secretion is provided by means of 
basolateral potassium recycling through Na+, K+-ATPase and K+ channels [Barrett and Keely, 
2000]. Infected FVB mice demonstrated marked increase in expression of Atp1b2 that encodes 
Na+, K+-ATPase beta-2 isoform at both 4 and 9 dpi, and to a lesser extent stimulated expression 
of potassium channels KCNN4 and NKCC1 at 9 dpi. Furthermore, Na+, K+-ATPase activity was 
recently shown to be indirectly stimulated by SNX6 [Yoon et al., 2006]. This gene was not only 
consistently overexpressed in FVB mice at all times compares to SW mice, but also was 
upregulated in FVB mice at 4 and 9 dpi. These changes could potentiate electrogenic Cl- 
secretion and, hence, fluid loss. While basolateral potassium transporters were mainly 
upregulated in infected FVB mice, the luminal ouabain-sensitive H+, K+-ATPase (cHKA) 
encoded by Atp12a was downregulated in FVB mice but not in SW mice at 9 dpi. This ATPase 
was suggested to regulate Dra activity in colons of in NHE3-deficient mice [Melvin et al., 1999]. 
Furthermore, compensatory increase in intestinal cHKA expression was observed in a number of 
ion transporter gene knockout mouse models [Schultheis et al., 1998b; Schweinfest et al., 2006], 
indicating its role in maintaining intestinal ion homeostasis. Thus, impaired transcriptional 
activity of cHKA can contribute to the pathogenesis of diarrhea in C. rodentium-susceptible 
animals. 
 Bicarbonate metabolism and pH regulation. The activity of many intestinal 
transporters is regulated by intracellular pH. Rapid diffusion and equilibration of protons 
entering enterocytes at the apical membrane is dependent on carbonic anhydrases (CA), enzymes 
that catalyze the reversible hydration/dehydration of CO2 and water [Stewart et al., 1999]. 
Carbonic anhydrases, especially cytosolic CA I and membrane-associated CA IV, are known to 
play a role in ion and water transport in the small intestine and distal colon [Alvarez et al., 2003; 
Charney and Dagher, 1996; Clarke and Harline, 1998; Fonti et al., 1998; Goldfarb et al., 2000; 
Sterling et al., 2002]. Because inhibition of carbonic anhydrases is associated with marked 
decrease in sodium, chloride and water absorption as well as bicarbonate secretion [Charney et 
al., 2002; Charney et al., 2004; Goldfarb et al., 2000], profound downregulation of CA I and CA 
IV in infected FVB mice at 9 dpi suggest their critical role in C. rodentium-induced mortality. 
 Additional proteins able to affect intracellular pH include oligopeptide-protons 
symporters Pept1 and Pept2, whose expression was differentially expressed between FVB and 
SW mice. Although H+/dipeptide transport is coupled with Na+/H+ exchanger and carbonic 
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anhydrase activity in Caco-2 cells and mouse enterocytes isolated from small intestine [Stewart 
et al., 1999; Thwaites et al., 1999], the function of these transporters in distal colon is not clear 
[Boll et al., 1996; Meredith and Boyd, 2000; Shen et al., 2001]. 
 SCFA transport. Both cytosolic and luminal pH is regulated by butyrate and other 
SCFAs produced by enteric bacterial fermentation of undigested carbohydrates and dietary fiber. 
SCFAs, following ileal or colonic absorption by nonionic diffusion or via SCFA/HCO3–(OH–) 
exchange mechanism, maintain mucosal integrity and stimulate water and electrolyte absorption 
by acidification of colonocytes and activation of apical Na+/H+ and Cl–/ HCO3– exchangers 
[Borthakur et al., 2006; Charney and Dagher, 1996; Vidyasagar et al., 2005]. Therefore, 
decreased butyrate/SCFAs availability due to downregulation of Na+-dependent SCFA 
transporter Slc5a8 (Ait) in FVB mice at 9 dpi might affect mucosal permeability, disturb acid-
base homeostasis, and inhibit ion absorption in colon, thereby contributing to C. rodentium-
mediated diarrhea in susceptible FVB mice. This is similar to the decreased expression of the 
epithelial SCFA transporter MCT-1, and subsequent decrease in butyrate uptake reported in 
Caco-2 cells infected with EPEC [Borthakur et al., 2006]. This inhibitory effect depended on 
functional type III secretion system (TTSS) (escN, espA, espB, or espD genes), but did not 
require known effector proteins encoded by espF, espG, espH, and map EPEC genes [Borthakur 
et al., 2006]. These results suggest that intimate attachment is necessary for butyrate uptake in 
host cells, but yet unidentified bacterial effector proteins are implicated in the process. This 
further justifies using C. rodentium in mice as a model for EPEC infections. 
 Water transport. As was mentioned above, water passes through cells either passively, 
following osmotic gradient created by chloride and sodium transport, or can be absorbed by 
means of specific water channels, aquaporins [reviewed in Ma and Verkman, 1999; and 
Matsuzaki et al., 2004]. A number of aquaporins were differentially expressed in infected FVB 
mice compared with SW mice. Apical channel Aqp8 was profoundly downregulated in FVB 
mice at 9 dpi, which could interfere with fluid transport from the intestinal lumen in susceptible 
animals. In resistant SW mice, fluid loss caused by decreased ion reabsorption is compensated by 
upregulation of basolateral channel Aqp4, which prevents fluid accumulation in colon of resistant 
animals. Although a slight increase in Aqp4 expression was observed in FVB mice at 4 dpi, the 
transcripts levels returned to baseline at 9 dpi. These results are consistent with a recent report 
implicating mislocalization of aquaporins 2 and 3 in C. rodentium diarrrhea [Guttman et al., 
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2007]. Thus, the function of water channels in C. rodentium-infected FVB mice deserves further 
investigation. 
 Transcriptional regulation. Among the transcription factors differentially expressed 
between susceptible and resistant mice, Fosb was the most affected by infection at 4 dpi (by 12-
fold). Its expression increased in FVB mice at 9 dpi as well (by 16-fold), whereas a subtle 3-fold 
increase was observed in SW mice at 4 and 9 dpi. FosB is an “immediate-early” nuclear protein 
from the Fos family of transcription factors. Dimerization of Fos and Jun proteins causes binding 
to activator protein 1 (AP-1) promoter sites. AP-1 complexes affect expression of a many genes, 
including ion channels, receptors, cytoskeletal proteins and signaling molecules [Chen et al., 
2001; Nestler and Hyman, 2002; Turi et al., 2002]. Within the set of genes with a strain effect, 
67% were predicted to have AP-1 binding sites. This included many potential candidates for 
susceptibility, such as Aqp4 and Aqp8, Alox12, cHKA, CA I, Slc26a3, Slc5a8, Slc9a2, NHERF1, 
and Fosb itself (data not shown). Early upregulation of Fosb in infected FVB mice may indicate 
that FosB contributes to fatal diarrhea independent of and prior to inflammation-mediated 
effects. Further studies are needed to determine signals that upregulate Fosb expression in 
susceptible mice, FosB partners in DNA binding and FosB target genes.  
 Inflammatory effectors. Inflammatory mediators are also implicated in pathogenesis of 
diarrhea. A good example is adenosine, a secretagogue released by polymorphonuclear cells, 
eosinophils and mast cells in inflammatory conditions [Madara et al., 1993; Marquardt et al., 
1984; Strohmeier et al., 1995]. Adenosine released from the breakdown of ATP released from 
injured cells during infection is an additional possible source, as has been proposed for type-III 
secretion possessing pathogens such as EPEC, E. coli O157:H7, and Salmonella enterica [Crane 
et al., 2002]. Adenosine signaling is mediated by G-protein-coupled receptors of which A2BAR 
encoded by Adora2b is the predominant adenosine receptor in intestinal epithelial cells 
[Strohmeier et al., 1995]. Downstream signaling by activated A2BAR results in cAMP- and 
arachidonic acid-dependent activation of potassium channels and intestinal Cl- secretion [Barrett 
et al., 1990; Barrett and Bigby, 1993; Cobb et al., 2002; Kolachala et al., 2005a; Kolachala et al., 
2005b; Madara et al., 1993; Strohmeier et al., 1995; Wang et al., 2004]. The consistently higher 
Adora2b expression in FVB mice may predispose susceptible animals to this diarrhea-inducing 
pathway and contribute to the susceptibility of FVB mice to C. rodentium infection. 
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 Epithelial differentiation. Notably, a number of genes profoundly downregulated in 
susceptible FVB mice, such as Slc26a3 (Dra), Aqp8, CAIV, and Slc5a8 (Ait), are also implicated 
in the development of colonic tumors [Agrawal et al., 2002; Birkenkamp-Demtroder et al., 2005; 
Croner et al., 2005; Fischer et al., 2001; Haila et al., 2000; Hoglund et al., 1996; Reichling et al., 
2005]. Thus, relative loss of differentiated epithelium due to erosions and ulcerations and/or 
expansion of less well differentiated proliferating cells in the crypt compartment [Borenshtein et 
al., submitted] could contribute to altered transcriptional activity in infected FVB mice. 
However, expression of other markers of differentiation, such as sucrase-isomaltase, alkaline 
phosphatase, villin, intestinal trefoil factor 3, Kruppel-like factor 4, [Ho 1992; Mariadason et al., 
2005], was unchanged or not altered to the same extent in infected FVB mice, indicating that 
erosions or hyperplasia alone can not fully account for the dramatic loss of expression of Dra, 
Aqp8, CAIV, and Ait in susceptible FVB mice. 
  Developmental regulation. Expression of many genes identified in our global analysis 
changes during postnatal development. This includes sodium exchangers, aquaporins and 
carbonic anhydrases with higher levels of expression and PEPT proteins with lower expression 
in adults animals compared with suckling or weanling animals [Bates et al., 2002; Bekku et al., 
1998; Collins et al., 1997; Collins et al., 1998; Fleming et al., 1993; Purkerson and Schwartz, 
2005; Shen et al, 2001]. The results suggest that high mortality in C. rodentium-infected adult 
FVB mice and young mice of all strains and stocks may result from common pathogenic 
mechanism, such as inadequate apical ion, proton and water transport in distal colon leading to 
dehydration and hypovolemic shock. Therefore, genes identified by microarray analysis are 
integral for understanding the mechanisms of susceptibility to fatal infectious diarrhea in young 
mice and other mammals. 
 Applications for other models of diarrhea. Ion imbalances are implicated in other non-
infectious animal models of diarrhea. Thus, mice with defect in cytoskeletal intermediate 
filaments, like keratin 8-deficient mice (on FVB/N background), demonstrate ion transport 
impairment before the onset of colonic hyperproliferation and inflammation. Interestingly, those 
animals develop diarrhea despite normal tight junction permeability [Toivola et al., 2004], raising 
the possibility that tight junction abnormalities contribute but do not directly cause mortality in 
C. rodentium-infected FVB mice. In addition, significant impairment of sodium and chloride 
absorption and bicarbonate secretion is found in colitis-prone IL-2-/- mice [Barmeyer et al., 
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2004]. Chemical induction of colitis by treatment with dextran sulfate sodium (DSS) results in 
substantial downregulation of carbonic anhydrases CA I and CA IV and aquaporins Aqp4 and 
Aqp8 [Hardin et al., 2004; Mizoguchi et al., 2003; Renes et al., 2002]. These results indicate that 
infectious diarrhea and noninfectious inflammation-associated diarrhea may have common 
mechanisms of pathogenesis and further justify the use of our model for studying fluid and 
electrolyte imbalance. 
  
 In a summary, we present the first gene expression profiling of C. rodentium infection in 
vivo. The genomic analysis of the host response to infection generated novel testable hypotheses 
about how this enteric murine pathogen causes disease and mortality in FVB mice. Marked 
impairment in intestinal ion homeostasis was predicted by microarray analysis and confirmed by 
quantitative RT-PCR and serum electrolyte measurements. The fact that the majority of 
genetically manipulated mice with deficiency in ion transporters develop mild if any diarrhea 
and no appreciable serum electrolyte disturbances indicates the existence of compensatory 
mechanisms. It is likely that in the disease state (i.e. diarrhea induced by C. rodentium) many 
genes involved in intestinal ion transport, signaling and regulation act together. In that regard, 
orchestrated alterations, such as down-regulation of main apical colonic transporters, 
upregulation of basolateral ion channels and other changes in regulatory signals observed in 
susceptible strain upon C. rodentium infection, may provide a basic mechanism for the 
development of severe diarrhea and fatal dehydration in infected FVB mice compared with the 
resistant SW mice. Our study identified potential candidate genes for susceptibility that can be 
used to develop new strategies for preventing and treating intestinal inflammation and fatal 
diarrhea. 
 
3.4 Selected Methods 
 Animal infections. Inbred FVB/NTac and outbred Swiss Webster Tac:SW moms with 40 
and 36 female two-week-old pups respectively were purchased from Taconic Laboratories 
(Germantown, N.Y.). Because animals came from different barrier units, mixing of bedding from 
the weaning till the required age (12 weeks old) was performed twice a week to obtain 
comparable bacterial background and minimize commensal flora-related bias. The animals were 
housed in microisolator cages within a specific pathogen-free facility approved by Association 
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for Assessment and Accreditation of Laboratory Animal Care and maintained on pelleted rodent 
chow and water ad libitum. At 12 weeks of age, infectious colitis was induced by intragastric 
inoculation with 1.9 x 109 CFU of DBS120 as described Appendix 1: General Methods. A total 
of 37 FVB and 36 SW mice were used in the inoculation study as described in Table 3-1. 
Animals were weighed and monitored for fecal bacterial shedding prior to inoculation and at 3, 
6, and 8 DPI. Fecal bacterial shedding was assessed by plating serial dilutions of feces from 
individual animals on MacConkey lactose agar supplemented with 40 μg/ml Kan. The lower 
limit of detection was 1 CFU/mg of feces. Animals were euthanized at 4 and 9 DPI. At necropsy, 
the colon of each mouse was collected aseptically, cleared of feces, and the distal colon was 
dissected in half longitudinally. The one half of the distal colon was snap frozen in liquid 
nitrogen and stored at -80°C until RNA was extracted. The rest of the tissues were fixed, 
processed and scored as described in Appendix 1. All experiments were approved by the MIT 
Animal Care and Use Committee. 
 RNA extraction. Total RNA was extracted from frozen distal colon using Trizol reagent 
according to the recommendations of the manufacturer (Invitrogen, Carlsbad, CA). The resultant 
RNA was DNase I treated and purified with RNeasy Clean-up kit as recommended by the 
manufacturer (Qiagen, Valencia, CA). The total RNA concentration and 260/280 ratio was 
evaluated spectrophotometrically. Only samples with a 260/280 ratios range of 1.8 to 2.1 were 
further processed. RNA samples were evaluated by the Agilent 2100 Bioanalyzer (Agilent, Palo 
Alto, CA) and consistently demonstrated high-quality RNA with distinct 28S and 18S peaks and 
no evidence of degradation.  
 Array design and hybridization. Global gene expression analysis was performed on the 
distal colon with 2-3 mice per group. Because no difference for any parameters was observed in 
uninfected mice at 4 or 9 dpi, the animals were pooled into uninfected control groups for each 
line of mouse. The selection of representative samples for microarray analysis was based on 
known infection status and colonic lesions. The final number of biological replicates for each 
condition was n = 5 uninfected FVB mice (“Fp” group), n = 4 uninfected SW mice (“Sp” group), 
and n = 3 infected animals from each stock at each time point (“Fi4”, “Si4”, “Fi9”, and “Si9” 
respectively, Table 3-1). One-cycle target labeling of isolated RNA, hybridization, 
washing/staining and scanning was carried out in the Whitehead Institute Center for Microarray 
Technology (Cambridge, MA) as detailed at http://www.wi.mit.edu/CMT/protocols.html. First- 
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and second-strand cDNA syntheses were performed using SuperScript double-stranded cDNA 
synthesis kit (Invitrogen, Carlsbad, CA). The second strand DNA synthesis, the clean-up of the 
double-stranded cDNA, the synthesis and the clean-up of the biotin-labeled cRNA were 
completed according to Affymetrix protocols (Santa Clara, CA). Twenty μg of cRNA were 
fragmented and hybridized as recommended by Affymetrix to the GeneChip Murine Genome 
430 2.0 Arrays (Affymetrix, Santa Clara, CA) containing 45,037 probe sets that correspond to 
over 34,000 well characterized mouse genes. Each sample was hybridized to one array, with 21 
total chips used. The arrays were scanned using GeneChip scanner 3000 enabling for high-
resolution scanning as recommended (Affymetrix, Santa Clara, CA). The expression output for 
all the samples met the Quality control requirements (data not shown). The presence call for all 
the arrays ranged from 58% to 66%. Microarray results were tightly correlated between 
biological replicates within and between the animal groups (Figure 3-14). 
 Identifying differentially expressed genes. The cell intensity files (*.cel) containing 
hybridization signals were generated with GeneChip Operating Software (GCOS 1.2).  The 
normalization and processing of the results were done by DNA-Chip Analyzer (dChip) software 
(www.dchip.org) implementing model-based expression index (MBEI) analysis using outlier 
detection algorithm to eliminate potential cross-hybridizing probes [Li and Wong, 2001a, Li and 
Wong 2001b]. Normalization using invariant set of genes, in which all arrays are normalized to 
the common baseline array with median intensity, was followed by background correction and 
log2 transformation. The perfect match-only model was applied in order to reduce noise. A mean 
value was calculated from signal log2 ratios for each gene and group. Gene expression was 
considered to be significant when it was changed by more than two-fold (an average log2 ratios 
of above 1.0 or below -1.0). Genes were clustered by tightness with centroid-linkage method 
using 1 – r (where r is the Pearson correlation coefficient) as the distance measure while 
redundant probes were masked. Results were visualized with the help of heat maps showing 
color-coded expression levels (red = high expression, black = medium expression, and green = 
low expression) and vertically drawn gene trees. Enrichment analysis was done within dChip 
software using Hypergeometric test with p<0.05 and at least 4 functionally annotated genes if not 
otherwise indicated. FatiGO (Fast Assignment and Transference of Information using Gene 
Ontology (GO)) Plus web-based tool [Al-Shahrour et al., 2004; Al-Shahrour et al., 2005, 
http://fatigo.bioinfo.cipf.es] was used for calculating the prevalence of GO functional groups. 
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The results of inclusive analysis at the deepness of 5th level and more than 5% of GO categories 
enrichment were presented. Temporal changes in response to infection were addressed using a 
“delta eta” analysis to identify significant differential transcript modulation in response to 
treatment where for each transcript [log2 (FVB infected/FVB uninoculated) – log2 (SW 
infected/SW uninoculated)] where FC>1.5 For each gene, delta eta values for 4 and 9 dpi were 
calculated as log2(Si4vs.Sp) – log2(Fi4vs.Fp) and log2(Si9vs.Sp) – log2(Fi9vs.Fp), respectively. 
The results were processed in Spotfare and subjected to enrichment GO analysis by dChip. All 
the Affymetrix and GO annotations based on October 2006 datafiles. 
 Results obtained by dChip data processing were verified by RMA method [Irizarry et al., 
2003], available as part of the BioConductor software. Differential expression between the 
animal groups was assessed by calculating a moderated t-statistic for each gene using the Limma 
package [Smyth, 2005] and 2-fold threshold. Temporal infection-induced trends between the 
groups were determined by linear model with false discovery rate (FDR) < 0.05 and 2-fold cut 
off threshold. To discriminate gene behavior, random forest analysis to predict four classes 
(strain x infection status) was applied with p<0.05. Enrichment analysis was performed within 
dChip with p<0.0005, and the prevalence of functional groups was determined with FatiGO as 
indicated above. 
 TaqMan quantitative RT-PCR. cDNA generation and qRT-PCR using Applied 
Biosystems predesigned primers and probes (Table 3-3) were done as described in Appendix 1: 
General Methods. The resultant ratios were matched with corresponding comparisons from 
microarray analysis and subjected to Pearson correlation analysis. The number of samples used 
for TaqMan were n=10 in uninoculated control groups and n=6 to 8 samples for infected groups 
in each line of mice (Tables 3-1). Each reaction was carried out in duplicates.  
 Measuring serum electrolyte levels. Electrolytes were detected in serum by IDEXX 
Preclinical Research Services (IDEXX Laboratories Inc., MA) using electrolyte Panel 957, 
which included detection of bicarbonate, chloride, potassium, sodium, Na/K ratio and anion gap 
in 200 μl of serum samples. 
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3.5 Tables and Figures 
 
 
Table 3-1. Number of animals used for microarray analysis, quantitative RT-PCR (TaqMan) and 
experiment 
 
Array 
sample 
name 
Days post 
inoculation 
Group Group 
label 
Total number 
of arrays in a 
group 
Total number 
of samples for 
TaqMan 
Total number of 
mice in a group 
 
S4_1 
S4_2 
S9_1 
S9_2 
 
 
4 
4 
9 
9 
 
SW 
pooled 
controls 
 
Sp 
 
4 (2 + 2) 
 
10 (5 + 5) 
 
16 (8 + 8) 
F4_1 
F4_2 
F9_1 
F9_2 
F9_3 
 
4 
4 
9 
9 
9 
FVB 
pooled 
controls 
Fp 5 (2 + 3) 10 (5 + 5) 20 (10 + 10) 
 
Si4_1 
Si4_2 
Si4_3 
 
4 
4 
4 
SW 4 dpi Si4 3 6 10 
Fi4_1 
Fi4_2 
Fi4_3 
 
4 
4 
4 
FVB 4 dpi Fi4 3 8 10 
Si9_1 
Si9_2 
Si9_3 
 
9 
9 
9 
SW 9 dpi Si9 3 6 10 
Fi9_1 
Fi9_2 
Fi9_3 
9 
9 
9 
FVB 9 dpi Fi9 3 7 7 
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A. B.  
 
C.            
 
 
Figure 3-1. C. rodentium infection in adult susceptible inbred FVB mice and resistant outbred SW mice. 
A. Significant weight loss was observed in infected FVB mice at 8 dpi (p<0.05). Weight was normalized and 
expressed as percent change of initial baseline. Data presented as mean ± SEM. 
B. Infection kinetics was similar in both groups at 3 dpi, but higher bacterial shedding was observed in FVB 
mice at 8 dpi (p<0.05). Bacterial counts were log10 transformed. Each dot represents one animal; line 
indicates mean of the group. 
C. FVB mice infected with C. rodentium developed significant colonic inflammation and hyperplasia, at 9 dpi. 
Infected SW mice developed less inflammation (p<0.0001), but comparable hyperplasia at 9 dpi. Each dot 
represents one animal; line indicates median of the group. 
Experimental groups included 20, 10, and 7 uninoculated control, 4 dpi, and 9 dpi FVB mice, and 16, 10, and 10 SW 
mice in the corresponded groups. 
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Comparisons 
 
Number of 
altered probe 
sets 
Number of 
corresponding 
transcripts 
   
strain - basal effect Spvs.Fp 462 410 
strain – early infection response  Si4vs.Fi4 557 476 
strain - late infection / inflammatory response Si9vs.Fi9 1,065 904 
        
SW 4 dpi response compared with uninfected Si4vs.Sp 1,798 1,481 
SW 9 dpi response compared with uninfected Si9vs.Sp 1,945 1,523 
SW disease progression response 9 dpi 
compared with 4 dpi Si9vs.Si4 901 746 
        
FVB 4 dpi response compared with uninfected Fi4vs.Fp 2,195 1,784 
FVB 9 dpi response compared with uninfected Fi9vs.Fp 3,297 2,490 
FVB disease progression response 9 dpi 
compared with 4 dpi Fi9vs.Fi4 1,506 1,212 
        
Total 
 
All combined 
comparisons 
 
5,585 
 
4,257 
 
A.   
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B. 
 
Figure 3-2. Differential expression of genes between and within the strains prior to or in response to C. rodentium 
infection. 
A. Summary of transcripts differentially expressed in individual and combined comparisons. The analysis was 
performed using Affymetrix whole mouse genome oligonucleotide chip (430 2.0 Array), which contains 
>45,000 probe sets comprising expression levels of >39,000 transcripts and variants from >34,000 well-
characterized mouse genes. The normalization and processing of the results were performed using DNA-
Chip Analyzer (dChip) software implementing model-based expression analysis. One percent of the total 
probe sets presented on the array was more than two-fold differentially expressed between SW and FVB 
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mice prior to infection. In response to C. rodentium inoculation, 11.4% of probe sets were either induced or 
repressed in one or both of the lines of mice. There were more differentially expressed genes in response to 
infection in susceptible FVB mice than in resistant SW mice, especially as disease progressed. Overall, 
alterations in 12.4% probe sets were detected throughout the experiment.  
B. Validation of microarray results by quantitative real-time PCR (TaqMan) of selected genes. Transcript 
levels were normalized to the endogenous control GAPDH, and expressed as fold change compared with 
uninoculated control FVB mice, which were set at 1, using the Comparative Ct method. The resultant log2 
ratios were matched with corresponding log2 ratios detected in microarray analysis and subjected to 
Pearson correlation analysis. Significant correlation was observed between the two assays (Pearson 
correlation coefficient r = 0.87, R2 = 0.75, p<0.0001). Pearson correlations for individual genes ranged from 
0.67 to 1. Only two out of 35 examined genes did not confirm the array results, yielding a predictability 
rate of 94% (Table 3-2).  
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Table 3-2. Validation of microarray results by quantitative RT-PCR (TaqMan) on selected genes 
 
Gene 
 
Gene Symbols 
 
ABI ID for 
predesigned assay-
on-demand 
Pearson 
correlation 
 
P value 
 
R2 of 
linear 
fit 
adenosine A2b receptor Adora2b Mm00839292_m1 0.91 0.0007 0.83 
angiogenin, ribonuclease A family, member 4 Ang4, Rnase5d Mm01315577_s1 0.97 <0.0001 0.95 
aquaporin 8 Aqp8 Mm00431846_m1 0.97 <0.0001 0.95 
arachidonate 12-lipoxygenase Alox12 Mm00545833_m1 0.98 <0.0001 0.96 
arginase type I, liver Arg1 Mm00475988_m1 0.93 0.0002 0.87 
arginase type II Arg2 Mm00477592_m1 0.88 0.0019 0.77 
ATPase, Na+/K+ transporting, beta 2 
polypeptide Atp1b2 Mm00442612_m1 0.89 0.0014 0.79 
beta galactoside alpha 2,6 sialyltransferase 1 Siat1, ST6GaI1 Mm00486119_m1 0.86 0.0028 0.74 
bone morphogenetic protein 5 Bmp5, se Mm00432091_m1 0.94 0.0001 0.89 
carbonic anhydrase 1 Car1, CA I Mm00486717_m1 0.99 <0.0001 0.99 
carbonic anhydrase 4 Car4, CA IV Mm00483021_m1  1.00 <0.0001 0.99 
CD14 antigen Cd14 Mm00438094_g1 0.91 0.0007 0.83 
CD34 antigen Cd34 Mm00519283_m1  0.90 0.0009 0.81 
complement receptor related protein Crry Mm00785297_s1 -0.38 0.3123 0.14 
cystic fibrosis transmembrane conductance 
regulator homolog CFTR, Abcc7 Mm00445197_m1      
extracellular proteinase inhibitor Expi, WDNM1 Mm00433159_m1 0.98 <0.0001 0.97 
FBJ osteosarcoma oncogene B FosB Mm00500401_m1 0.89 0.0014 0.79 
glyceraldehyde-3-phosphate dehydrogenase  GAPDH Mm99999915_g1       
histocompatibility 2, class II antigen E beta H2-Eb1, IIa-4 Mm00439221_m1 0.86 0.0027 0.75 
immunoglobulin lambda chain, variable 1 Igl-V1 Mm01627739_g1 0.81 0.0086 0.65 
Intelectin Itln Mm01616618_g1 0.67 0.0468 0.45 
Interferon activated gene 202B Ifi202b Mm00839397_m1 0.97 <0.0001 0.93 
Interferon activated gene 203 Ifi203 Mm01238610_m1 1.00 <0.0001 0.99 
Interferon activated gene 205 Ifi205 Mm01315309_m1 0.75 0.0189 0.57 
lectin, galactose binding, soluble 6 Lgals6 Mm02524460_s1 0.92 0.0005 0.85 
mucin 2 muc2 Mm00458304_g1  0.98 <0.0001 0.96 
myelocytomatosis oncogene Myc Mm00487804_m1 0.94 0.0001 0.89 
nitric oxide synthase 2, inducible, macrophage iNOS, Nos-2 Mm00440485_m1 0.69 0.0416 0.47 
protein kinase C, mu Prkcm, PKD1 Mm00435790_m1 0.91 0.0006 0.84 
sialyltransferase 4C (beta-galactoside alpha-
2,3-sialytransferase) 
Siat4c,  
ST3Gal IV  Mm00501503_m1 0.83 0.0052 0.69 
sialyltransferase 7 ((alpha-N-acetylneuraminyl 
2,3-betagalactosyl-1,3)-N-acetyl 
galactosaminide alpha-2,6-sialyltransferase) D 
Siat7d, 
ST6GalNAc IV  Mm00488228_m1 0.94 0.0001 0.89 
sialyltransferase 7 (alpha-N-acetylneuraminyl 
2,3-beta-galactosyl-1,3)-N-acetyl 
galactosaminde alpha-2,6-sialyltransferase) A) 
Siat7a, 
ST6GalNAc I  Mm00488218_m1 0.93 0.0003 0.87 
solute carrier family 10, member 2 Slc10a2, ASBT Mm00488258_m1 0.64 0.0661 0.40 
solute carrier family 15 (H+/peptide 
transporter), member 2 Slc15a2, Pept2 Mm00451610_m1  0.75 0.0212 0.56 
solute carrier family 26, member 3 Slc26a3, Dra Mm01291071_m1  1.00 <0.0001 1.00 
solute carrier family 5 (iodide transporter), 
member 8 Slc5a8, Ait Mm00520629_m1 0.92 0.0005 0.84 
tumor necrosis factor TNFa Mm00443258_m1 0.92 0.0004 0.85 
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Figure 3-3. Side-by-side comparison of gene expression analyzed by microarray and qRT-PCR 
 88
CD34
1416072_at
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
A
rr
ay
CD34
Mm00519283_m1
Sp Fp Si4 Fi4 Si9 Fi9
0.01
0.1
1
10
Ta
qm
an
Crry
1430131_at
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
p < 0.0005p < 0.000005 p < 0.005
A
rr
ay
Crry
Mm00785297_s1
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
p < 0.001
Ta
qm
an
Expi
1417160_s_at
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
100 p < 0.01 p < 0.05 p < 0.05
A
rr
ay
Expi
Mm00433159_m1
Sp Fp Si4 Fi4 Si9 Fi9
0.01
0.1
1
10
100
 p < 0.01  p < 0.001
Ta
qm
an
FosB
1422134_at
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
100 p < 0.05
A
rr
ay
FosB
Mm00500401_m1
Sp Fp Si4 Fi4 Si9 Fi9
0.01
0.1
1
10
100
p < 0.05 p < 0.01
Ta
qm
an
H2-Eb1
1417025_at
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
100 p < 0.05 p < 0.0005
A
rr
ay
H2-Eb1
Mm00439221_m1
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
100
1000
10000
 p < 0.001  p < 0.001
Ta
qm
an
Igl-V1
1428720_s_at
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
p < 0.05
p < 0.01
A
rr
ay
Igl-V1
Mm01627739_g1
Sp Fp Si4 Fi4 Si9 Fi9
0.0001
0.001
0.01
0.1
1
10
100  p < 0.001
Ta
qm
an
Intelectin
1418165_at
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
100
p < 0.05p < 0.05
A
rr
ay
Intelectin
Mm01616618_g1
Sp Fp Si4 Fi4 Si9 Fi9
0.01
0.1
1
10
100
1000
10000
p < 0.001p < 0.001
Ta
qm
an
Ifi202b
1457666_s_at
Sp Fp Si4 Fi4 Si9 Fi9
0.01
0.1
1
10
p < 0.005
A
rr
ay
Ifi202b
Mm00839397_m1
Sp Fp Si4 Fi4 Si9 Fi9
0.00001
0.0001
0.001
0.01
0.1
1
10
p < 0.001p < 0.05
Ta
qm
an
Ifi203
1426906_at
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
100
p < 0.005p < 0.005p < 0.001
A
rr
ay
Ifi203
Mm01238610_m1
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
100
1000
10000
p < 0.001p < 0.001p < 0.001
Ta
qm
an
Ifi205
1452349_x_at
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
p < 0.05p < 0.05
A
rr
ay
Ifi205
Mm01315309_m1
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
Ta
qm
an
Lgals6
1422071_at
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
100 p < 0.05
A
rr
ay
Lgals6
Mm02524460_s1
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
100
1000
10000
100000
1000000
p < 0.001
Ta
qm
an
Muc2
Mm00458304_g1
Sp Fp Si4 Fi4 Si9 Fi9
0.01
0.1
1
10 p < 0.001p < 0.05
Ta
qm
an
Muc2
1428435_at
Sp Fp Si4 Fi4 Si9 Fi9
0.1
1
10
p < 0.01
A
rr
ay
 
 
Figure 3-3. Side-by-side comparison of gene expression analyzed by microarray and qRT-PCR (cont.) 
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Figure 3-3. Side-by-side comparison of gene expression analyzed by microarray and qRT-PCR (cont.)
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A.   B.  
 
C.  
 
Figure 3-4. Exploring 1,547 genes with the host (strain) effect. 
A. Principle Component Analysis (PCA) shows distinct groups correlating to the different lines of mice or 
status of infection. Less tight clustering of uninoculated SW mice was observed compared with inbred FVB 
mice, which reflected their heterogeneous outbred nature. Components analyzed were sufficient to 
distinguish FVB mice throughout infection, whereas the separation between controls and infected SW mice 
was less robust (smaller distances between the animals, Table 3-3). This result was consistent with more 
severe disease in the sensitive FVB mice.   
B. Sets of differentially expressed SW to FVB genes, as shown in the Venn Diagram, are represented as 7 
distinct groups. Group A represented genes that were differentially expressed between the mouse lines at 
all times. Groups B, C, and D revealed genes that were differentially expressed at 2 conditions/time points. 
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Groups E, F, and G symbolized genes unique to uninfected status, 4 dpi and 9 dpi respectively. Each circle 
represents the comparison of resistant outbred SW mice over susceptible inbred FVB mice at three different 
time points. Numbers in parentheses represent number of genes corresponding to differentially expressed 
probe sets in each group. Significantly enriched GO clusters for each group and for all set of genes with 
strain effect are given in Table S2. 
C. The prevalence of genes within GO categories was assessed by FatiGO analysis. Only categories 
containing more than 5% of genes are shown. Genes from transport processes were overrepresented. 
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Table 3-3. Two-dimensional principal component analysis (PCA) in the subspace of 
genes differentially regulated between FVB and SW mice. 
 
  Sample PC1 PC2 
 
F4_1 10.0345 -24.7474 
F4_2 14.3277 -24.3638 
F9_1 12.9357 -23.798 
F9_2 9.91588 -22.0406 
FVB uninfected controls (Fp)      
 
 
 
 F9_3 6.89841 -20.4539 
 
Fi4_1 -6.26868 -7.04468 
Fi4_2 -10.0843 -5.28929 
FVB 4 dpi (Fi4) 
 
 Fi4_3 -6.18853 -5.25129 
 
Fi9_1 -40.8488 -3.05197 
Fi9_2 -48.3705 -5.546 
FVB 9 dpi (Fi9) 
 
 Fi9_3 -37.1858 -2.71321 
 
S4_1 29.3196 7.28819 
S4_2 15.6219 3.93392 
S9_1 24.2379 2.07921 
SW uninfected controls (Sp) 
 
 
 S9_2 13.8939 5.7856 
 
SI4_1 4.58773 26.0865 
SI4_2 7.49687 22.5136 
SW 4 dpi (Si4) 
 
 SI4_3 9.4241 16.2882 
 
Si9_1 -10.0365 20.8283 
Si9_2 5.91621 19.448 
SW 9 dpi (Si9) 
 
 Si9_3 -5.62731 20.0485 
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Figure 3-5. Hierarchical clustering of 1,547 genes exhibiting host effect. 
Redundant probe sets were excluded from the analysis. The heat map shows color-coded expression levels (red = 
high expression, black = medium expression, and green = low expression). Gene trees are drawn vertically and 
sample trees vertically.  
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Table 3-4. The top genes differentially expressed between susceptible and resistant strains prior to 
C. rodentium infection and/or at 4 and 9 dpi. 
 
Probe set ID Gene Gene 
name/ 
aliases 
Locus
Link 
SW 
over 
FVB, 
controla 
SW 
over 
FVB,  
4 dpi 
SW 
over 
FVB,  
9 dpi 
Main functions 
 
1454714_x_at 
1456471_x_at 
 
3-phosphoglycerate 
dehydrogenase 
 
Phgdh 
 
236539 
 
-3.37*** 
 
-5.2*** 
 
-4.8** 
 
Oxidoreductase activity, 
amino acid biosynthesis, 
metabolism 
1418979_at aldo-keto reductase family 1, 
member C14 
Akr1c14 105387    3.06* Oxidoreductase activity 
1417920_at amnionless Amn 93835  3.58****  3.06****  1.9 Development, protein 
localization 
1438364_x_at angiogenin, ribonuclease A 
family, member 4 b 
Ang4 219033  1.39  3.56 -2.09 Antimicrobial humoral 
response, defense 
response to bacteria 
1418069_at apolipoprotein C-II Apoc2 11813  0.53   3.61* Lipid transporter 
activity 
1417828_at aquaporin 8 b Aqp8 11833    3.14* Water channel activity, 
transport 
1438841_s_at arginase type II b Arg2 11847  3.09**  0.96  2.64* Arginine metabolism 
1419393_at ATP-binding cassette, sub-
family G (WHITE), member 5 
Abcg5, 
sterolin 1 
27409  1.02  0.64  3.18*** ATPase activity, 
transport 
1455869_at calcium/calmodulin-dependent 
protein kinase II, beta 
Camk2b 12323 -0.85 -3.39 -2.46 G1/S transition of 
mitotic cell cycle, 
calcium ion transport, 
calcium signaling  
1416193_at carbonic anhydrase 1 b Car1, CA I 12346    3.4* one-carbon compound 
metabolism,  
maintenance of pH , 
anion transport     
1448949_at 
1418094_s_at 
carbonic anhydrase 4 b Car4, CA IV 12351    5.32* one-carbon compound 
metabolism,  
maintenance of pH , 
anion transport  
1416306_at chloride channel calcium 
activated 3 
Clca3, gob-5 23844   0.65  3.06 Chloride transport 
1418626_a_at 
1454849_x_at 
clusterin Clu, ApoJ 12759   0.71 -3.17* Cell death 
1419349_a_at cytochrome P450, family 2, 
subfamily d, polypeptide 9 
Cyp2d9 13105    3.04* Oxidoreductase activity 
1440016_at dihydrolipoamide branched 
chain transacylase E2 
Dbt 13171  3.63*  2.52  1.37 Metabolism 
1458099_at EST   -3.21*  -1.43  
1446934_at EST   -3.49* -2.36* -2.73  
1451948_at gene model 1409, (NCBI) Gm1409, 
IGKV5-39 
620017   2.66*  3.24* Immunoglobulin-like 
1449526_a_at glycerophosphodiester 
phosphodiesterase domain 
containing 3 
Gdpd3 68616 -5.1**** -4.35*** -3.98** Glycerol metabolism 
1457231_at hypoxia inducible factor 1, alpha 
subunit 
Hif1a, 
MOP1 
15251  1.64  2.9*  3.05** Cell differentiation, 
signal transduction, 
transcription factor 
activity 
1460423_x_at Ig kappa chain Cr1, IgK 381774 -1.18  2.33*  3.28** Immune response 
1429381_x_at 
1421653_a_at 
1425763_x_at 
immunoglobulin heavy chain 
(J558 family) 
Igh-VJ558, 
Igh-A 
16061  -2.12  1.15*  3.65* Immune response 
1460423_x_at immunoglobulin heavy chain 
(V7183 family) /// Ig kappa 
chain variable 1 (V1) /// Ig 
kappa chain variable 1-117 /// Ig 
kappa chain 
Igh-V7183 
Igk-V1 
Igkv1-117 
Cr1 
16059 
/// 
16081 
/// 
16098 
-1.18  2.33*  3.28**  
1460423_x_at Ig kappa chain Cr1, IgK 381774 -1.18  2.33*  3.28** Immune response 
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Table 3-4. Continued 
 
Probe set ID Gene Gene 
name/ 
aliases 
Locus
Link 
SW 
over 
FVB, 
controla 
SW 
over 
FVB,  
4 dpi 
SW 
over 
FVB,  
9 dpi 
Main functions 
1452577_at immunoglobulin heavy chain 
complex 
Igh, J558 111507   2.19  4.52*  1.89* Immune response 
1424931_s_at immunoglobulin lambda chain, 
variable 1 b 
Igl-V1 16142  0.83  4.08**  1.28 Antigen binding, 
humoral immune 
response 
1418165_at intelectin a b Itlna, Lfr 16429  3.14*  5.67* -0.44 Sugar binding, response 
to nematode   
1457666_s_at interferon activated gene 202bb Ifi202b 26388 -2.04 -2.4 -4.3** Immune response 
1426906_at interferon activated gene 203b Ifi203 15950  5.17**  5.82*  4.52** Immune response, 
regulation of 
transcription 
1422071_at lectin, galactose binding, soluble 
6 
Lgals6, 
galectin-6 
 
16857  3.61*   2.05 Sugar binding, 
immunomodulation 
1426573_at malic enzyme 2, NAD(+)-
dependent, mitochondrial 
ME2,  
NAD-ME 
107029  2.55****  2.32*  3.08*** Oxidoreductase activity, 
metabolism 
1423467_at membrane-spanning 4-domains, 
subfamily A, member 4B 
Ms4a4b, 
Chandra 
60361  2.12*  3.15*  3.0* Immune response, Th1 
differentiation 
1447252_s_at 
1450719_at 
meprin 1 alpha Mep1a 17287  0.71*  0.9*  3.39* Metallopeptidase 
activity, proteolysis 
1418215_at meprin 1 beta Mep1b 17288    3.14* Metallopeptidase 
activity, proteolysis 
1453070_at protocadherin 17 Pcdh17 219228 -3.24*** -1.95 -2.09 Calcium ion binding 
1432579_at radial spokehead-like 2 Rshl2a 66832  0.68  3.16***  0.97* Transporter activity 
1418368_at resistin like beta Retnlb, Fizz2 57263 -3.1   Hormone activity 
1427963_s_at retinol dehydrogenase 9 Rdh9 103142  0.6   3.14** Oxidoreductase activity, 
transport 
1424784_at RIKEN cDNA 1700029I01  433791 -2.75**** -3.15** -2.54 Zinc ion binding 
1428359_s_at 
1428358_at 
1434137_x_at 
RIKEN cDNA 1810010M01 ZG16p 69036    3.94 Sugar binding 
1417735_at RIKEN cDNA 1810030J14  66289  0.57  1.43  4.75** similar to Serum 
amyloid P-component 
precursor (SAP) 
1434152_at RIKEN cDNA 2210421G13  108956  1.53  3.72****  2.01 Lipid binding 
1428604_at RIKEN cDNA 2610305D13  112422  2.5****  3.17***  2.68* Zinc ion binding, 
regulation of 
transcription 
1426936_at RIKEN cDNA 2610305J24  192885  2.91**  2.87***  4.18*  
1429896_at RIKEN cDNA 5830408B19  74756 -0.87* -0.76** -3.71*  
1437128_a_at RIKEN cDNA A630033E08  240041 -1.76 -2.69** -3.81*** Zinc ion binding, 
regulation of 
transcription 
1460147_at RIKEN cDNA A730009E18  319603 -3.07**** -2.59** -2.59**  
1439065_x_at Similar to zinc finger protein 
665 
 626316  2.48*  3.03*  3.58*** Zinc ion binding, 
regulation of 
transcription 
1417600_at solute carrier family 15 (H+/ 
peptide transporter), member 
2 b 
Slc15a2, 
Pept2 
57738 -5.28**** -3.69** -5.53**** oligopeptide transport 
1419343_at solute carrier family 15 
(oligopeptide transporter), 
member 1 
Slc15a1, 
Pept1 
56643   0.59  3.79* oligopeptide transport 
1429467_s_at 
1421445_at 
1427547_a_at 
solute carrier family 26, 
member 3 b 
Slc26a3, Dra 13487    6.04** Anion exchanger 
activity, transport 
1444057_at Transcribed locus    3.03****  2.36*  1.11  
1456111_at Transcribed locus    2.41  4.09***  0.87  
1459649_at Transcribed locus    4.08****  3.27**  3.44*  
1451602_at sorting nexin 6 Snx6,  
TFAF2 
72183 -3.98**** -4.01 -4.95** Protein and ion 
transport 
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Table 3-4. Continued 
 
Probe set ID Gene Gene 
name/ 
aliases 
Locus
Link 
SW 
over 
FVB, 
controla 
SW 
over 
FVB,  
4 dpi 
SW 
over 
FVB,  
9 dpi 
Main functions 
1447458_at 
1425668_a_at 
ST3 beta-galactoside alpha-2,3-
sialyltransferase 4, mRNA b  
Siat4c, 
St3gal4 
20443  6.24****  4.99****  5.65*** Glycosyl transferase 
activity, protein amino 
acid glycosylation 
1421517_at ST6 (alpha-N-acetyl-
neuraminyl-2,3-beta-galactosyl-
1,3)-N-acetylgalactosaminide 
alpha-2,6-sialyltransferase 1 b 
Siat7a, 
St6galnac1 
20445  2.42*  3.29***  1.95* Glycosyl transferase 
activity, protein amino 
acid glycosylation 
1450813_a_at troponin I, skeletal, slow 1 Tnni1 21952    3.24* Actin binding, structural 
constituent of 
cytoskeleton 
1419453_at ubiquitin carboxyl-terminal 
esterase L5 
Uchl5, 
Uch37 
56207  3.22****  3.56***  3.23*** ubiquitin-dependent 
protein catabolism 
        
 
a, the numbers represent log2 ratios resulted from individual groups comparison. Significance by t-test was  
*, p < 0.05 
** p ≤ 0.005 
***, p ≤ 0.0005 
****, p ≤ 0.00005 
b, gene expression was confirmed by quantitative real-time PCR (TaqMan) 
Genes discussed in the text are bolded 
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Figure 3-6. Hierarchical clustering of the most differentially expressed genes exhibiting host effect. 
Redundant probe sets were excluded from the analysis. The heat map shows color-coded expression levels (red = 
high expression, black = medium expression, and green = low expression). Gene trees are drawn vertically.  
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Table 3-5. Enrichment of GO categories from analysis of the most differentially expressed genes 
exhibiting host effect (p<0.05 by Hypergeometric test and at least 4 functionally annotated genes) 
   
probe set gene LocusLink 
   
Found 9 Gene Ontology "transporter activity" genes in a list with 48 annotated genes (all: 2752/31850, PValue: 0.020300) ** 
1416306_at chloride channel calcium activated 3 23844 
1417600_at solute carrier family 15 (H+/peptide transporter), member 2 57738 
1417828_at aquaporin 8 11833 
1418069_at apolipoprotein C-II 11813 
1419343_at solute carrier family 15 (oligopeptide transporter), member 1 56643 
1419393_at ATP-binding cassette, sub-family G (WHITE), member 5 27409 
1421445_at solute carrier family 26, member 3 13487 
1451602_at sorting nexin 6 72183 
1432579_at radial spokehead-like 2 66832 
   
Found 5 Gene Ontology "carrier activity" genes in a list with 48 annotated genes (all: 761/31850, PValue: 0.005634) *** 
1416306_at chloride channel calcium activated 3 23844 
1417600_at solute carrier family 15 (H+/peptide transporter), member 2 57738 
1419343_at solute carrier family 15 (oligopeptide transporter), member 1 56643 
1421445_at solute carrier family 26, member 3 13487 
1432579_at radial spokehead-like 2 66832 
   
Found 12 Gene Ontology "extracellular region" genes in a list with 48 annotated genes (all: 3950/31850, PValue: 0.012438) 
** 
1417735_at RIKEN cDNA 1810030J14 gene /// similar to Serum amyloid P-component precursor (SAP) 630754 /// 66289 
1417920_at amnionless 93835 
1418069_at apolipoprotein C-II 11813 
1418094_s_at carbonic anhydrase 4 12351 
1418165_at intelectin a 16429 
1418215_at meprin 1 beta 17288 
1418368_at resistin like beta 57263 
1418626_a_at clusterin 12759 
1425668_a_at ST3 beta-galactoside alpha-2,3-sialyltransferase 4 20443 
1450719_at meprin 1 alpha 17287 
1434152_at 
RIKEN cDNA 2210421G13 gene /// hypothetical protein LOC193676 /// similar to 
apolipoprotein L, 3 (predicted) 
108956 /// 193676 
/// 666661 
1438364_x_at angiogenin, ribonuclease A family, member 4 219033 
   
Found 11 Gene Ontology "extracellular space" genes in a list with 48 annotated genes (all: 3531/31850, PValue: 0.014240) 
** 
1417735_at RIKEN cDNA 1810030J14 gene /// similar to Serum amyloid P-component precursor (SAP) 630754 /// 66289 
1417920_at amnionless 93835 
1418069_at apolipoprotein C-II 11813 
1418094_s_at carbonic anhydrase 4 12351 
1418165_at intelectin a 16429 
1418215_at meprin 1 beta 17288 
1418368_at resistin like beta 57263 
1418626_a_at clusterin 12759 
1425668_a_at ST3 beta-galactoside alpha-2,3-sialyltransferase 4 20443 
1450719_at meprin 1 alpha 17287 
1438364_x_at angiogenin, ribonuclease A family, member 4 219033 
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Table 3-5. Continued 
   
probe set gene LocusLink 
   
Found 4 Gene Ontology "immune response" genes in a list with 48 annotated genes (all: 667/31850, PValue: 0.017922) ** 
1421551_s_at interferon activated gene 202B 26388 
1424931_s_at immunoglobulin lambda chain, variable 1 16142 
1426906_at interferon activated gene 203 15950 
1438364_x_at angiogenin, ribonuclease A family, member 4 219033 
   
Found 6 Gene Ontology "oxidoreductase activity" genes in a list with 48 annotated genes (all: 1491/31850, PValue: 
0.023848) ** 
1418979_at aldo-keto reductase family 1, member C14 105387 
1419349_a_at cytochrome P450, family 2, subfamily d, polypeptide 9 13105 
1426573_at malic enzyme 2, NAD(+)-dependent, mitochondrial 107029 
1427963_s_at retinol dehydrogenase 9 103142 
1454714_x_at 
3-phosphoglycerate dehydrogenase /// similar to 3-phosphoglycerate dehydrogenase /// 
similar to 3-phosphoglycerate dehydrogenase /// similar to 3-phosphoglycerate 
dehydrogenase /// similar to 3-phosphoglycerate dehydrogenase 
236539 /// 668771 
/// 670155 /// 
671972 /// 673015 
1457231_at Hypoxia inducible factor 1, alpha subunit 15251 
   
Found 11 Gene Ontology "extracellular region part" genes in a list with 48 annotated genes (all: 3743/31850, PValue: 
0.021262) ** 
1417735_at RIKEN cDNA 1810030J14 gene /// similar to Serum amyloid P-component precursor (SAP) 630754 /// 66289 
1417920_at amnionless 93835 
1418069_at apolipoprotein C-II 11813 
1418094_s_at carbonic anhydrase 4 12351 
1418165_at intelectin a 16429 
1418215_at meprin 1 beta 17288 
1418368_at resistin like beta 57263 
1418626_a_at clusterin 12759 
1425668_a_at ST3 beta-galactoside alpha-2,3-sialyltransferase 4 20443 
1450719_at meprin 1 alpha 17287 
1438364_x_at angiogenin, ribonuclease A family, member 4 219033 
   
Found 4 Protein Domain "Immunoglobulin-like // 3.4E-7" genes in a list with 18 annotated genes (all: 326/10020, PValue: 
0.002344) *** 
1421653_a_at 
immunoglobulin heavy chain (J558 family) /// similar to immunoglobulin heavy chain 
variable region /// similar to immunoglobulin mu-chain /// similar to anti-poly(dC) monoclonal 
antibody heavy chain 
16061 /// 238447 /// 
544903 /// 544907 
1451948_at gene model 1409, (NCBI) 620017 
1452577_at Immunoglobulin heavy chain complex 111507 
1460423_x_at 
immunoglobulin heavy chain (V7183 family) /// immunoglobulin kappa chain variable 1 (V1) 
/// immunoglobulin kappa chain variable 1-117 /// Ig kappa chain 
16059 /// 16081 /// 
16098 /// 381774 
   
Found 8 Chromosome "12" genes in a list with 49 annotated genes (all: 1367/37379, PValue: 0.000372) **** 
1417920_at amnionless 93835 
1421445_at solute carrier family 26, member 3 13487 
1421653_a_at 
immunoglobulin heavy chain (J558 family) /// similar to immunoglobulin heavy chain 
variable region /// similar to immunoglobulin mu-chain /// similar to anti-poly(dC) monoclonal 
antibody heavy chain 
16061 /// 238447 /// 
544903 /// 544907 
1438841_s_at arginase type II 11847 
1451602_at sorting nexin 6 72183 
1452577_at Immunoglobulin heavy chain complex 111507 
1460423_x_at 
immunoglobulin heavy chain (V7183 family) /// immunoglobulin kappa chain variable 1 (V1) 
/// immunoglobulin kappa chain variable 1-117 /// Ig kappa chain 
16059 /// 16081 /// 
16098 /// 381774 
1457231_at Hypoxia inducible factor 1, alpha subunit 15251 
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Figure 3-7. Hierarchical clustering of the most differentially expressed genes from delta eta analysis.  
Red and green colors indicate up- and downregulation respectively. 
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Table 3-6. Enrichment of GO categories of the most differentially expressed genes from delta eta 
analysis (p<0.05 by Hypergeometric test and at least 4 functionally annotated genes) 
  
gene LocusLink
  
Found 7 "transporter activity" genes in a list with 30 annotated genes (all: 2752/31850, PValue: 0.012322) ** 
1416306_at chloride channel calcium activated 3 23844 
1417828_at aquaporin 8 11833 
1418069_at apolipoprotein C-II 11813 
1419343_at solute carrier family 15 (oligopeptide transporter), member 1 56643 
1425382_a_at aquaporin 4 11829 
1427547_a_at solute carrier family 26, member 3 13487 
1439727_at chloride channel calcium activated 6 /// expressed sequence AI747448 
99663 /// 
99709 
   
Found 6 "immune system process" genes in a list with 30 annotated genes (all: 1101/31850, PValue: 0.000490) **** 
Found 6 "immune response" genes in a list with 30 annotated genes (all: 667/31850, PValue: 0.000032) ***** 
Found 6 "humoral immune response" genes in a list with 30 annotated genes (all: 116/31850, PValue: 0.000000) ********* 
Found 6 "physiological response to stimulus" genes in a list with 30 annotated genes (all: 1417/31850, PValue: 0.001816) *** 
1423153_x_at complement component factor h 12628 
1424305_at immunoglobulin joining chain 16069 
1424931_s_at immunoglobulin lambda chain, variable 1 16142 
1427660_x_at 
immunoglobulin kappa chain variable 28 (V28) /// immunoglobulin kappa chain variable 8 (V8)-
16 
16114 /// 
640340 
1427860_at 
immunoglobulin kappa chain variable 6-23 /// immunoglobulin kappa chain variable 19 (V19)-14 
/// immunoglobulin kappa chain variable 19 (V19)-13 /// similar to Ig kappa chain V-V region 
MPC11 precursor /// similar to Ig kappa chain V-V region MPC11 precursor /// similar to Ig kappa 
chain V-V region MPC11 precursor /// similar to Ig kappa chain V-V region MPC11 precursor /// 
similar to Ig kappa chain V-V region MPC11 precursor 
637227 /// 
667881 /// 
667899 /// 
669053 /// 
669070 /// 
676136 /// 
676162 /// 
676175 
1438364_x_at angiogenin, ribonuclease A family, member 4 219033 
   
Found 6 "antigen binding" genes in a list with 30 annotated genes (all: 103/31850, PValue: 0.000000) ********* 
1424305_at immunoglobulin joining chain 16069 
1424931_s_at immunoglobulin lambda chain, variable 1 16142 
1425763_x_at 
immunoglobulin heavy chain (J558 family) /// similar to immunoglobulin heavy chain variable 
region /// similar to immunoglobulin mu-chain /// similar to anti-poly(dC) monoclonal antibody 
heavy chain 
16061 /// 
238447 /// 
544903 /// 
544907 
1427660_x_at 
immunoglobulin kappa chain variable 28 (V28) /// immunoglobulin kappa chain variable 8 (V8)-
16 
16114 /// 
640340 
1427860_at 
immunoglobulin kappa chain variable 6-23 /// immunoglobulin kappa chain variable 19 (V19)-14 
/// immunoglobulin kappa chain variable 19 (V19)-13 /// similar to Ig kappa chain V-V region 
MPC11 precursor /// similar to Ig kappa chain V-V region MPC11 precursor /// similar to Ig kappa 
chain V-V region MPC11 precursor /// similar to Ig kappa chain V-V region MPC11 precursor /// 
similar to Ig kappa chain V-V region MPC11 precursor 
637227 /// 
667881 /// 
667899 /// 
669053 /// 
669070 /// 
676136 /// 
676162 /// 
676175 
1452463_x_at Immunoglobulin kappa chain complex 243469 
   
Found 4 "sugar binding" genes in a list with 30 annotated genes (all: 337/31850, PValue: 0.000272) **** 
Found 4  "carbohydrate binding" genes in a list with 30 annotated genes (all: 500/31850, PValue: 0.001190) *** 
1418165_at intelectin a 16429 
1422071_at lectin, galactose binding, soluble 6 16857 
1434137_x_at RIKEN cDNA 1810010M01 gene 69036 
1451440_at chondrolectin 246048 
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Table 3-6. Continued 
  
gene LocusLink
  
Found 11  "extracellular region" genes in a list with 30 annotated genes (all: 3950/31850, PValue: 0.000597) **** 
Found 11  "extracellular space" genes in a list with 30 annotated genes (all: 3531/31850, PValue: 0.000224) **** 
Found 11   "extracellular region part" genes in a list with 30 annotated genes (all: 3743/31850, PValue: 0.000374) **** 
1417735_at RIKEN cDNA 1810030J14 gene /// similar to Serum amyloid P-component precursor (SAP) 
630754 /// 
66289 
1418069_at apolipoprotein C-II 11813 
1418094_s_at carbonic anhydrase 4 12351 
1418165_at intelectin a 16429 
1418215_at meprin 1 beta 17288 
1418368_at resistin like beta 57263 
1419476_at ADAM-like, decysin 1 58860 
1424305_at immunoglobulin joining chain 16069 
1449033_at tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) 18383 
1438364_x_at angiogenin, ribonuclease A family, member 4 219033 
1439853_at beta-1,4-N-acetyl-galactosaminyl transferase 2 14422 
   
Found 4  "channel or pore class transporter activity" genes in a list with 30 annotated genes (all: 777/31850, PValue: 
0.005817) *** 
Found 4  "alpha-type channel activity" genes in a list with 30 annotated genes (all: 732/31850, PValue: 0.004716) *** 
1416306_at chloride channel calcium activated 3 23844 
1417828_at aquaporin 8 11833 
1425382_a_at aquaporin 4 11829 
1439727_at chloride channel calcium activated 6 /// expressed sequence AI747448 
99663 /// 
99709 
   
Found 8 "organismal physiological process" genes in a list with 30 annotated genes (all: 2672/31850, PValue: 0.002650) *** 
1423153_x_at complement component factor h 12628 
1424305_at immunoglobulin joining chain 16069 
1424931_s_at immunoglobulin lambda chain, variable 1 16142 
1425382_a_at aquaporin 4 11829 
1427660_x_at 
immunoglobulin kappa chain variable 28 (V28) /// immunoglobulin kappa chain variable 8 (V8)-
16 
16114 /// 
640340 
1427860_at 
immunoglobulin kappa chain variable 6-23 /// immunoglobulin kappa chain variable 19 (V19)-14 
/// immunoglobulin kappa chain variable 19 (V19)-13 /// similar to Ig kappa chain V-V region 
MPC11 precursor /// similar to Ig kappa chain V-V region MPC11 precursor /// similar to Ig kappa 
chain V-V region MPC11 precursor /// similar to Ig kappa chain V-V region MPC11 precursor /// 
similar to Ig kappa chain V-V region MPC11 precursor 
637227 /// 
667881 /// 
667899 /// 
669053 /// 
669070 /// 
676136 /// 
676162 /// 
676175 
1450813_a_at troponin I, skeletal, slow 1 21952 
1438364_x_at angiogenin, ribonuclease A family, member 4 219033 
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A.   
 
 
B. 
 
Figure 3-8. FatiGO (fast assignment and transference of information) analysis of genes with strain effect (A) and 
infection x strain effect (B) identified by BioConductor analysis. After exclusion of unknown and redundant probe 
sets, 106 out of 232 genes and 126 out of 167 genes were analyzed respectively. Transport-related categories were 
markedly overrepresented when compared with immune-related ones, recapitulating the results obtained by dChip 
analysis. 
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Table 3-7. Enrichment of genes detected by BioConductor analysis by Hypergeometric test with 
p<0.0005 
 
Strain effect - Found 232 genes or SNPs; 21 redundant probe sets excluded; 211 left 
  
  Finding significant Gene Ontology clusters... 
    Found 4 "phosphoric ester hydrolase activity" genes in a cluster with 17 annotated genes (all: 687/31850, PValue: 0.000408) 
    Found 5 "hydrolase activity\, acting on ester bonds" genes in a cluster with 16 annotated genes (all: 1367/31850, PValue: 
0.000425) 
  
  Finding significant Chromosome clusters... 
    Found 5 "2 H4" genes in a cluster with 175 annotated genes (all: 118/37379, PValue: 0.000242) 
    Found 6 "4 E1" genes in a cluster with 175 annotated genes (all: 116/37379, PValue: 0.000019) 
  
Infection effect - Found 167 genes or SNPs; 20 redundant probe sets excluded; 147 left 
  
  Finding significant Gene Ontology clusters... 
    Found 48 "membrane" genes in a cluster with 90 annotated genes (all: 10764/31850, PValue: 0.000106) 
    Found 39 "membrane part" genes in a cluster with 90 annotated genes (all: 8454/31850, PValue: 0.000419) 
    Found 5 "lytic vacuole" genes in a cluster with 79 annotated genes (all: 258/31850, PValue: 0.000464) 
    Found 17 "transporter activity" genes in a cluster with 79 annotated genes (all: 2752/31850, PValue: 0.000353) 
1417828_at aquaporin 8 
1422699_at arachidonate 12-lipoxygenase 
1421129_a_at ATPase, Ca++ transporting, ubiquitous 
1428988_at ATP-binding cassette, sub-family C (CFTR/MRP), member 3 
1435613_x_at cytochrome c oxidase, subunit Vb 
1425525_a_at purinergic receptor P2X, ligand-gated ion channel 4 
1424364_a_at RIKEN cDNA 1110020P15 gene 
1452326_at RIKEN cDNA 1810010G06 gene 
1419343_at solute carrier family 15 (oligopeptide transporter), member 1 
1426600_at solute carrier family 2 (facilitated glucose transporter), member 1 
1421445_at solute carrier family 26, member 3 
1428793_at solute carrier family 36 (proton/amino acid symporter), member 1 
1452445_at solute carrier family 41, member 2 
1425606_at solute carrier family 5 (iodide transporter), member 8 
1426069_s_at solute carrier family 7 (cationic amino acid transporter, y+ system), member 4 
1437259_at solute carrier family 9 (sodium/hydrogen exchanger), member 2 
1429240_at StAR-related lipid transfer (START) domain containing 4 
1441927_at Synaptotagmin VII  
    Found 5 "lysosome" genes in a cluster with 79 annotated genes (all: 258/31850, PValue: 0.000464) 
    Found 31 "integral to membrane" genes in a cluster with 70 annotated genes (all: 7545/31850, PValue: 0.000119) 
    Found 31 "intrinsic to membrane" genes in a cluster with 70 annotated genes (all: 7564/31850, PValue: 0.000125) 
    Found 5 "vacuole" genes in a cluster with 68 annotated genes (all: 301/31850, PValue: 0.000467) 
    Found 5 "integral to plasma membrane" genes in a cluster with 18 annotated genes (all: 1199/31850, PValue: 0.000426) 
    Found 5 "intrinsic to plasma membrane" genes in a cluster with 18 annotated genes (all: 1220/31850, PValue: 0.000462) 
 
  Finding significant Chromosome clusters... 
    Found 5 "10 C1" genes in a cluster with 93 annotated genes (all: 254/37379, PValue: 0.000445) 
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Figure 3-9. Genes with most predictive power obtained from BioConductor analysis.  
When random forest evaluation of gene importance in predicting four classes (strain x infection status) was applied, 
a subset of genes appeared as having high predictive capacity. Genes such as Slc26a3 and Aqp8 were identified as 
most differentially expressed by dChip analysis as well.  
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Figure 3-10. Quantitative real-time PCR of genes involved in intestinal transport and its regulation. 
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Figure 3-11. Hierarchical clustering of genes discussed in text as potentially contributing to development of 
intestinal ion disturbances and diarrhea. Red and green colors indicate up- and downregulation respectively. 
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Figure 3-12. Serum electrolyte levels.  
Infected FVB mice exhibit hypochloremia (A), hyponatremia (B), and altered Na+/K+ ratio in serum compared with 
infected SW mice. Scattergrams of all measurements are shown; lines indicate means of the groups.  
*, p < 0.05; ** p < 0.01 
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Figure 3-13. Working model for the contribution of alterations in colonic ion transport to fatal diarrhea in C. 
rodentium-infected FVB mice.  
 A. normal ion transport in large intestine mediated largely by a coupled action of anion exchanger DRA, 
CFTR, sodium/proton exchangers NHE2/3, potassium transporters and carbonic anhydrases; 
 B. alterations in ion transport in C. rodentium-infected SW mice included subtle decreases in expression of 
some apical transporters and compensatory increase in basolateral water channel Aqp4 expression;  
 C. profound changes in infected FVB consisted of mild to marked downregulation of majority of apical 
transporters involved in intestinal NaCl absorption and bicarbonate secretion, along with upregulation of basolateral 
transporters providing driving force for chloride secretion. In addition, constitutively higher levels of Pept2 and 
Adora2b expression in FVB mice (indicated by *) can contribute to alterations in cytosolic pH and cAMP during 
infection, thereby further affecting ion exchange. The cumulative effect may ultimately result in severe diarrhea and 
lead to death in susceptible animals. 
Vesicular trafficking of some proteins (i.e. A2B receptor, aquaporins, NHE3, ATPases) and paracellular transport 
are not addressed here.       
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Figure 3-14. Correlation of raw intensities between biological replicates.  
Microarray results were tightly correlated between biological replicates within FVB mice groups (r between 0.96 to 
0.99 for controls, 0.94 to 0.99 for 4 dpi, and 0.97 to 0.98 for 9 dpi). Samples from uninoculated SW mice were less 
tightly correlated in accordance with the outbred nature of the animals (r between 0.92 to 0.98 for controls, 0.96 to 
0.99 for 4 dpi, and 0.97 to 0.98 for 9 dpi). The correlations between the control and infected mice were smaller and 
reflected the severity of the disease progression. Thus, comparison of 4 dpi and 9 dpi FVB mice with the 
uninoculated controls or between each other resulted in r between 0.90 to 0.95, 0.89 to 0.92, and 0.88 to 0.96 
respectively. Similar comparisons in SW mice lead to higher correlations (r between 0.91 to 0. 94, 0.90 to 0.96, and 
0.93 to 0. 97 for 4 dpi and 9 dpi mice compared with controls or between each other) in accordance with the 
subclinical disease in the outbred animals. None of the correlations was substantially low (all r were higher than 
0.85) indicating that 9 days of infection did not robustly change global gene expression profile. 
A. Representative examples of array-to-array correlations between uninoculated and infected animals within 
the same genetic group.  
B. Correlation matrix with r values for all array-to-array comparisons.  
The following code for individual samples was used: F or S correspond to FVB or SW lines; “i” indicates infection 
status, 4 and 9 represent 4 and 9 dpi respectively, and “_1”, “_2”, and “_3” specify biological replicate. 
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4.1. Introduction 
 
 Citrobacter rodentium is a naturally occurring murine pathogen. C. rodentium infects 
large intestine and causes attaching and effacing (A/E) lesions, colonic hyperplasia and variable 
degrees of colitis in the majority of genetically non-manipulated (referred to hereafter as wild 
type) mouse strains [reviewed in Luperchio and Schauer, 2001; Mundy et al, 2005]. The disease 
was initially characterized in outbred Swiss mice [Barthold, 1980; Barthold et al., 1976; Barthold 
et al., 1977; Barthold et al., 1978; Barthold and Jonas, 1977; Ediger et al, 1974; Johnson and 
Barthold, 1979] with subsequent characterization in a variety of inbred strains [Barthold et al., 
1977; Goncalves et al., 2001; Itoh et al., 1979; Itoh et al., 1988; Khan et al., 2006; Li et al., 2004; 
Maaser et al., 2004; Okutani et al., 2001; Silverman et al., 1979; Vallance et al., 2003]. Among 
the lines of mice that have been characterized, C3H mice are the only wild type strain 
demonstrating fatal infection so far [Barthold et al., 1977; Deng et al., 2004; Gruenheid et al., 
2004; Khan et al., 2006; Nagai et al., 2005; Tatsuno et al., 2006; Vallance et al., 2003]. However, 
C3H mice are genetically distant from C57BL/6 and Swiss mice [Beck et al., 2000]. Therefore, 
differences in C. rodentium-induced disease can be explained by distinct genealogy.   
 We recently showed different susceptibility to C. rodentium infection in closely related 
outbred Swiss Webster (SW) and inbred FVB/N (FVB) mice [Chapters 2 and 3]. FVB mice 
demonstrated high mortality rate, profound weight loss, development of severe colitis and 
substantial downregulation in expression of apical ion transporters, making it a second inbred 
strain with marked susceptibility to C. rodentium infection. Our results are highly important 
considering extensive use of FVB in transgenic studies [Barthold, 2002]. However, SW mice, 
used as control animals in our experiments, are randomly bred and, hence, genetically variable 
[Chia et al., 2005]. To get better insight into the mechanisms of susceptibility to fatal infectious 
diarrhea and colitis, a genetically defined inbred strain would be desired. SWR and SJL mice, 
widely used in general and immunology-related research, are both derived from Swiss mice. 
Based on the genetic comparison of biochemical and coat color markers [Taketo et al., 1991, 
Table 1-3], FVB mice have the highest degree of relatedness with SWR mice (77% of matching) 
compared with C57BL/6, SJL, and C3H mice (61%, 70%, and 73%, respectively). However, C. 
rodentium infection was not characterized in SWR and SJL strains yet. The aim of this study was 
to examine effects of C. rodentium infection on gross and microscopic lesions, gene expression, 
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and diarrhea development in inbred mice from Swiss origin: FVB/NJ, SWR/J, and SJL/J. Two 
additional control groups, consisting of C57BL/6 and C3H mice that are well-characterized in 
terms of outcome of C. rodentium infection (resistant and susceptible strain, respectively) were 
used as non-Swiss control strains. The C3H/HeOuJ substrain (endotoxin sensitive) rather than 
C3H/HeJ (TLR4-deficient) was chosen to avoid the bias of LPS-nonresponsiveness. 
 
 
4.2. Results 
 
C3H and FVB mice, but not SWR, SJL and C57BL/6 mice, develop fatal C. 
rodentium infection.  
 As expected, C3H/HeOuJ (referred hereafter as C3H) mice developed overt disease 
leading to 100% mortality in 8-11 days post C. rodentium infection (DPI) (Figure 4-1). FVB 
mice were also susceptible and demonstrated 61.5% mortality. Median survival rate was 9 and 
12 days for C3H/HeOu and FVB mice respectively (p<0.0001 by Logrank test).  SWR, SJL, and 
C57BL/6 mice were resistant and survived throughout the two week period post-inoculation. 
 Severe clinical disease in C3H mice was associated with rapid decline in body weight 
reaching 26.7 ± 2.4% loss by 9 DPI (p<0.001 by two-way ANOVA followed by Bonferroni 
posttest) (Figure 4-2). The body weight loss in FVB mice was somewhat less severe but still 
greater than in resistant strains reaching 18.3 ± 2.5% by 12 DPI (p<0.01 by two-way ANOVA 
followed by Bonferroni posttest). The changes in body weight in the rest of inbred strains 
fluctuated within +/-10% range and were not significant in SJL and SWR mice.  
 
Fecal bacterial load in inbred mice infected with C. rodentium. 
 Bacterial counts in feces obtained from susceptible C3H mice and resistant SWR and 
C57BL/6 mice were similar at all time points (Figure 4-3). The levels of C. rodentium in SJL 
mice at 3 DPI were lower compared with C3H mice, but higher compared with FVB mice 
(p<0.01 by two-way ANOVA followed by Bonferroni posttest). In addition, SJL mice 
demonstrated delayed clearance and had the highest level of fecal C. rodentium shedding at 12 
DPI. Susceptibility in FVB mice was not associated with increased bacterial load, as fecal 
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bacterial counts were lower in FVB mice at 3 and 6 DPI compared with the rest of the strains 
(p<0.01 by two-way ANOVA followed by Bonferroni posttest). Furthermore, 2 out of 15 FVB 
mice failed to become infected and were excluded from further analysis. 
 
Culturing C. rodentium from tissues 
 C. rodentium load in the colon was highest in C3H mice, intermediate in SJL and FVB 
mice, and lowest in SWR, FVB and C57BL/6 mice (p<0.0001 by one-way ANOVA, Figure 4-4). 
High bacterial colonization of cecum was comparable in all the strains. High MLN counts of the 
pathogen were found in all C3H mice (p=0.0003 by one-way ANOVA), and in some FVB mice. 
However, only limited number of animals had C. rodentium counts in spleen. These results are 
somehow inconsistent with fecal shedding found in all the groups by 9-12 dpi. However, because 
some animals had to be euthanized at different time points post inoculation, the C. rodentium 
load in tissues is not directly comparable. Thus, tissues were collected at 9-10 DPI from C3H 
mice, at 12-14 DPI from FVB mice, and at 14 DPI from the rest of the groups.  
 
Development of C. rodentium–specific humoral immune response in Swiss mice. 
 Early humoral response represented by IgM titers, developed in all inbred strains from 
Swiss origin by 12 DPI (Figure 4-5). Although it tended to be highest in SWR/J mice, the 
difference did not reach statistical significance (p = 0.058 by ANOVA). By 12 dpi, earlier than 
substantial IgG titers would be expected to be seen, SWR/J mice developed IgG1 (NS by 
ANOVA) and IgG2 (p = 0.02) responses specific to the pathogen. There was no difference in 
IgG1 to IgG2 ratios between the strains. These results suggest that humoral immune response is 
not likely to account for differences in susceptibility and mortality between the strains. 
 
Measuring diarrhea in inbred mice infected with C. rodentium. 
 C. rodentium infection induced diarrhea in all the animals (p<0.0001 by two-way 
ANOVA, Figure 4-6). One of the most drastic responses was observed in C3H mice. Animals 
from that group demonstrated increase in fecal water content from 60.4 ± 1.4% in uninfected 
state to 81.6 ± 0.5% and 87.8 ± 1.6% at 6 and 9 DPI respectively (p<0.05 by two-way ANOVA 
followed by Bonferroni posttest), indicating rapid development of severe diarrhea. The water 
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content in the rest of the strains has increased from 58-62% in uninfected state to 75-78% at 9 
and 12 DPI. Notably, substantial diarrhea in C. rodentium-infected FVB mice was associated 
with the failure to develop well-formed feces, which made quantitative comparison of stool 
water content with other strains impossible.  
 
Intestinal lesions in inbred mice infected with C. rodentium. 
 Grossly, in the majority of the strains the distal half of the colon was rigid and distended 
and a prominent cecal patch was observed. The only exception was FVB mice that developed 
gross lesions in the whole colon, including the proximal parts. No gross cecal changes were seen 
in infected FVB mice. Histologically, infected mice of all strains developed mild to moderate 
inflammation and hyperplasia, minimal dysplasia, mild edema, and a wide range of epithelial 
defects (p<0.0001 by Kruskal-Wallis test, Figures 4-7 and 4-8). No significant differences were 
found between the groups in any of the parameters, although colonic epithelial defects and 
cumulative disease index tended to be higher in C3H mice (p>0.05 by post-hoc Dunn's Multiple 
Comparison Test). The pathological changes in cecum were milder than in colon in all infected 
animals (data not shown). Interestingly, the cecal inflammation, hyperplasia, edema and 
cumulative disease index in C3H mice were more severe than in FVB mice, but comparable to 
other inbred strains (p<0.0001 by Kruskal-Wallis test). The only exception was significantly 
higher dysplasia in cecum of C3H mice compared with all other strains (p<0.05 by post-hoc 
Dunn’s test, data not shown). The majority of the FVB, C3H and a few of the SWR mice had 
gland herniation into GALT. Multifocal hepatic lesions, including coagulative necrosis, were 
observed in 80% of the infected SJL mice. In addition, SJL mice demonstrated profound 
splenomegaly in response to infection, whereas mild increase in spleen weight was observed in 
SWR and C57BL/6 mice and no change in C3H and FVB mice (p<0.0001 by one-way ANOVA, 
Figure 4-9). Colon weight was increased in all the animals infected with C. rodentium (Figure 4-
9). The most significant change was detected in C3H and FVB mice, and the least in SJL and 
C57BL/6 mice (p<0.0001 by one-way ANOVA). Colon weight was positively correlated with 
inflammation, hyperplasia and disease index scores in distal colon of infected mice (p<0.05 by 
Spearman correlation test, Figure 4-10).  
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Quantitative real-time RT-PCR on genes involved in intestinal transport and its 
regulation (validation of the results obtained from microarray analysis) 
 Expression of the majority of the genes involved in intestinal transport was similar to the 
previously reported for FVB mice (Chapter 3). Upon infection, the expression of Slc26a3 (Dra), 
Aqp8, CA I and CA IV was lower and expression of Atp1b2 and Fosb was higher in susceptible 
strains compared with resistant strains, though in few cases the differences did not reach 
statistical significance (Figure 4-11). C3H mice were the most severely affected, whereas FVB 
mice had intermediate level of differential gene expression. At the same time, FVB mice had 
constitutively higher expression of Adora2b than the rest of the animals at all time points 
(p<0.0001 by ANOVA).  The expression profile of Ait (Slc5a8) was similar between the groups. 
In addition, both susceptible FVB and resistant SWR mice had the highest and C3H mice had the 
lowest levels of Pept2 (Slc15a2) expression. Cftr was differentially expressed between the 
infected groups with highest level of transcripts in FVB mice, intermediate in C3H, SWR and 
SJL mice, and lowest in C57BL/6 mice. 
 
Detection of mast cells in inbred mice infected with C. rodentium 
 Toluidine-positive mast cells were rare in colon tissues from SWR, SJL, C3H and 
C57BL/6 mice, and ranged from 0 to 4 cells/mm2 (Figure 4-12). In contrast, dense accumulation 
of mast cells, mainly in the most distal colorectal area, was observed in FVB mice (p<0.0001 by 
ANOVA). The number of mast cells was 16.3 ± 3.3 cells/mm2 and 11.0 ± 3.3 cells/mm2 in 
uninoculated and infected FVB mice, respectively (p<0.001 by post-hoc t test compared with the 
rest of the groups). The highest density was found in close proximity to the rectum reaching 25-
27 cells/mm2 in uninfected FVB mice. The infection was associated with the decrease in number 
of toluidine-positive cells that was statistically significant for FVB mice only (p<0.01 by post-
hoc t test). 
 
FVB mice from different vendors develop distinct responses to C. rodentium. 
 FVB mice obtained from Taconic Farms and The Jackson Laboratories (FVB/NTac and 
FVB/NJ, respectively) exhibited differences in disease progression. Thus, clinical signs and 
mortality in infected FVB/NJ developed later than in FVB/NTac (latent period of 12 DPI vs. 8 
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DPI, respectively), though no statistical significance in the survival rate was achieved (Figure 4-
13A). Body weight loss was also comparable between the Taconic and Jackson FVB substrains, 
despite lower fecal bacterial shedding in FVB/NJ at 3 and 6 DPI (p<0.0001 by t test, Figure 4-
13B and C). Furthermore, development of colonic inflammation, hyperplasia and dysplasia was 
more severe in FVB/NTac mice by 12 DPI (p<0.0005 by Mann-Whitney test, Figure 4-14). 
 
4.3. Discussion 
 Here, we characterized the progression of C. rodentium infection in two inbred strains of 
Swiss mice that have not been characterized previously.  Infected SWR and SJL mice developed 
minimal morbidity in response to the pathogen and survived throughout 14 days of the study, 
indicating their resistance to infection. The results were comparable to C57BL/6 mice, a non-
Swiss strain that has been characterized as being resistant to the disease [Barthold et al., 1977; 
Maaser et al.,2004; Simmons et al., 2003; Vallance et al., 2002al Vallance et al., 2002b; Vallance 
et al., 2003]. Consistent with our previous studies (Chapter 2), FVB mice developed high 
morbidity and mortality upon infection, although the response was less dramatic than in 
C3H/HeOu mice that have been characterized as being C. rodentium-susceptible strain [Barthold 
et al., 1977; Deng et al, 2004; Gruenheid et al., 2004; Khan et al., 2006; Nagai et al., 2005; 
Tatsuno et al., 2006; Vallance et al., 2003].  
 Fecal bacterial shedding reached approximately 108-109 CFU/g feces at 3 DPI and was 
comparable between susceptible C3H, and resistant SWR and C57BL/6 mice at all time points. 
This is in contrast with previous report of susceptibility to C. rodentium in inbred strains 
[Vallance et al., 2003], where susceptible C3H mice had high colonic counts of C. rodentium at 4 
DPI (~109 CFU/g colon) compared with poor colonization (≤~104 CFU/g colon) in resistant 
C57BL/6, BALB/c, 129S1/SvImJ, and NIH Swiss mice. Furthermore, at 6 DPI there was a log 
difference in colonic counts between C3H mice and resistant strains in this study [Vallance et al., 
2003]. The reason for such a discrepancy with our results is not clear, though different tissues 
used for C. rodentium culturing (colon vs. feces) may play a role. Strikingly, high mortality rate 
in FVB mice was not correlated with bacterial burden; an increase in fecal C. rodentium counts 
was lower in this strain at 3 and 6 DPI compared with other groups. To clarify the contribution of 
immune response to these differences, serum antibody titers were analyzed in inbred mice of 
Swiss origin (referred to hereafter as Swiss mice). Due to high degree of mortality in FVB mice, 
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assessment of humoral immune response was done at 12 DPI. At that time point, C. rodentium-
specific IgM titers were detected in all infected Swiss mice, demonstrating development of early 
humoral immune responses. However, appreciable C. rodentium-specific IgG1 and IgG2 titers 
were detected in SWR, but not in SJL and FVB mice at that time point. Although inconsistent 
development of adaptive immunity (IgG responses) in mice within two weeks post C. rodentium 
infection was shown [Simmons et al., 2002; McBee and Schauer, unpublished results], these 
distinct IgG titers can contribute to delayed bacterial eradication in SJL mice. Nevertheless, the 
observed humoral immune response cannot account for the differences in mortality between 
FVB, SJL and SWR mice. Moreover, both resistant SWR and susceptible FVB mice possess the 
H-2q haplotype, indicating that polymorphisms in major histocompatibility complex are not 
responsible for the observed differences in the disease outcome between inbred strains. 
 Despite similar fecal bacterial load in susceptible C3H/HeOu and resistant SWR and 
C57BL/6 mice, high C. rodentium counts were cultured from colon and MLN of C3H mice 
compared with other strains. This may be attributable to different day of sample collection. Thus, 
due to severe morbidity, C3H mice were euthanized and necropsied at 9-10 DPI, representing the 
peak of infection. Samples from FVB mice and other strains were collected when decline in 
infection took place, i.e. at 12-14 DPI and at 14 DPI, respectively. Therefore, higher tissue 
bacterial counts in C3H mice should be interpreted with caution. Furthermore, only a few 
animals demonstrated limited bacterial counts in spleen (1/10 in SJL, 2/7 in FVB, and 1/8 in 
C3H infected mice). Although an earlier translocation of bacteria to spleen cannot be denied at 
this point, the results suggest that C. rodentium infection in adult wild-type animals is contained 
within intestinal/abdominal compartment. This disagrees with the report of disseminated disease 
in C3H mice [Vallance et al., 2003]. Other factors may be responsible for early and severe 
mortality in C3H and FVB mice. Based on the studies presented in Chapters 2 and 3, we 
suggested that fatal C. rodentium infection in susceptible animals is caused by hypovolemia due 
to extensive diarrhea. 
 Consistent with that hypothesis, analysis of stool water content indicated significant 
diarrhea in C3H mice beginning as early as 3 DPI, but statistically significant from 6 DPI. The 
magnitude of diarrhea in this strain was comparable to levels reported in DRA-deficient mice 
used as a model of congenital chloride diarrhea [Schweinfest et al., 2006]. Moreover, the lack of 
well-formed feces in moribund FVB mice indicated development of remarkable diarrhea in this 
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strain as well, though making quantitative analysis of that parameter impossible. This finding 
suggests that both susceptible strains may suffer from severe dehydration induced by C. 
rodentium infection. Studying effects of fluid therapy in C3H mice would be helpful in clarifying 
the contribution of fluid loss to the disease outcome in that strain.  
 Colon weight was positively correlated with histological lesion scores, consistent with 
other reports using this parameter as a marker of intestinal pathology in C. rodentium infection 
[Deng et al., 2004; Ghaem-Maghami et al., 2001; Goncalves et al., 2001; Khan et al., 2006; 
Higgins et al., 1999; Mundy et al., 2003; Mundy et al., 2004; Nagai et al., 2005; Simmons et al., 
2003; Vallance et al., 2002a; Vallance et al., 2002b; Vallance et al., 2003]. Despite the fact that 
colon weight was higher in susceptible animals, the lesion grades were comparable between the 
strains. This is consistent with our hypothesis that susceptibility does not fully depend on degree 
of intestinal damage (Chapters 2 and 3). However, tissue collection day bias should be taken in 
account for that parameter as well. Thus, non-significant trend to develop more severe pathology 
in C3H mice could be much more profound if all the groups were compared at the same date. 
Therefore, contribution of epithelial damage to C. rodentium-induced diarrhea can not be 
excluded for C3H mice. Additional experiment studying the disease progression with the same 
end-point for all the strains (9 DPI) should be performed.   
 We next evaluated contribution of intestinal ion transport to distinct disease phenotypes 
in susceptible and resistant mice. To accomplish this, we measured the expression of genes 
predicted by microarray analysis (Chapter 3).  Transcriptional activity for the main candidates 
for susceptibility was comparable to our previous findings. In response to infection, CA I and CA 
IV were markedly downregulated, while Atp1b2 and Fosb were significantly upregulated in both 
susceptible FVB and C3H strains compared with SWR and C57BL/6 mice. This indicates the 
importance of FosB, Na+/K+-ATPase and carbonic anhydrases I and IV in regulating ion 
homeostasis and mediating susceptibility to C. rodentium infection. In addition, the decrease in 
Dra (Slc26a3) expression was remarkable in C3H mice and comparable to the levels in 
FVB/NTac mice in previous study (Chapter 3). However, decline in Dra message was milder in 
FVB/NJ mice and not different from the levels in the resistant SWR mice. These striking 
differences in Dra expression between current and previous study led us to think about other 
possible factors affecting gene expression. The most plausible cause for distinct gene behavior 
can be again different time point for tissue collection. To prove that, we compared side-by-side 
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C3H/HeOuJ and FVB/NTac mice which were euthanized at the same time point (9 DPI) in 
current and previous studies. This analysis revealed that expression of majority of genes, 
including Dra, Fosb, Atp1b2, Aqp8 and Slc5a8, was similar in C3H/HeOuJ and FVB/NTac mice 
(Figure 4 Supplemental 1). Furthermore, expression of TNFa, which increases with the time 
post-infection [Goncalves et al., 2001; Li et al., 2004; McBee and Schauer, unpublished results], 
was markedly higher in colons collected from SWR, SJL, and C57BL/6 mice at 14 DPI 
compared with tissues collected from Swiss Webster, FVB/NTac, and C3H/HeOuJ at 9 dpi. 
Therefore, the role of predicted genes in mediating fatal infectious diarrhea in FVB and C3H 
mice needs further evaluation. Conducting a study in which all test subjects are euthanized at a 
comparable time point would be critical. Nevertheless, the results strongly suggest the possibility 
of common pathogenic mechanism of C. rodentium-induced mortality in susceptible inbred 
strains of different origins. 
 SJL mice had slightly different phenotype than the rest of the resistant animals. 
Compared with susceptible and resistant inbred strains, SJL mice had intermediate expression of 
majority of the genes involved in intestinal ion transport. Moreover, unlike the rest of the groups, 
SJL mice had delayed clearance of infection and demonstrated profound splenomegaly and liver 
pathology despite comparable intestinal lesions. Although SJL mice are considered to be 
immunocompetent, they have high circulating levels of T cells, defective TCR-induced IL-4 and 
IgE production, elevated IL-12p40 expression by antigen presenting cells, and a high incidence 
of spontaneous B-cell type lymphomas [Alleva et al., 2001; Beutner et al., 1997; Festing, 1999; 
Tang et al., 1998;  Yoshimoto et al., 1995]. Considering these facts and the highest degree of 
relatedness between SWR and FVB/N mice [Taketo et al., 1991, Table 1-3], SWR may serve as 
better control strain for studying fatal infectious diarrhea in FVB mice. 
 While most of the expression changes were similar between C3H and FVB mice, 
overexpression of Adora2b was found in FVB mice only. This receptor is activated by 
adenosine, a secretagogue released by different types of immune cells, and mediates signals 
suggested to be implicated in diarrhea [Strohmeier et al., 1995]. Activated mast cells secrete  
adenosine and other inflammatory mediators, and their role in the pathogenesis of diarrhea has 
long been recognized [Barrett, 1991; Brandt et al., 2003; Crowe et al., 1997; Crowe and Perdue, 
1992;  Jakate et al., 2006; Marquardt et al., 1984; McDermott et al., 2003; Rijnierse et al., 2006]. 
We therefore quantified mast cells in colon tissue of inbred strains by toluidine staining. Notably, 
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FVB mice (both control and C. rodentium-inoculated) had remarkably higher counts compared 
with the rest of the groups. Similar colonic mastocytosis was found in OVA-challenged Balb/c 
mice, which serve as a model of oral allergen-induced diarrhea [Brandt et al., 2003]. Saline-
treated mice in this study did not develop diarrhea [Brandt et al., 2003] and had colonic counts of 
mast cells comparable to levels we found in SWR, SJL, C3H, and C57BL/6 mice. Infection was 
associated with the reduction in toluidine-positive cells in all mice, but significant in FVB strain 
only. Because the efficiency of toluidine blue staining is substantially reduced in degranulated 
mast cells [Bischoff et al., 1996], this result may be indicative of extensive mast cells activation. 
Therefore, despite being indispensable for C. rodentium clearance [Wei et al., 2005], abundant 
mast cells in colorectal areas of FVB mice can be activated during C. rodentium infection, and 
release adenosine and other secretagoges which will ultimately contribute to the development of 
fatal diarrhea in FVB mice. The discovery of enriched mast cell population in colorectal areas of 
FVB mice may have far-reaching implications. For example, recent reports indicate increased 
morbidity, mortality, and colitis development in mice co-infected with C. rodentium and 
helminth Heligomosomoides polygyrus [Chen et al., 2005]. Although this outcome was attributed 
to activation of dendritic cells and imbalanced Th1, Th2, and T regulatory cell responses [Chen 
et al., 2005; Chen et al., 2006], the increased susceptibility of mice coinfected with C. rodentium 
and H. polygyrus may also result from mastocytosis, which usually accompanies nematode 
parasites infections. Considering this and the high susceptibility of FVB mice to allergic diseases 
[Baker et al., 2000; Knoops et al., 2005; Whitehead et al., 2003], the role of mast cells in 
pathogenesis of fatal infectious diarrhea in FVB mice needs further investigation. 
 Another interesting observation from our study was the distinct response of FVB mice 
supplied from different vendors, which could be an additional factor responsible for differences 
found in gene expression between this and previous studies (Chapters 2 and 3). Thus, FVB/NJ 
mice had less morbidity but showed no difference in body weight loss. They also demonstrated 
longer latent period before the development of clinical signs (i.e. FVB/NTac mice had an earlier 
onset of disease), though mortality rate was not significantly different between the substrains. 
Notably, fatal disease was observed in both strains despite significantly lower increase in 
bacterial counts in FVB/NJ mice, which further supports our conclusion that high bacterial load 
is not required for development of mortality. At the same time, differences in bacterial load may 
at least partially account for lower lesion scores and delayed clinical disease found in FVB/NJ 
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mice. The reasons for those differences are unclear, but distinct microbial flora in animals 
supplied by different vendors would the possible factor. Also, genetic segregation and/or 
mutation can not be excluded. To examine the possibility that mastocytosis in the distal colon is 
unique feature of FVB/NJ mice, we stained the tissues from Swiss Webster and FVB/NTac mice 
with toluidine as well (Figure 4 Supplemental 2). As in current study, FVB/NTac mice had 
higher counts of mast cells prior to infection, which went down as infection progressed. 
However, the levels were comparable to those found in FVB/NJ mice and cannot explain the 
differences in fecal bacterial burden, latent period until appearance of clinical signs and 
mortality, and pathological lesions. 
 
 In conclusion, this study is the first report on C. rodentium infection in SWR and SJL 
mice, which were found to be resistant to disease. SWR mice will be more suitable as a control 
strain for studying C. rodentium induced fatal disease in FVB mice than random bred Swiss 
Webster mice because of their genetic uniformity. Our data indicate that susceptible animals die 
from severe dehydration due to pathogen-induced diarrhea. Solid evidence from our work 
suggests the existence of common pathologic mechanism in C. rodentium-infected C3H and 
FVB mice despite their different genetic background. To further confirm diarrhea-induced 
hypovolemia as the main cause of fatality in C3H mice, fluid therapy should be evaluated in 
those animals. Designing experiment in which all the tissues will be collected at the same time 
will help to exclude temporal changes in organ culturing, pathology, and gene expression profile.  
Our studies demonstrate that C. rodentium infection in FVB mice can be used for studying the 
mechanisms of infectious diarrhea. Potential involvement of mast cells and their mediators 
presents a new paradigm for high susceptibility in C. rodentium-infected FVB mice. 
 
4.4. Selected methods 
 Mouse infections. Specific pathogen free 10-week-old inbred FVB/NJ, SWR/J, SJL/J, 
C3H.HeOuJ, and C57BL/6J female mice (The Jackson Laboratory, Bar Harbor, Maine) were 
housed and maintained as described in Appendix 1: General methods. The numbers of mice 
within each experimental group are given in Table 4-1, and represent 2 independent experiments. 
Mice were inoculated by oral gavage with 100 µl of a bacterial culture grown overnight and 
concentrated 1:10 in 3% (w/v) sodium bicarbonate NaHCO3 (approximately 3-5 x 109 
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CFU/mouse as determined by plate counts on MacConkey lactose agar) or with 100 µl of sterile 
vehicle. Every three days, fecal shedding of C. rodentium was determined as described in 
Appendix 1. On the same days feces were collected for measuring water content as a marker for 
diarrhea. The animals were euthanized and necropsied as described in Appendix 1 at 14 DPI, or 
earlier if moribund. At necropsy, spleen, MLN, liver, colon and cecum were collected, cleaned of 
feces (in the case of the large intestine), weighed and plated or subjected for histopathological 
scoring. Tissue weight was expressed as a percentage of body weight. Small pieces of distal 
colon were also snap-frozen for subsequent RNA isolation and qRT-PCR analysis.  
 
 Detection of humoral response in serum. Titers against C. rodentium were determined 
on serum samples by ELISA, as recommended by manufacturer (http://www.bdbiosciences.com) 
ELISA Immulon II plates (Thermo Labsystems, Franklin, MA) were coated with C. rodentium 
diluted 1/20 in PBS. Coated plates were washed in PBS plus 0.5% Tween 20, blocked for 1 h in 
1% BSA in PBS, and washed before addition of serially diluted standards, namely mouse 
monoclonal purified IgG1, IgM (BD PharMingen, San Diego, CA), IgG2a (Southern 
Biotechnology Associates, Birmingham, AL), and standardized sera with 55 µg/ml mouse IgG2c 
(Bethyl Laboratories, Montgomery, TX), or unknowns. Plates were washed 3 times in PBS plus 
0.5% Tween 20. Ig isotypes were detected with biotin-conjugated rabbit anti-mouse IgM, IgG1, 
IgG2a (BD PharMingen), or goat anti-mouse IgG2c (Southern Biotechnology), incubated with 
extravidin peroxidase (Sigma, St. Louis, MO) and 2,2'-azinobis-(3-ethylbenzothiazoline-6-
sulfonic acid), diammonium salt (ABTS) substrate (Kirkegaard & Perry Laboratories, 
Gaithersburg, MD) for color development. Absorbance development at at OD450 was recorded by 
an ELISA plate reader (Dynatech MR7000, Dynatech Laboratories, Inc., Chantilly, VA) and 
quantity was determined against the standard curve for each plate.  
 
 Detection of water content in stool. Feces were weighed immediately after collection to 
define “wet weight” (WW). Following the incubation at 37ºC for 72 hours, feces were weighed 
to define “dry weight” (DW). The water content in stool was expressed as percentage of (WW-
DW)/WW.  
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 Histopathology. The 10% formalin-fixed and paraffin embedded tissues were processed 
as described in Appendix 1. H&E-stained colonic sections were scored for pathological lesions 
by veterinary pathologists (BHR, ABR) blinded to experimental groups. Inflammation, 
hyperplasia, dysplasia, edema and epithelial defects within intestinal tissue sections were graded 
on a scale of 0 to 4 as described in Appendix 1. The cumulative disease index was calculated as 
sum of all grades with 20 as a maximal possible score. 
 
 Mast cells detection. Formalin-fixed paraffin-embedded intestinal sections from 3 mice 
per group were stained with 0.1% toluidine blue. Mast cells appear as deep violet cells on a blue 
background. The positive cells in distal colon were counted in five to ten microscope fields 
(x200), averaged and expressed as number of cells per mm2.  
 
 Real-time quantitative RT-PCR. Total RNA was isolated as described in Appendix 1. 
The qRT-PCR was performed as described in Appendix 1 and Chapter 3 with predesigned ABI 
probe and primer sets (see Table 3-2). 
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4.5 Tables and Figures 
 
 
 
 
 
 
 
Table 4-1. Number of animals used in the experiments 
 
   
Mouse strain Uninfected Infected 
   
FVB/NJ  9   13a 
SWR/J  9 15 
SJL/J  9 15 
C3H/HeOuJ 6 10 
C57BL/6J  6 10 
   
 
a, two out of 15 FVB/NJ mice failed to become infected and have been excluded from the study.
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Figure 4-1. Survival of inbred mice in response to C. rodentium infection.  
Two strains demonstrated susceptible phenotype; 100% of C3H mice died in between 8 and 11 DPI, and 61.5% 
FVB mice died from 12 DPI. SWR, SJL, and C57BL/6 mice were resistant and showed 100% survival in two weeks 
post-inoculation (p<0.0001 by Logrank test). 
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Figure 4-2. C. rodentium effects on body weight in inbred strains. 
Severe clinical disease was observed in C3H mice that lost >25% of body weight by 9 DPI, and FVB mice that lost 
>15% of body weight by 12 DPI (p<0.0001 by two-way ANOVA). The changes in body weight in resistant SJL, 
SWR, and C57BL/6 mice fluctuated within +/-10% range and were not significant in Swiss mice.  
The weight loss was calculated as % of initial body weight in infected mice subtracted from control mice. Data 
presented as mean ± SEM.  
*, p<0.01 by Bonferroni posttest compared with the rest of the groups. 
#, p<0.05 by Bonferroni posttest compared with one, two or three groups. 
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Figure 4-3. Fecal bacterial shedding in inbred mice infected with C. rodentium. 
FVB mice, compared with other strains used in the study, demonstrated lower bacterial counts at 3 and 6 DPI 
(p<0.0001 by two-way ANOVA). SJL mice had lower bacterial load than in C3H mice at 3 DPI, but higher fecal 
counts compared with other groups at 12 DPI.  
Fecal bacterial counts in susceptible C3H mice were not different from those in resistant SWR and C57BL/6 mice. 
The limit of detection was 103 CFU/g feces. Data was log10 transformed and presented as mean ± SEM.  
*, p<0.01 by Bonferroni posttest compared with the rest of the groups. 
#, p<0.01 by Bonferroni posttest compared with one, two or three groups. 
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Figure 4-4. C. rodentium counts in tissues. 
The bacterial load in colon was highest in C3H mice, intermediate in SJL and FVB mice, and lowest in SWR, and 
C57BL/6 mice (p<0.0001 by one-way ANOVA). High colonization of cecum was comparable in all the strains. 
C3H mice demonstrated high bacterial counts in mesenteric lymph nodes (MLN) (p=0.0003 by one-way ANOVA). 
However dissemination of C. rodentium to spleen was rare in all the strains. The interpretation of these results is 
confounded by different end points; tissue were collected at 9-10 DPI from C3H mice, at 12-14 DPI from FVB 
mice, and at 14 DPI from the rest of the groups. 
The limit of detection was 103 CFU/g feces. Data was log10 transformed. Each dot represents one animal. Lines 
indicate mean of the group. Letters indicate significant differences as detected by post-hoc t test. 
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Figure 4-5. Development of humoral C. rodentium-specific response in Swiss mice. 
C. rodentium-specific IgM titers were detected by ELISA in all inbred strains by 12 DPI but not significantly 
different (p = 0.058 by ANOVA). The levels of IgG1 and IgG2 were higher in SWR mice at 12DPI (NS and p = 
0.02 by ANOVA, respectively). However, the IgG1 to IgG2 ratios were comparable between the groups.  
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Figure 4-6. Development of diarrhea in C. rodentium-infected animals. 
C3H mice demonstrated rapid increase in fecal water content by 9 DPI (p<0.0001 by two-way ANOVA). The stool 
water content was not analyzed in FVB mice due to lack of well-formed feces in majority of moribund animals, 
which indicated development of severe diarrhea in this strain. 
Data presented as mean ± SEM.  
*, p<0.05 by Bonferroni posttest compared with the rest of the groups. 
#, p<0.05 by Bonferroni posttest compared with SJL mice. 
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A.  
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Figure 4-7. Histopathology of distal colon in C. rodentium-infected inbred Swiss mice. 
Comparable lesions were observed in FVB/NJ (A), SJL/J (B), and SWR/J (C) mice at 13-14 dpi. 
H&E staining. Original magnification x100. 
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Figure 4-8. Colonic pathology in C. rodentium-infected inbred mice. 
No significant differences in intestinal pathology were found between the groups. 
Each dot represents one animal. Lines indicate group median. 
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Figure 4-9. Organ weight in inbred mice infected with C. rodentium. 
A. Colon weight, as a measure of intestinal pathology, was increased in all the infected animals, but to highest 
extent in C3H and FVB mice (p<0.0001 by one-way ANOVA).  
B. Significant splenomegaly was observed in infected SJL mice, mild splenomegaly was found in infected 
SWR and C57BL/6 mice, whereas no change in spleen weight was detected in C3H and FVB mice infected 
with C. rodentium  (p<0.0001 by one-way ANOVA). 
Data was calculated as % of body weight. Each dot represents one animal. Lines indicate group means. Letters 
indicate significant differences as detected by post-hoc t test. 
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Figure 4-10. Correlation of colon lesions with colon weight in C. rodentium-infected inbred mice. 
Positive association between colon weight and hyperplasia (A), inflammation (B), and cumulative disease score (C) 
in distal colon of infected mice was found by Spearman correlation test (r and p values are given). Each dot 
represents one animal. 
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Figure 4-11. Quantitative real-time PCR (TaqMan) analysis of genes involved in intestinal ion transport that were 
identified by microarray analysis (Chapter 3). 
The expression of genes was normalized to uninoculated FVB mice. Each dot represents one animal. Lines indicate 
group means. For genes with p<0.0001 by ANOVA, Tukey’s posttest was applied (statistically significant 
differences are indicated by letters). 
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Figure 4-12. Identification of mast cells in colon tissues from C. rodentium-infected mice by toluidine staining. 
Mast cells were frequently found in colorectal area in FVB mice, but rare in other inbred strains. The images show 
representative areas of distal colon in uninoculated FVB (A), SWR (B), and SJL (C, D) mice (toluidine-positive 
cells are indicated by arrows). Mast cells identified in rectal epidermis are shown as positive control (C). Original 
magnification 200x. 
The quantified levels of mast cells in each strain and condition are presented in panel E (p<0.0001by ANOVA). 
Each dot represents one animal. Lines indicate group means.  
*, p<0.001 by post-hoc t test compared with the rest of the groups. 
#, p<0.01 by post-hoc t test compared with uninoculated mice. 
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Figure 4-13. Comparison of C. rodentium infection in FVB mice supplied by different vendors. 
Mortality (A) and body weight loss (B) were comparable in FVB mice obtained from The Jackson Laboratories or 
from Taconic Laboratories. However, FVB/NTac demonstrated higher fecal bacterial counts at 3 and 6 DPI (C)     
(*, p<0.0001 by t test). 
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Figure 4-14. Comparison of C. rodentium induced-lesions in FVB mice supplied by different vendors. 
FVB/NTac developed more severe lesions in response to C. rodentium compared with FVB/NJ at 12 DPI (p<0.0005 
by Mann-Whitney test). Data from the FVB/NTac mice presented in Chapter 2 was used for comparison. 
Lines indicate group median. 
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Figure 4 Supplemental 1. Combined quantitative real-time PCR (TaqMan) analysis of gene expression from 
microarray study (Chapter 3) and Swiss study (Chapter 4). Tissues were collected at 9 DPI for Tac:SW, FVB/NTac, 
and C3H/HeOuJ mice, at 12-14 DPI for FVB/NJ mice, and at 14 DPI for SWR/J, SJL/J, and C57BL/6J mice. 
The expression of genes was normalized to uninoculated FVB mice. Each dot represents one animal. Lines indicate 
group means. Expression of Tnf-α was used as a control for temporal changes. 
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Figure 4 Supplemental 2. Identification of mast cells by toluidine staining in colon tissues from C. rodentium-
infected Swiss Webster and FVB/NTac mice (from Chapter 3). 
The number of mast cells in FVB/NTac was higher than in Swiss Webster mice (p<0.005 by ANOVA) and 
comparable to the levels in FVB/NJ mice (Figure 4-11).  
Each dot represents one animal. Lines indicate group means.  
*, p<0.001 by post-hoc t test compared with the rest of the groups. 
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Chapter 5:  Conclusions and future work 
 
  
 C. rodentium is the only known murine pathogen causing attaching and effacing (A/E) 
lesions. Because human A/E pathogens do not readily infect laboratory mice [Frankel et al., 
1996; Klapproth et al., 2005; Mundy et al., 2006], C. rodentium serves as the only murine model 
for human infections with pathogenic E. coli, EPEC and EHEC. Both pathogens are among the 
most important bacterial causes of acute diarrheal illness (ADI) worldwide. EPEC infection leads 
to the deaths of hundreds of thousands of children each year in developing countries, while 
EHEC, the causal agent of hemolytic uremic syndrome, is a growing health threat in North 
America and Europe, causing sporadic diarrheal outbreaks and deaths. For many years, studies 
elucidating the pathogenesis of C. rodentium have focused on signal transduction, host immune 
responses, and intestinal proliferation, neglecting the potential of this microorganism to affect 
intestinal ion homeostasis. Studies presented in this thesis strongly suggest that C. rodentium 
infection is able to disrupt ion transport in the distal colon leading to development of severe 
diarrhea, dehydration and fatal disease in affected animals. The discovery of susceptible and 
resistant lines of mice with very similar genetic backgrounds facilitated identification of host 
factors responsible for the outcome of the infection, thereby shedding important insight into the 
pathogenesis of C. rodentium. While the work described here was in the final stages, a few 
laboratories reported C. rodentium-induced disruption of tight junctions, mislocalization of 
aquaporins and interaction of bacterial effectors with host regulators of ion channels [Guttman et 
al., 2006a; Guttman et al., 2006b; Guttman et al., 2007; Ma et al., 2006; Simpson et al., 2006]. 
This indicates growing interest of researchers in diarrhea-inducing effects of C. rodentium. 
 
 In order to explore the role of the host factors in susceptibility to C. rodentium infection, 
the infection was examined in FVB mice, whose response to the pathogen was never 
characterized before. Inbred FVB mice belong to the same genealogic tree as Swiss Webster 
(SW) mice, well known for their resistance to C .rodentium. Investigating the infection in mice 
with similar genetic background will help to avoid “genetic polymorphism” bias in interpreting 
results. Our data show that adult FVB mice develop profound mortality and colitis when infected 
with C. rodentium, making it the second inbred strain (in addition to C3H mice) with extreme 
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susceptible to this pathogen. These results are especially important because FVB mice are widely 
used to create transgenic animals [Barthold, 2002]. Several studies characterizing this model 
suggested hypovolemia as the cause of death. We attempted to achieve amelioration of the 
disease by different methods (see Appendixes), but only preventive fluid therapy was successful. 
This is the first report demonstrating the protective effect of fluid therapy intervention in this 
animal model of diarrhea and intestinal ion imbalance. It remains to be determined if this 
approach will effectively prevent fatal disease in other C. rodentium-susceptible mice, such as 
young, immunodeficient animals and substrains of C3H mice. 
 
 To elucidate the genetic basis for high mortality of C. rodentium-infected FVB mice 
compared with cognate outbred animals, a microarray approach using full-genome Affymetrix 
DNA chips was applied. It has to be mentioned that although global genomic and proteomic 
responses of the host to EPEC were previously reported [de Grado et al., 2001; Hardwidge et al., 
2004; Zyrek et al., 2006], these studies were performed in cell lines, such as HeLa, Caco-2 and 
T84 cells, and cannot reproduce the full spectrum of the disease. Therefore, our study is the first 
report of global gene expression analysis of host response to infection with an A/E pathogen in 
vivo. This led to a discovery of important potential candidates for susceptibility to C. rodentium-
induced mortality. Strikingly, genes significantly different between the susceptible and resistant 
mice were more enriched for transporter activity than for immune response. Predicted by 
microarray analysis, misbalanced water and ion transport in infected colon of FVB mice was 
confirmed by serum electrolyte levels. This study extended our knowledge of C. rodentium 
pathogenesis and suggested that infected FVB mice can be used for modeling fatal diarrhea. 
 Future work should include validation of microarray results at the transcriptional level. 
Protein expression encoded by target genes should be verified by Western blotting and by 
immunohistochemical analysis. In addition, ex vivo techniques, i.e. Ussing chambers, and 
measuring electrolyte contents in stool, will be helpful in elucidating the relative impact of C. 
rodentium infection on certain intestinal ion transport pathways. For example, increased chloride 
content in stool may indicate that impairment of chloride absorption exceeds sodium transport 
disturbances, and vice versa.  
 Notably, many mice with ion transporter deficiencies, such as NHE2-/-, NHE3-/-, cHKA-/-, 
Aqp4-/- and Aqp8-/- mice [Bachmann et al., 2004; Meneton et al., 1998; Schultheis et al., 1998a; 
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Schultheis et al., 1998b; Wang et al., 2000; Yang et al., 2005], develop minimal if any diarrhea 
and no serum electrolyte abnormalities, suggesting the existence of compensatory mechanisms 
when only a single gene is deleted. In that regard, C. rodentium-induced cumulative changes in 
intestinal ion transporters and their regulators may represent a better model for studying 
pathogenesis of diarrhea and development of new remedies for this life-threatening condition. 
Nevertheless, ion transporter-deficient mice on the resistant C57BL/6 background can be used 
for biological validation of genes identified by expression profiling. For example, it can be 
determined if C. rodentium infection in these animals will result in greater susceptibility to 
disease. In addition, inhibitors of different targets, i.e. carbonic anhydrases and ion transporters, 
can be applied in resistant mice in order to increase their susceptibility. Moreover, a number of 
genes identified by microarray analysis are known to be regulated during postnatal development. 
In light of the high susceptibility of infants and young mice to infection-induced diarrhea, 
exploring the regulation of these genes in development may lead to the identification of new 
therapies for this fatal disease.  
 The discovery of genes potentially responsible for mortality in infected animals may also 
facilitate research on molecular pathogenic determinants of C. rodentium and other A/E bacteria. 
First, similar changes in gene expression need to be confirmed in primary intestinal cells or cell 
lines used in gastrointestinal in vitro studies upon encounter with the pathogen. Then, infecting 
the cells with a panel of bacterial mutants may be used to identify pathogen effectors mediating 
diarrheal responses in host. Such studies will also be helpful to find changes in signal 
transduction and protein expression that could be involved in severe diarrheal response but were 
not captured by our global gene expression analysis. 
 
 The effects of C. rodentium on additional inbred strains from Swiss genealogical tree 
were investigated. SWR and SJL strains, widely used in biomedical research, survived through 
C. rodentium infection and developed minimal if any clinical signs, demonstrating their 
resistance to the disease. Because SWR mice show high degree of relatedness to FVB mice 
[Taketo et al., 1991], they may serve as a good control strain in future studies exploring host 
susceptibility to C. rodentium.  
 Notably, our data demonstrated that C3H mice, the only other inbred strain highly 
susceptible to C. rodentium, develop remarkable diarrhea. Furthermore, using a panel of genes 
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identified by microarray analysis as contributing to susceptibility, we showed that expression 
changes in C3H mice were comparable to FVB mice. These results indicate that disturbances in 
intestinal ion transport contribute to the development of fatal diarrhea in both susceptible strains, 
FVB and C3H mice, and suggest the existence of common pathogenic mechanisms. These 
observations are in contrast to the hypothesis that disseminated infection causes mortality in C. 
rodentium-infected C3H mice [Vallance et al., 2003]. Future work is necessary to validate our 
theory. Treatment of C3H mice with fluid therapy may clarify the role of fluid and electrolyte 
homeostasis in susceptibility of that strain to C. rodentium infection.  
 Strikingly, susceptible FVB mice demonstrated unique responses to C. rodentium as well. 
High level of expression of Adora2b, the adenosine receptor in cells, was found in FVB mice but 
not in the rest of inbred and outbred mice tested in this thesis. Because adenosine is one of the 
mast cell mediators and because mastocytosis is a known factor implicated in inflammatory or 
allergen-associated diarrhea, we explored the possibility of mast cells association with the 
susceptibility to C. rodentium infection. We found remarkably higher number of mast cells in 
colorectal areas of FVB mice only, indicating that at least some aspects of C. rodentium-induced 
diarrhea can be different between susceptible C3H and FVB mice. This discovery opens a new 
direction in studying mechanisms of susceptibility of FVB mice to C. rodentium. Further 
characterization of this pathway should include evaluation the role of IgE, histamine and 
serotonin in infected FVB mice. Depletion of mast cells with neutralizing antibodies prior to 
infection will help to shed a light on the role of this immune compartment in fatal infectious 
diarrhea. 
 
 In a summary, ADI, which is a major problem worldwide today, is not well studied due 
to ethical issues of conducting research in humans and lack of appropriate small animal models. 
Although C. rodentium has been useful for studying hyperplasia, colitis, and host immune 
response for many years, alterations in transport have been overlooked or underappreciated. The 
expression profile analysis, serum electrolyte results, and fluid therapy intervention demonstrate 
the utility of C. rodentium infection in FVB mice as a good model for ADI. This work adds FVB 
mice to the short list of known susceptible inbred strains, but also presents a new paradigm for 
susceptibility to fatal infectious diarrhea. 
Appendix 1:  General Methods 
 
  
 
 Media, bacterial strains, and growth conditions. Lennox L broth (LB) and LB agar 
(Difco Laboratories, Detroit, Michigan) were used for routine cultivation of bacteria. 
MacConkey lactose agar (Difco) supplemented with 40 μg/ml kanamycin was used for bacterial 
detection in feces and tissues. Kanamycin resistant C. rodentium strain DBS120 (pCRP1::Tn5) 
[Schauer and Falkow, 1993b], was used for infections. 
 
 Mouse infections. Specific pathogen free mice obtained from Taconic Laboratories 
(Germantown, N.Y), The Jackson Laboratory (Bar Harbor, Maine) or bred within MIT animal 
facilities. Animals were housed in polycarbonate microisolator cages within a facility approved 
by the Association for Assessment and Accreditation of Laboratory Animal Care. Animals were 
housed in a barrier facility and were viral antibody-free for 11 murine viruses and negative for 
enteric Helicobacter spp., Salmonella spp., and Citrobacter rodentium, as well as endoparasites 
and ectoparasites. The animals were maintained on pelleted rodent diet (LabDiet, Purina Mills, 
Inc., Richmond, Indiana) and water ad libitum. All experiments were approved by the MIT 
Animal Care and Use Committee. Mice were inoculated by oral gavage with 100 µl of a bacterial 
culture grown overnight and concentrated 1:10 in LB broth or 3% (w/v) sodium bicarbonate 
NaHCO3 (approximately 3-5 x 109 CFU/mouse as determined by plate counts on MacConkey 
lactose agar). The control mice were inoculated with 100 µl of sterile vehicle. Mice were 
weighed prior to infection and body weight changes were calculated as a percent of initial body 
weight. Mice were checked daily for morbidity or signs of C. rodentium infections, such as coat 
ruffling, diarrhea, hunched posture, reluctance to move, and recumbancy. Animals with these 
signs were euthanized and necropsied prior to end-time point. At designated time points, fecal 
shedding of C. rodentium was determined by plating serial dilutions of feces from individual 
animals on MacConkey lactose agar supplemented with kanamycin. The lower limit of detection 
was 1 CFU/mg of feces.  
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 Necropsy and histopathology. Animals were euthanized with CO2 at different time 
points or when moribund. At necropsy, the entire colon and cecum of each mouse was collected 
aseptically and cleared of feces. The most distal 5 mm of the descending colon and the cecum 
were removed, homogenized in PBS and used for culturing bacteria by plating serial dilutions as 
described above. The rest of the tissues were snap-frozen in liquid nitrogen or fixed in neutral-
buffered formalin for 24-48 hours, processed routinely, paraffin embedded, sectioned at 5 μm, 
and stained with hematoxylin and eosin (H&E). Frozen tissues were used for immunofluorescent 
staining or for DNA/RNA isolations as described below. H&E-stained colonic sections were 
scored for pathological lesions by a veterinary pathologist blinded to experimental groups. The 
lesions were graded on a scale of 0 to 4 with ascending severity as previously described [Erdman 
et al., 2005; Luperchio et al., 2000], where 0 corresponded to none, 1 to minimal, 2 to mild, 3 to 
moderate, and 4 to severe. In some studies, the cumulative disease index was calculated. The 
detailed grading system is provided in Appendix 1 supplemental materials. 
 
 Real-time quantitative RT-PCR. Total RNA was prepared from frozen distal colon 
using Trizol reagent according to the recommendations of the manufacturer (Invitrogen, 
Carlsbad, CA). Five micrograms of total RNA were used to generate cDNA using SuperScriptII 
RT (Invitrogen) as recommended by manufacturer. One hundred ng of resultant cDNA was 
amplified in a 25 μl reaction volume with Applied Biosystems predesigned primers and probes 
(TaqMan Gene Expression Assays) in an ABI Prism Sequence Detection System 7700 (Applied 
Biosystem, Branchburg, New Jersey, USA) using standard TaqMan protocols. Transcript levels 
were normalized to the endogenous control glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), and expressed as fold change relative to averaged uninoculated FVB group, which 
were set at 1, using the Comparative Ct method [PE Applied Biosystems, User Bulletin no. 2]. 
Each reaction was carried out in duplicates.  
 
 Statistics. All data are presented as mean values + the standard error of mean (SEM) 
unless otherwise indicated. Statistical analyses were performed with either GraphPad PRISM 
version 4.0 (GraphPad Software, Inc., San Diego, CA) or JMP 5.0.1 software (SAS Institute Inc., 
Cary, NC). The survival Kaplan-Meier curves were analyzed by logrank test and χ2 analysis to 
determine median survival time. When two groups were compared, t test and Mann Whitney U 
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test were applied for parametric and nonparametric data, respectively. For more than 3 groups, 
statistical differences were determined by using nonparametric Kruskal-Wallis test followed by 
Dunn's Multiple Comparison Test or with one-way ANOVA followed by Student’s t-test or 
Tukey's Multiple Comparison Test. In some cases, differences were evaluated using two-way 
ANOVA test (for mouse group and time post-inoculation) followed by Bonferroni post-tests. 
Whenever Bartlett's test showed unequal variances, analysis of gene expression was performed 
on transformed data. A p value of < 0.05 was regarded as statistically significant. 
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A1. Supplemental protocols - Lower bowel lesion scoring criteria 
Inflammation 
0: Normal 
1: Multifocal aggregates of submucosal leukocytes 
2: Diffuse submucosal inflammatory infiltrates & edema 
3: Extension of inflammation into mucosa and/or muscularis; prominent lymphoid follicles 
4: Transmural inflammation 
 
Hyperplasia 
0: Normal 
1: ~1.5 X normal 
2: ~2 X; +/- mitotic figures 1/3 way up to surface 
3: ~3 X; +/- mitotic figures 1/2 way up to surface 
4: ~4X+; +/- mitotic figures >1/2 way up to surface 
Dysplasia/Neoplasia 
0: Normal 
1: Aberrant crypt foci, dysplasia characterized by epithelial cell pleomorphism, plump & 
attenuated forms, gland malformation with splitting, branching, and infolding 
2: Low-grade gastrointestinal intraepithelial neoplasia (GIN): polyploid hyperplasia/dysplasia, 
moderate dysplasia characterized by pleomorphism, early cellular & nuclear atypia, piling & 
infolding, occasional cystic dilation, bulging towards muscularis mucosae & projection into 
lumen, loss of normal glandular, mucous, or goblet cells  
3: Adenomatous and/or sessile hyperplasia/dysplasia; high-grade GIN or carcinoma in situ, 
marked dysplasia confined to mucosa, features as above but greater severity, frequent & 
sometimes bizarre mitoses 
3.5: Intramucosal carcinoma (extension of severely dysplastic regions into muscularis mucosae) 
4: Invasive carcinoma: Submucosal invasion (differentiate from herniation) or any demonstrated 
invasion into blood or lymphatic vessels, regional nodes, or other metastasis.  
 
Crypt atrophy/fibrosis 
0: Normal 
1: Scattered decreased crypts with thin fibrous connective tissue (CT) replacement (<10%) 
2: Multifocal prominent loss of crypts with up to 25% replacement by CT 
3: Markedly depleted crypts with loose fibrous CT comprising up to 50% of mucosa 
4: Severe loss of crypts with >50% fibrous CT comprising mucosa 
 
Epithelial defects 
0: None 
1: Focally dilated glands and/or attenuated surface epithelium, decreased goblet cells 
2: Focally extensive gland dilation and/or surface epithelial attenuation. Shallow surface erosions 
and/or marked epithelial sloughing & mucus (catarrhal enteritis) 
3: Erosions (mucosal necrosis terminating above muscularis mucosae) 
4: Ulceration (full-thickness mucosal necrosis extending into submucosa or deeper) 
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Appendix 2:  Effects of chronic infection with Helicobacter 
hepaticus on the progress of C. rodentium infection 
in FVB mice. 
 
  
 
 
 
 
Diana Borenshtein, Hilda Holcombe, Prashant R. Nambiar, David B. Schauer. 
 
  
Biological Engineering Division, Division of Comparative Medicine, Massachusetts Institute of 
Technology, Cambridge, MA, 02139. 
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A2.1 Introduction 
 The impact of the microbiota on C. rodentium infection has long been recognized 
[Bathold et al., 1977; Itoh et al., 1978; Itoh et al., 1979; Itoh et al., 1980]. Itoh and coworkers 
have shown that specific pathogen free DDD and CF1 mice rapidly succumb to infection 
compared with animals maintained conventionally [Itoh et al., 1979]. On the other hand, germ 
free mice of different inbred strains do not develop clinical disease and mortality despite having 
high bacterial burden and disseminated infection [Barthold et al., 1976; Itoh et al., 1978]. 
Antibiotics pretreatment [Luperchio and Schauer, 2001], as well as coinfections with helminths 
[Chen et al., 2005a; Chen et al., 2006], exacerbate TMCH, whereas probiotics administration 
ameliorates the disease in C. rodentium-infected mice [Chen et al., 2005b; D’Arienzo et al., 
2006; Johnson-Henry et al., 2005; Varcoe et al., 2003]. Results from our lab demonstrated 
attenuated response to C. rodentium in Rag2-/- mice with concurrent chronic H. hepaticus 
infection [Holcombe and Schauer, unpublished data]. We therefore tested the hypothesis that 
FVB mice infected with both H. hepaticus and C. rodentium will have ameliorated disease 
outcome. 
 
A2.2 Results 
 All mice inoculated with H. hepaticus at 5-week old age, were positive by PCR at 5 WPI 
(data not shown). H. hepaticus infection did not have any effects on mortality, growth rate and 
intestinal pathology in FVB mice and were undistinguishable from uninoculated mice (Figures 
A2-1 and A2-3). No gender effect was found in any experimental group (data not shown). 
 Consistent with our previous results (Chapters 2, 3, and 4), FVB mice infected with C. 
rodentium developed high mortality (p<0.0001 by Logrank test compared to uninfected animals; 
Figure A2-1A). The latent period was longer in mice infected with both C. rodentium and H. 
hepaticus (median survival 13.5 versus 16 days in single- compared to double-infected mice). 
However, the difference did not reach statistical significance. Both C. rodentium-infected groups 
lost weight compared with uninoculated animals (p<0.0001 by two-way ANOVA; Figure A2-
1B), but the response was delayed in double-infected mice at 13 DPI (p<0.01 by Bonferroni 
post-test). 
 The increase in fecal C. rodentium counts was faster in single infected mice, though did 
not reach statistical significance (Figure A2-2A). On the other hand, delayed C. rodentium 
 155
clearance in double-infected mice was observed at 16 DPI (p<0.05 by t test). Higher C. 
rodentium levels were found in tissues obtained from double-infected animals at 16 DPI, though 
statistically significant in cecum and spleen only (p<0.05 by t test; Figure A2-2B). 
 Mice infected with C. rodentium developed remarkable pathology in distal colon at 16 
DPI (p<0.0001 by Kruskal-Wallis test, Figure A2-3) independent of H. hepaticus-infection 
status. 
  
A2.3 Discussion 
 Our results indicate that, although chronic infection of mice with H. hepaticus resulted in 
increase latency in appearance of clinical signs and mortality, it did not prevent high 
susceptibility and development of colonic lesions in FVB mice infected with C. rodentium. The 
attenuation of clinical disease, as well as delayed clearance of C .rodentium from feces and 
tissues at 16 DPI, can be explained by slower increase in C. rodentium colonization of FVB mice 
preinfected with H. hepaticus. This may indicate reprogramming of immune response in double-
infected animals, though needs further evaluation. However, due to high mortality in FVB mice 
infected with C. rodentium the experiments had to be terminated and no further characterization 
was performed. 
 
A2.4 Experimental Design 
 Five-week old 20 male and 20 female FVB/NTac mice were inoculated with 
Helicobacter hepaticus as previously described [Young et al. 2004]. H. hepaticus was harvested 
after 48 h of growth on agar plates and resuspended in a small volume of tryptic soy broth. The 
optical density at 600 nm of the inoculum was measured, and 10-fold serial dilutions of the 
inoculum were plated to quantify the CFU used for infection. Mice were inoculated with a 
suspension of bacteria with an optical density of 1.0 at 600 nm ( 108 CFU) in a volume of 0.2 ml. 
Bacteria were introduced directly into the stomach with a 24-gauge ball-tipped gavage needle. 
Mice were challenged with a total of three doses of bacteria on three alternating days. Control 
mice were inoculated with sterile tryptic soy broth.  
 The H. hepaticus infection was confirmed five weeks thereafter by PCR amplification of 
DNA isolated from fecal pellets using Qiagen DNA kit as recommended by manufacturer. PCR 
amplification was performed using the Helicobacter-specific primers 5'-ACT TCA CCC CAG 
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TCG CTG-3' (C05) and 5'-GCT ATG ACG GGT ATC C-3' (C97), which produce a 1200-bp 
amplicon [Fox et al., 1998]. H. hepaticus and water was used as positive and negative controls 
for PCR reactions respectively. PCR was performed with 5 µl of the template at approximately 
250 ng/µl. Each 25-µl PCR mixture contained 20 pmol of each primer, a 200 µM concentration 
of each deoxynucleoside triphosphate, and 1.5 U of Taq DNA polymerase in a solution of 10 
mM Tris-HCl, 50 mM KCl, and 1.5 mM MgCl2 (final concentrations; Ready To Go PCR beads; 
Amersham Pharmacia Biotech, Piscataway, N.J.). Cycling conditions included 30 cycles of 
denaturation at 94°C for 1 minute, annealing at 55°C for 2½ minutes, and elongation at 72°C for 
3 minutes. PCR products were visualized by agarose gel electrophoresis.  
 At 6 weeks post H. hepaticus infection, half of each H. hepaticus-negative or –positive 
groups were infected with ~109 CFU of o/n culture of DBS120, resulting in 4 groups of n = 10 (5 
of each gender) mice used in the study. Animal monitoring, necropsy and samples collection was 
done as described in Appendix 1: General Methods.  
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Figure A2-1. C. rodentium infection with or without concurrent infection with H. hepaticus. 
A. C. rodentium infection resulted in high mortality rate in FVB mice regardless of H. hepaticus infection 
status (p<0.0001 by Logrank test). Although median survival was higher in mice infected with both 
pathogens, the difference did not reach statistical significance. 
B. The decrease in body weight was delayed in mice infected with C. rodentium and H. hepaticus at 13 DPI. 
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Figure A2-2. C. rodentium recovery from tissues. 
A. Changes in fecal bacterial shedding were affected by concurrent H. hepaticus infection (p<0.05 by t test). 
B. Recovery of C. rodentium was higher in cecum and spleen of double-infected mice at 16 DPI (p<0.05 by t 
test). 
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Figure A2-3. Histopathology in C. rodentium-infected mice with or without concurrent infection with H. hepaticus. 
C. rodentium infection was associated with the development of moderate to severe inflammation and hyperplasia, 
and mild to moderate dysplasia (p<0.0001 by Kruskal-Wallis test). Chronic infection with H. hepaticus did not 
affect the histopathology in C. rodentium-infected FVB mice. Lines indicate group median. 
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Appendix 3:  Effects of dietary intervention with anti-
inflammatory triterpenoids on the progress of C. 
rodentium infection in FVB mice. 
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A3.1 Introduction 
 
 Synthetic triterpenoids, the most known of which is 2-cyano-3,12-dioxooleana-1,9-dien-
28-oic acid (CDDO), are steroid-like analogs of oleanolic or ursolic acid with potent 
antiproliferative, differentiating, and anti-inflammatory activities [Dinkova-Kostova et al., 2005; 
Liby et al.,2005; Minns et al., 2004; Place et al., 2003; Suh et al.,1998] (Figure A3-1). They were 
shown to inhibit proliferation and induce apoptosis at nanomolar concentrations. These 
compounds also suppress oxidative stress in vitro and in vivo mainly by effecting NO production 
and iNOS and COX-2 expression. The exact mechanism is unknown, but the involvement of 
transcription factor Nrf2 regulating expression of a number of antioxidant and detoxification 
proteins has been exhibited. The protection was associated with increased expression of the 
cytoprotective heme oxygenase-1 (HO-1) enzyme and decrease in NF-kB [Dinkova-Kostova et 
al., 2005; Liby et al., 2005; Suh et al., 1998]. Furthermore, CDDO suppresses development of 
ileitis in Toxoplasma gondii-infected mice in TGF-β-dependent manner [Minns et al., 2004].  
 The profound inflammation observed in FVB mice infected with C. rodentium prompted 
us to seek for interventions allowing FVB mice to resist deleterious effects of infection. We, 
therefore, supplemented FVB mice with dietary triterpenoids ethyl 2-carboxy-3,12-dioxooleana-
1,9(11)-dien-28-oate (NSC #D722320, TP-222). TP-222 (Figure A3-1) is a derivative of CDDO 
synthesized in laboratory of Dr. Michael B. Sporn from Darmouth Medical School to overcome 
pharmacokinetic limitations (low bioavailability) of CDDO in vivo. TP-222 has shown a 
promising in vivo activity [Sporn, personal communication]. 
 
A3.2 Results 
  
 Administration of TP-222 in diet did not ameliorate C. rodentium-induced disease in 
FVB mice; infected mice fed TP-222 exhibited higher mortality (p<0.05 by Logrank test) and 
more severe weight loss (p<0.01 by two-way ANOVA) (Figure A3-2). Moreover, substantial 
weight loss was observed in uninoculated TP-222-administrated mice.   
 Administration of triterpenoids was associated with delayed clearance of infection and 
high translocation of C. rodentium to spleen, whereas none of the infected animals on control 
diet had spleen bacterial counts (Figure A3-3). 
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Majority of histopathological parameters were comparable between the infected groups 
on different dietary regimes. Tendency to higher ulceration and submucosal lesions, as well as 
colonica dysplasia, in TP-222-fed infected FVB mice was not statistically significant (Figure A3-
4). 
 
A3.3 Discussion 
 
Opposite to the expected, no benefits to the TP-222 containing diet were observed. The 
weight loss in TP-222-fed C. rodentium- infected mice happened faster and was more severe 
than in mice on the control diet, leading to a forced termination of the experiment after 12 dpi. 
Tendency to marked ulceration, submucosal lesions and higher dysplasia, though not statistically 
significant, correlated with more severe disease outcome in infected mice treated with 
triterpenoids. Furthermore, the uninfected mice on the TP-222 diet also lost the weight during the 
first week. This is consistent with few animal studies, in which toxicity associated with 
triterpenoids administration was characterized by weight loss [Hyer et al., 2005; Place et al., 
2003; Yates et al., 2006]. In those studies, the use of the drug despite toxicity was approved due 
to significant efficacy in lowering tumor burden [Place et al., 2003; Yates et al., 2006]. Although 
in some cases, the weight loss was transient and mice recovered after 1 to 2 weeks from the 
beginning of triterpenoid treatment [Hyer et al., 2005], weight loss early during C. rodentium 
infection can be detrimental in FVB mice. It is not clear why FVB mice on triterpenoid diet are 
more susceptible to the effect of the pathogen. However, one possible explanation may be a 
sustained and disseminated infection characterized by higher bacterial counts in feces and spleen 
of TP-222-fed animals. In addition, CDDO injected in high-doses to mice was associated with 
swelling of the small bowel [Minns et al., 2004]. Although the exact mechanism of such an 
effect was not addressed, it may indicate changes in intestinal ion and fluid transport and 
resultant diarrhea. This could further exacerbate C. rodentium-induced effects in FVB mice. 
Since the main goal (attenuation of C. rodentium infection in FVB mice) was not achieved, 
further mechanistic characterization of the observed effects of dietary triterpenoids was not 
pursued.  
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A3.4 Experimental Design 
 
 Thirty 10-week-old female FVB/NTac mice were divided randomly into the following 
groups: mice on control diet inoculated with 0.1 ml bicarbonate (control, n=5); mice on TP-222 
diet inoculated with 0.1 ml bicarbonate (TP-222 alone, n=5); mice on control diet inoculated 
with 109 CFU DBS120 (C. rodentium alone, n=10); and mice on TP-222 diet inoculated with 109 
CFU DBS120 (C. rodentium + TP-222, n=10). The concentration of TP-222 in diet was 800 
mg/kg. Considering and averaged food consumption of 4 g/d in mice, the daily dose of 
triterpenoids was ~3.2 mg/d. Animal maintenance, necropsies and sample collection was 
performed as described in Appendix 1: General Methods. 
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A3.5 Figures 
 
 
 
 
 
 
TP-222 
 
 
Figure A3-1. Structure of natural (OA) and synthetic (CDDO aka TP-151 and TP-222) triterpenoids.  
Adapted from [Dinkova-Kostova et al., 2005; Suh et al.,1998] 
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Figure A3-2. Dietary administration of triterpenoids augments C. rodentium-induced disease in FVB mice. 
A. Development of higher mortality in infected mice supplemented with TP-222 (p<0.05 by Logrank test). 
B. TP-222 treated animals had retarded growth rate with or without C. rodentium administration (p<0.01 by 
two-way ANOVA with Bonferroni post-test). 
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Figure A3-3. Impairment of C. rodentium infection in FVB mice treated with triterpenoids. 
A. Delayed bacterial clearance in infected mice supplemented with dietary triterpenoids (p<0.05 by t test). 
B. Increased bacterial translocation to extraintestinal tissues, i.e. spleen, in mice supplemented with TP-222 
(p<0.005 by t test). 
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Figure A3-4. Pathology in C. rodentium-infected FVB mice supplemented with or without dietary triterpenoids. 
No significant differences were observed between the groups as indicated by Kruskal-Wallis test. Lines indicate 
group median. 
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Appendix 4:  Evaluation of genomic instability in C. rodentium-
infected FVB mice. 
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A4.1 Introduction 
 As discussed in the Chapter 1: Introduction, C. rodentium exhibit pro-carcenogenic 
potential and can promote tumor formation in ApcMin/+ mice or DMH-treated animals [Barthold 
and Beck, 1980; Barthold and Jonas, 1977; Newman et al., 2001]. Alterations in β-catenin 
pathway [Sellin et al., 2001] and 8-fold increase in mutation rate [Sohn, 2005] in distal colon of 
affected mice can contribute to this process. There is growing evidence that genomic instability 
(GI) plays an important role in development of human colorectal cancers (CRCs). The two main 
types of genomic abnormalitites in CRCs are chromosomal instability (CIN) and microsatellite 
instability (MSI), accounting for 85 and 15% of sporadic CRCs, respectively [Itzkowitz and Yio, 
2004; Lengauer et al., 1998; Lindblom, 2001]. Chromosomal instability, the predominant form, 
causes abnormal segregation of chromosomes and abnormal DNA content (aneuploidy). As a 
consequence, loss of heterozygosity (LOH) may result in loss of function of key tumor 
suppressor genes such as adenomatous polyposis coli (APC) and p53. CIN considered to be an 
early event during carcinogenesis and mainly affects distal colon [Ilyas et al., 1999; Lengauer et 
al., 1997; Nowak et al., 2002; Shih et al., 2001]. The second form of GI is microsatellite 
instability (MSI) which is commonly found in hereditary non-polyposis colorectal cancer 
(HNPCC) but rare (~15%) in sporadic CRCs. MSI arises from the progressive accumulation of 
somatic alterations in the length of simple repeat nucleotide sequences known as microsatellites. 
MSI is characterized by diploidy and normal rate of chromosomal change, mainly affects 
proximal colon and is a marker for underlying DNA mismatch repair defects [Itzkowitz and Yio, 
2004;  Lengauer et al., 1998; Lindblom, 2001]. As was shown in Chapter 2, FVB mice infected 
with C. rodentium developed marked dysplasia. We, therefore, were interested in studying 
genetic instability in these animals. 
  
A4.2 Results 
Chromosomal instability was examined by unequal DNA segregation determined with 
Feulgen microdensitometry. Feulgen densitometry is in situ method, based on the reactions of 
free aldehyde groups in DNA molecule (released by strong acid) with aromatic amines, which 
results in development of color in a direct proportion to the amount of present DNA [Hardie et 
al., 2002]. Such an approach allowed us to localize and characterize the nature of the 
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chromosomal instability events in each individual crypt from the C. rodentium-infected whole 
tissue specimen.  
Dividing cell in uninoculated mice were confined, as expected, to the lower part of the 
crypt, and spread though the whole crypt in infected animals. To analyze chromosomal 
instability, we assumed that variability in DNA content of daughter nuclei in anaphase/telophase 
cells within the 5% variation range means equal DNA segregation. More than 5% variation 
indicates unequal DNA segregation. Both infected and uninfected mice had mitoses with unequal 
DNA segregation, but the nature of it was different between experimental groups. Thus, unequal 
DNA segregation was observed at the bottom of normal crypts (Figure A4-1a), but was found 
along most of the axis in hyperpalstic crypts (Figure A4-1d,e). In many cases, mitoses in infected 
colons were characterized by non-disjunction of the daughter chromosomes (Figure A4-1b,c) and 
few apoptotic cells were found in the bottom of hyperplastic crypts (data not shown). Although 
the absolute number of mitoses with unequal DNA segregation was higher in colon from infected 
mice, the fractions were comparable between the groups and comprised of 24.0 + 0.6 % in 
uninoculated FVB mice and 25.0 + 0.7 % in C. rodentium-infected animals (p>0.05).  
The accepted cell positional scoring technique (Figure A4-2A, [Renehan et al., 2002]) 
which relies on well-oriented crypts lined by monolayer of epithelium, was no longer appropriate 
in whole tissue specimen (Figure A4-2B). We, therefore, developed a new system for crypt cell 
positional analysis by dividing the crypt into layers assuming binomial division of cells (Figure 
A4-2C). In that schematic representation, first few layers (A through D) build the bottom part of 
the crypt and layer E represent the rest of the cells in the crypt. Consistent with that system of 
scoring, approximately 250 cells were found to populate the normal crypts (layers A through E), 
which is in agreement with reports by others [Booth and Potten 2000], and approximately 500 
cells were counted in hyperplastic crypts (layers A through F). Using this scoring method, we 
were able to find the differences in positional distribution of unequally segregated DNA between 
the experimental groups. Thus, in control animals proliferating cells residing in levels B through 
D displayed unequal DNA segregation (Figure A4-3, upper panel). The variability in DNA 
content between the daughter nuclei was not high achieving maximum of 12% difference (Figure 
A4-3, lower panel). In infected animals, on the other hand, mitotic cells with unequal DNA 
segregation were observed in levels A through E, with the highest fraction (73%) found in the 
very bottom of hyperplastic crypts. Furthermore, cells proliferating in levels A and B had high 
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levels of divergence in DNA content up to 40-60% difference between daughter nuclei (Figure 
A4-3).  
 
Microsatellites are short, tandemly repeated DNA sequences from 1 to 6 base pairs in 
length, distributed throughout genome. One mononucleotide and five dinucleotide repeats, 
previously associated with murine colonic tumors [Guda et al., 2004; Kohonen-Corish et al., 
2002; Lipkin et al., 2000; Sohn et al., 2001] (Table A4-1) were used for detection of 
microsatellite instability (Table A4-1). MSI, defined as change in length of microsatellite allele 
due to either insertion or deletion of repeating units, was analyzed by fluorescence polymerase 
chain reaction on DNA isolated from mouse tissues (Figure A4-4). Distal and proximal colons 
were compared with liver samples as non-target tissue representing negative control. Allelic size 
variations were not detected in any of those markers in tissues from C. rodentium-infected FVB 
mice. 
  
A4.3 Discussion 
In this experiment we aimed to characterize genomic changes in mouse colon as potential 
mechanism for tumor promotion by murine pathogen C. rodentium. Because genomic instability 
can developed by two independent mechanisms, we examined both chromosomal and 
microsatellite instability in colon from untreated or C. rodentium-infected FVB mice.  
 To evaluate changes at the chromosomal level, we applied Feulgen densitometry in 
whole colonic tissues. The proliferating cells in normal mouse colon were confounded to the 
lower parts of the crypt, consistent with the current concepts on epithelial proliferation in normal 
intestine [Booth and Potten 2000; Renehan et al., 2002]. Surprisingly, approximately 25% of 
those cells exhibited unequal DNA segregation, though the differences in DNA content between 
daughter nuclei were not drastic (up to 12%). Interestingly, none of the dividing cells at the very 
bottom of the crypt (layer A) displayed that feature, indicating preservation of DNA content 
within this population of cells. The nature of those observations is not clear. Considering 
accepted hypotheses on stem cell hierarchy of the intestinal crypt [Booth and Potten 2000; 
Renehan et al., 2002], we can speculate that proliferating cells in the level A represent actual 
stem cells, whereas the portion of dividing cells in the rest of the layers in normal colon (B 
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through D) represents clonogenic stem cells, in which unequal DNA segregation is part of 
differentiation process.   
Analysis of anaphase/telophase cells in distal colons revealed changes in positional 
distribution and regional alterations of chromosomal instability in colonic crypts of infected 
animals. C. rodentium-infected mice displayed remarkable increase in fraction of dividing cells 
with DNA unequal segregation and higher aneuploidy in the basal levels of the hyperplastic 
crypts, where the stem cells reside [Booth and Potten 2000; Renehan et al., 2002]. Because C. 
rodentium infection is not sufficient for colon tumorigenesis (Chapter 2) but does exhibit co-
carcinogenic effects [Barthold and Beck, 1980; Barthold and Jonas, 1977; Newman et al., 2001], 
clonogenic, but not actual, stem cells may be potential target during infection. It is likely that 
massive lesions, such as epithelial hyperplasia, erosions, ulcers, loss of differentiation, in the 
infected colons induce regenerative responses that result in activation of clonogenic stem cells 
attempting to repopulate damaged crypt. Despite those novel observations, the overall rate of 
unequal DNA distribution during mitosis was similar in control and infected mice indicating the 
still existing steady state. This may explain the reversibility of dysplastic changes in FVB mice 
upon resolution of infection and inflammation in long-term studies (Chapter 2). One of the 
possible explanations could be removal of affected cells by apoptosis which was more frequently 
found in infected crypts and colocalized with chromosomal instability-exhibiting cells. These 
hypotheses require further evaluation and other karyotype analyses are needed to confirm CIN 
phenotype in colons from C. rodentium-infected FVB mice. 
Another type of genomic abnormalities addressed here is instability at the nucleotide 
level. MSI was found in few animal models of intestinal tumors, including colitis-associated 
tumors [Guda et al., 2004; Kohonen-Corish et al., 2002; Lipkin et al., 2000; Sohn et al., 2001]. 
However, many other reports failed to observe MSI [Edelmann et al., 1997; Engle et al., 1999; 
Qin et al., 2000; Song et al., 2000; Sturlan et al., 2001], consistent with the rare observation of 
MSI in sporadic CRCs in human [Itzkowitz and Yio, 2004; Lengauer et al., 1998; Lindblom, 
2001]. Allelic size variations were not detected in any of the analyzed MSI markers in proximal 
or distal colon of C. rodentium-infected FVB mice. Although possibility of microsatellite 
instability in other genomic markers cannot be excluded, out results suggest that C. rodentium 
infection does not induce widespread MSI, at least in those fragments frequently found in murine 
colonic tumors. 
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Because we saw an evidence of chromosomal abnormalities in C. rodentium-affected 
tissues, and due to existence of inverse relationship between CIN and MSI [Lengauer et al., 
1998], CIN can be considered as more dominant effect in colon of FVB mice infected with the 
pathogen. However these changes are not sufficient for development of colon tumor in C. 
rodentium-infected mice and other factors, such as chemical initiation or chronic inflammation 
may be required. 
 
A4.4 Experimental Design 
FVB mice infected with C. rodentium for 12 DPI from Chapter 2 were subjected to GI analysis.  
 
 Analysis of genomic instability (aneuploidy). Distal colons were cleaned from feces 
and longitudinally dissected into halves. One half was fixed in neutral-buffered formalin and 
used for histopathological analysis (Chapter 2) or MSI analysis (see below). The other half was 
cut into 2 mm pieces, fixed in freshly prepared 4°C Carnoy's fixative and processed for Feulgen 
staining of DNA as described elsewhere [Gostjeva et al., 2006]. The DNA content of nuclei in 
anaphase-telophase cells was detected by KS-400 Image Analysis System (version 3.0; Carl 
Zeiss Jena GmbH, Jena, Germany). More than 5% difference in DNA content between the 
daughter nuclei was considered as unequal DNA segregation (aneuploidy). 
 
 Microsatellite instability analysis. DNA was isolated from formalin-fixed paraffin-
embedded tissue samples (liver, proximal colon, and distal colon) using QIAamp DNA kit 
(Qiagen) as recommended by manufacturer. Fluorigenic PCR amplification was performed using 
microsatellite primer sets as indicated in table A4-1. Primer sequences for 5 dinucleotide markers 
were obtained from the Whitehead Institute for Genome Research database (Cambridge, MA) 
and sequence for mononucleotide uPAR marker was as in ref. [Kohonen-Corish et al., 2002]. 
One primer from each primer pair was synthesized with a 5’ fluorescent tag (HEX, 6-FAM, or 
TET). PCR was performed with 1 µl of the template at 25 to 100 ng/µl concentration. Each 25-µl 
PCR mixture contained 20 pmol of each primer, a 200 µM concentration of each 
deoxynucleoside triphosphate, and 1.5 U of Taq DNA polymerase in a solution of 10 mM Tris-
HCl, 50 mM KCl, and 1.5 mM MgCl2 (final concentrations; Ready To Go PCR beads; 
Amersham Pharmacia Biotech, Piscataway, N.J.). Water was used as negative control. PCR 
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amplification was initiated by denaturation at 94ºC for 4 minutes, followed by 35 cycles of 94ºC 
for 30 seconds, 58ºC for 30 seconds, 72ºC for 30 seconds, with a final 5 minutes 72ºC extension 
step. PCR products were purified using QIAquick PCR purification Kit as recommended. The 
purified samples were pooled in 1:1:2 concentration for 6-Fam:Tet:Hex labeled PCR products. 
Two μl of pooled samples (duplicates) or water were mixed with 0.5 μl GS350-TAMRA 
standards (Northern Biotechnology) and 12 μl Hi Di Formamide (Applied Biosystems), 
denaturated at 95ºC for 5 min, immediately cooled and subjected to electrophoresis in ABI 310 
Sequencer. Default settings for GS POP4 polymer and matrix C virtual filter, except for 24 min 
of electrophoresis time, were used. The data was analyzed with GeneScan and Genotyper 
software. Colon samples were compared with liver samples as negative tissue control. 
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A4.5 Figures 
e  
Figure A4-1. Representative images from analysis of anaphase/telophase cells by Feulgen microdensitometry.  
Chromosomal instability observed in normal mouse colonic crypt (a) and in hyperplastic crypts 12 DPI (b-e). 
Unequal DNA segregation was observed only at the bottom of the crypts. Panels a and d show daughter nuclei 
dividing unequally (arrowed) and equally. The numbers represent integrated optical density (absorbance). Panels b 
and c represent examples of non-disjunction during segregation. Panel e shows an example of whole hyperplastic 
crypt with extension of proliferative zone, approximately 20 mitoses (arrowheads), and higher position of unequally 
dividing cells along the crypt axis.  While the absolute number of unequally dividing cells goes up in C. rodentium-
induced hyperplasia, the fraction of such cells in a crypt remains constant (see Figure A4-3). 
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A B
C  
Figure A4-2. Analysis of colonic crypts in whole tissue sections. 
Classical crypt cell positional analysis [A, from Renehan et al., 2002] in longitudinal section of an intestinal crypt 
illustrates how the position of events up the crypt axis can be determined (position 1 being at the crypt base). This 
method no longer valid in whole tissue sections which do not posses monolayer of epithelium lining the crypt (B). 
Therefore, we developed new method for analysis of spatial distribution of cells in a whole crypt (C) based on the 
binomial cell division. Normal crypts are divided into 5 areas (A through E), whereas hyperplastic crypts have 
additional layer of cells (F).  
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Figure A4-3. Effect of C. rodentium infection on chromosomal instability in distal colon of FVB mice. 
Positional distribution of dividing cells with unequal DNA segregation (upper panel). While the overall rate of 
chromosomal instability is similar in both groups, the higher fraction of unequal DNA segregation was observed in 
the basal levels of hyperplastic crypts. Hyperplasia was also characterized by a higher aneuploidy in the basal levels 
of the crypt than in controls (lower panel). The difference of less than 5% in DNA content of daughter nuclei of 
anaphase/telophase cells was considered as equal DNA segregation. Numbers in red indicate unequal DNA 
segregation in dividing cells. 
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Table A4-1. Primers used for fluorigenic PCR amplification of MSI markers 
 
    
MSI 
marker 
Primers Amplicon 
sizea, (bp) 
Referenceb 
    
d15mit93 F 
                R 
5’-HEX-AAG AAT TGG GGT GGG TAA GG-3’ 
5’-CAT GTG CAG AAT ACT TAC ACA TAT GC-3’ 
168-170 
Black (Yellow) 
Kohonen-Corish et 
al., 2002 
Guda et al., 2004 
d17mit72 F 
                R 
5’-GGC TTG GCG ACA TTC TAA TC-3’ 
5’-6-FAM-CAG CAA ATT AAC TTT CCC ATC A-3’ 
209-211 
Blue 
Kohonen-Corish et 
al., 2002 
Guda et al., 2004 
d19mit36 F 
                R 
5’-TET-ATA AGA CTT GAG GTT GAC CTC TGG-3’ 
5’-CTG TAA CAA TGG GAA CTG TAG GG-3’ 
192-194 
Green 
Sohn et al., 2001 
d7mit91 F 
              R 
5’-6-FAM-TCT TGC TTG CAT ACA CTC ACG-3’ 
5’-GAG ACA AAC CGC AGT CTC CT-3’ 
162-164 
Blue 
Sohn et al., 2001 
d10mit2 F 
              R 
5’- TET-CTG CTC ACA ACC CAT TCC TT-3’ 
5’-GTT CAT TTG AGG CAC AAG CA-3’ 
147-149 
Green 
Guda et al., 2004 
uPAR F 
          R 
5’-GCT CAT CTT CGT TCC CTG TC-3’ 
5’- HEX-CAT TCG GTG GAA AGC TCT GA-3’ 
101-103 
Black 
Kohonen-Corish et 
al., 2002 
    
 
a, amplicon size as detected for FVB mice in this study 
b, reference studies in which MSI marker was associated with the development of colorectal tumors in mice 
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A. 
 
 
B. 
 
Figure A4-4. Examples of size detection of fluorescently labeled PCR-amplified DNA from liver (A) and distal 
colon (B). Each true microsatellite peak is surrounded by stutter peaks of lower intensity with the appropriate delta 
(2 bases for dinucleotide repeats in this case) from the dominant peak. Peaks without stutter were considered to be 
non specific amplicons and were disregarded. Stutter peaks are considered a signature of amplification of a 
repetitive element lying within a forward and reverse primer set. DNA amplified with d15mit93 primers (Hex 
labeled) are shown in Black, d19mit36 primers (Tet labeled) in Green, and d17mit72 primers (6-Fam labeled) in 
Blue, and correspond to 168-170 bp, 192-194 bp, and 209-211 bp peaks, respectively. GS350 standards (TAMRA 
labeled) are shown in Red and have 13 ssDNA fragments from 50 to 350 nucleotides with 25 nt spacing. 
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Appendix 5:  C. rodentium infection in mice with abnormal DNA 
damage repair. 
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A5.1 Introduction 
 Bacterial interaction with epithelial cells may lead to the recruitment and activation of 
inflammatory cells, which in turn release potentially mutagenic products, such as nitric oxide 
(NO⋅) and hydroxyl radical (OH⋅) [Balkwill and Mantovani, 2001; Jaiswal et al., 2001]. These 
reactive species can directly damage DNA, leading to mutations, DNA strand breaks, and 
shortening of telomeres. Alkylated DNA bases are primarily recognized and repaired via the 
actions of two kinds of repair proteins; O6-methylguanine DNA methyltransferases and 3-
methyladenine (3MeA) DNA glycosylases. Methyltransferases, the main of which is encoded by 
MGMT in humans and Mgmt in mice, directly remove alkyl groups from O6-alkylguanines (and 
to a lesser extent from O4-alkylthymines), toxic lesions generated by most chemotherapeutic 
alkylating agents [Glassner et al., 1999]. 3MeA DNA glycosylase, encoded by AAG/MPG/ANPG 
in humans and Aag/Mpg/Anpg in mice, initiates the base excision repair pathway and serves as 
major DNA glycosylase for repair of 3MeA, hypoxanthine, and ethenoadenine ( A) DNA lesions 
[Engelward et al., 1996; Engelward et al., 1997]. Evidence from animal and human studies 
implicate the importance of both AAG and MGMT in colorectal carcinogenesis [Hofseth et al., 
2003; Jackson et al., 2003; Povey et al., 2002; Wali et al., 1999]. As an example, increased levels 
of lipid peroxidation-derived etheno-adducts εA, εG and εC are found in the DNA of chronically 
inflammed tissues, including from colitis patients [Bartsch and Nair, 2006]. UC is associated 
with increases in AAG and apurinic/apyrimidinic endonuclease activity [Hofseth et al., 2003]. 
Recent studies from our laboratories indicate increased susceptibility to colitis and facilitated 
tumorigenesis in dextran sodium sulfate (DSS)-treated Aag-/- mice [Green et al., submitted]. In 
addition, nitric oxide inhibits and inactivates O6-alkylguanine transferases, including O6-
methylguanine (O6-MeG) DNA methyl-transferase (MGMT), by the formation of S-
nitrosylcysteine adducts at the active site [Laval and Wink, 1994; Liu et al., 2002]. O6-MeG 
adducts due to deficient MGMT activity most frequently occur in the normal mucosa of the 
distal colon and rectum [Jass et al., 2002; Povey et al., 2002], as well as in DMH-induced tumors 
in mice [Jackson et al., 2003]. Accumulation of unrepaired DNA damage can result in mutations 
and lead to development of colon cancer.  
 Considering pro-inflammatory and co-carcinogenic potential of C. rodentium (discussed 
in Chapter 1: Introduction), we were interested in investigating the effects of C. rodentium 
infection in mice deficient for DNA damage repair, namely Aag-/- and Mgmt-/- mice. Both models 
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were developed in laboratory of Dr. Leona Samson, and showed normal phenotype when no 
treatment was applied [Engelward et al., 1996; Engelward et al., 1997; Glassner et al., 1999]. In 
addition, similar approach was applied in C57BL6-Tg(Aag) mice (shortly tg-AAG) 
overexpressing 3MeA glycosylase. 
 
A5.2 Results 
C. rodentium infection does not cause overt disease in Aag-/- and Mgmt-/- mice. 
 C. rodentium infection was typical in both genotypes lacking DNA repair enzymes. Thus, 
differences in body weight between the infected and uninfected mice were comparable among all 
genotypes (Figure A5-1A, and A5-3A). Likewise, alterations in fecal bacterial shedding were 
similar in wild type and knockout mice (Figure A5-1B, and A5-3B). Splenomegaly was observed 
in C57BL/6 mice at 14-18 dpi (Figure A5-1C, and A5-3C), and to a lesser extent in Aag-/- mice. 
The trend to higher spleen weight was not significant in Mgmt-/- mice at 14 DPI. By 29 DPI, 
spleen weight was comparable to that of wild type and uninfected animals. In accordance with 
those results, no difference in colonic pathology was observed between different genotypes 
(Figure A5-2, and A5-4).  
 
C. rodentium infection is attenuated in mice overexpressing Aag.  
 Based on the lack of obvious phenotype in C. rodentium-infected Aag-/- mice and 
reported association of increased AAG activity and protein levels with microsatellite instability 
in ulcerative colitis [Hofseth et al., 2003], we investigated the effects of the pathogen in mice 
overexpressing Aag. We proposed in the working hypothesis that transgenic mice will be 
sensitized to hyperproliferative effect of the C. rodentium. 
 Surprisingly, overexpression of Aag resulted in attenuated phenotype in infected mice. 
Thus, transgenic animals continued to grow whereas wild type mice had retarded growth rate in 
response to C. rodentium (Figure A5-5A). In addition, 3 out of 12 transgenic mice had very low 
fecal shedding at 4 dpi resulting in diminished increase in bacterial load compared with C57BL/6 
mice (Figure A5-5B). Consistent with that, increase in colon weight, used as a marker for 
pathology, was attenuated in transgenic mice (Figure A5-5C). Histological scoring confirmed 
trends to lower pathology, which were statistically significant for epithelial defects and 
cumulative pathology index (Figure A5-6). 
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 The results were confounded by contamination of mice from transgenic colony with 
Helicobacter spp (Figure A5-7), which could contribute to delayed infectivity as we showed in 
Appendix 2. Therefore, the attenuated phenotype of C. rodentium infection in tg-AAG mice 
cannot be truly attributed to overexpression of AAG. 
 
A5.3 Discussion 
 Our data indicate that mice lacking DNA damage repair system, like AAG and MGMT, 
have normal classical response to C. rodentium infection which is not different form that 
demonstrated by wild type animals. None of the groups developed considerable dysplasia, 
suggesting that C. rodentium does not posses co-carcinogenic potential in those models, possibly 
due to compensatory effect of other repair mechanisms. In this case, dual-knockouts of Aag and 
Mgmt with each other or other participants in DNA damage repair may have a different outcome 
in response to the pathogen. In addition, the acute nature of infection and associated colitis may 
also play a role. Thus, treatment with 5 cycles of DSS, used to model chemical-induced colitis, 
did not lead to tumor formation and substantial dysplasia in Aag-/- mice despite profound 
inflammation and epithelial damage in those animals [Green et al., submitted]. Only when longer 
administration of DSS was applied to promote augmentation of chronic colitis, tumor incidence 
has increased in Aag-deficient animals and the differences between the genotypes become more 
obvious. Moreover, single administration of DSS resulted in no phenotype in Aag-/- mice [Green, 
Meira, and Samson, unpublished results], consistent with our observations and suggesting that 
chronic inflammation is required for tumor promotion in that model. 
 The most interesting result was attenuated response to C. rodentium infection in mice 
overexpressing Aag. While amelioration in pathology can be explained by better regenerative 
capacity of transgenic mice, delayed infectivity and subclinical disease was unexpected in those 
animals. Further studies are needed to understand the mechanisms of such effects.  However, 
possible contribution of Helicobacter spp contamination to the observed phenotype should be 
considered and needs further clarification. In addition, studies in transgenic mice on susceptible 
background (FVB) will be helpful to clarify the role of AAG on susceptibility to C. rodentium 
infection. 
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A5.4 Experimental Design and selected Methods 
 Four to five-weeks-old Aag-/-, Mgmt-/-, C57BL6-Tg(Aag) and C57BL/6Tac or wild type 
littermates mice of both genders were inoculated with ~109 CFU of DBS120 and 0.1 ml LB or 
3% (w/v) sodium bicarbonate as described in Appendix 1: General Methods. Number of mice 
was n = 6-20 for wild type, n = 6-13 for Aag+/- mice, and n = 4-16 for Aag-/- mice and followed 
for 18 or 29 DPI. For Mgmt-/- study, n = 6-8 wild type and n = 4-6 knockout animals for 14 DPI 
were used. Mice were monitored daily for morbidity and necropsied by CO2 overdose at 
designated time points. Sample collection was processed routinely as described in Appendix 1. 
The animals were screened for the Helicobacter spp. contamination by amplification of isolated 
DNA with Helicobacter-specific primers C05 and C97 creating a 1.2kb PCR product (Appendix 
2, [Fox et al., 1998]). H. bilis and water were used as positive and negative controls for PCR 
reactions, respectively.  
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A5.5 Figures 
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Figure A5-1. C .rodentium infection in mice with Aag deficiency. 
A. Comparable clinical disease in wild type and Aag-/- deficient mice. 
B. Comparable fecal bacterial shedding (p<0.01 for Aag+/- mice at 29 DPI by two-way ANOVA followed with 
Bonferroni post-test). 
C. Splenomegaly was more significant in wild type animals at 18 DPI, but returned to normal levels at 29 DPI 
(p<0.05 by ANOVA and post-hoc t test). 
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Figure A5-2. Pathology in Aag-/- mice infected with C. rodentium. 
None of the histological parameters were different between the groups. Lines indicate group median.
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Figure A5-3. C. rodentium infection in mice Mgmt deficiency. 
A. Comparable clinical disease in wild type and Mgmt-/-deficient mice. 
B. Comparable fecal bacterial shedding. 
C. Splenomegaly was more significant in wild type animals than in Mgmt-/-deficient mice at 14 DPI (p<0.05 
by ANOVA and post-hoc t test). 
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Figure A5-4. Pathology in Mgmt-/- mice infected with C. rodentium. 
None of the histological parameters were different between the genotypes. Significant increases in inflammation, 
hyperplasia and piled epithelium in response to infection were observed in wild type group only (p<0.01 by Kruskal-
Wallis test followed by Dunn’s Multiple Comparison Test). 
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Figure A5-5. Mice overexpressing Aag are protected from deleterious effects of C. rodentium infection.  
A. Experimental inoculation of mice with C. rodentium impairs weight gain in wild type, but not transgenic 
animals beginning by 7 dpi (p<0.01 by two-way ANOVA followed by Bonferroni post-test). 
B. Increase in fecal bacterial shedding was delayed in 25% of transgenic mice resulting in attenuated response 
in Aag overexpressing animals (p<0.05 by Student’s t test).  
C. Infection resulted in significant increase in colon and spleen weights in wild type mice at 14 dpi. The 
increase in organ weight in infected tg-AAG mice was attenuated and reached statistical significance for 
colon weight only (p<0.01 by ANOVA and post-hoc t test). 
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Figure A5-6. Intestinal pathology in C. rodentium-infected mice overexpressing Aag. 
Although transgenic mice tended to develop less C. rodentium-induced pathology at 14 dpi, the statistical 
significance was reached for epithelial defects and cumulative disease score only  (p<0.01 by Kruskal-Wallis test 
followed by Dunn’s Multiple Comparison Test).
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Figure A5-7. Helicobacter spp. contamination of mice overexpressing Aag. 
All the transgenic animals were positive for Helicobacter spp as indicated by PCR.  
L,100 bp ladder; w, wild type mice; t, transgenic mice; -, negative control; +, positive control. 
 
 
 
Appendix 6: Abbreviations 
 
  
 
 ε  Etheno 
3MeA  3-methyladenine 
AAG, Aag alkyladenine glycosylase, 3-methyladenine DNA glycosylase (also known as MPG, N-
methylpurine-DNA glycosylase) 
ADI acute diarrheal illness 
A/E  attaching and effacing 
CD Crohn’s disease 
CFU  colony forming units 
DMH  1,2-dimethylhydrazine 
DPI , dpi days post-inoculation 
DSS   dextran sodium sulfate  
EHEC  enterohemorrhagic E. coli 
EPEC  enteropathogenic E. coli 
FVB FVB/N mice 
H&E  hemotoxylin and eosin 
IBD inflammatory bowel disease 
IFN interferon 
IL interleukin 
LB Lennox L broth 
LEE locus of enterocyte effacement 
MLN   mesenteric lymph nodes 
PBS phosphate buffered saline 
PCR   polymerase chain reaction 
qRT-PCR  quantitative real-time reverse-transcriptase polymerase chain reaction 
SEM  standard error of mean 
SW Swiss Webster mice 
tg-AAG C57BL/6-Tg(Aag) mice overexpressing AAG 
TMCH  transmissible murine colonic hyperplasia 
TNF tumor necrosis factor 
UC Ulcerative colitis 
WPI   weeks post-inoculation 
wt  wild type 
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